and Injury, Growth Cell Cellular Death Adaptations,

I. BASIC PRINCIPLES

A. stress in with it. on organ An placed physiologic the is homeostasis

B. can stress adaptations. an on change or in growth organ result decrease, in An increase,

II. AND HYPERPLASIA HYPERTROPHY

A. leads increase increase size. stress organ An in an to in

1. size of via (hypertrophy) the cells increase and/or number Occurs in (hyperplasia) the an

production organelles. and gene involves activation, protein B. Hypertrophy synthesis, of

stem of from C. cells new cells. Hyperplasia production the involves

generally uterus (e.g., occur D. together Hyperplasia and pregnancy). hypertrophy during

1.

make new muscle, cannot hypertrophy Permanent and cells however, nerve), undergo skeletal cardiac muscle, only. (e.g., tissues and

2.

not myocytes undergo hyperplasia, hypertension (Fig. For hypertrophy, in cardiac response systemic example, to 1.1).

dysplasia cancer. Pathologic hyperplasia progress (e.g., and, eventually, endometrial to E. can hyperplasia)

1. cancer. A not increase is hyperplasia (BPH), prostate for prostatic risk benign does which exception notable the

III. ATROPHY

A. supply) decreased organ hormonal A in to nutrients/blood decrease size stimulation, leads decrease or (e.g., stress a disuse, decreased in (atrophy).

1. the in via of size Occurs decrease and number a cells

B. via Decrease occurs apoptosis. number in cell

of C. ubiquitin-proteosome Decrease of size degradation occurs the autophagy in cell via components. cellular cytoskeleton and

1.

filaments destroyed ubiquitin ubiquitin-proteosome intermediate In by are of "tagged" degradation, and proteosomes. with the cytoskeleton

2.

of of vacuoles. cellular Autophagy involves autophagic generation components with breakdown fuse enzymes components. whose lysosomes These hydrolytic vacuoles cellular

IV. METAPLASIA

A. an in change on organ type a leads cell (metaplasia). to change A in stress

1.

one involves or of columnar, 2. surface change (squamous, to type of urothelial) Most epithelium commonly another

to are stress. cells Metaplastic handle the new able better

a example. esophagus classic Barrett is B.

pathoma.com 1.

Esophagus to epithelium lined normally friction a food by nonkeratinizing of is bolus). squamous (suited handle

2.

reflux metaplasia handle to the mucin-producing cells causes (better stress from stomach to of Acid able the columnar nonciliated, acid, Fig. 1.2).

cells, cell type. the ofstem which produce occurs reprogramming via Metaplasia C. then new

1.

the driving is stressor. removal reversible, Metaplasia of theory, with in

2.

treatment gastroesophageal Barrett example, may of reverse For esophagus. reflux

and progress D. metaplasia dysplasia Under eventually in can cancer. result to persistent stress,

1.

the of For esophagus. example, Barrett progress may esophagus adenocarcinoma to

2.

risk of for metaplasia apocrine increased which A is carries breast, exception cancer. notable no

result E. in deficiency metaplasia. A can also Vitamin

1.

differentiation epithelial eye. of such conjunctiva the necessary is surfaces covering A the specialized as Vitamin for

2.

metaplasia thin vitamin the squamous deficiency, keratinizing stratified into conjunctiva In A lining the of squamous epithelium. undergoes (Fig. change This is keratomalacia called 1.3).

undergo can metaplasia. F. also tissues Mesenchymal (connective)

1. A during to tissue ossificans in muscle after connective which trauma example bone is (Fig. myositis healing classic changes within 1.4).

V. DYSPLASIA

cellular growth A. Disordered

B. to cells precancerous refers proliferation of 1. often Most intraepithelial is and dysplasia For a (CIN) cervical neoplasia example, cancer. cervical to represents precursor

Often C. hyperplasia (e.g., metaplasia endometrial longstanding (e.g., esophagus) or hyperplasia) arises pathologic from Barrett

in theory, alleviation of inciting stress. is D. Dysplasia with reversible,

1. dysplasia progresses Ifstress to carcinoma persists, (irreversible).

VI. APLASIA AND HYPOPLASIA

during of failure production (e.g., Aplasia embryogenesis unilateral cell is genesis). A. renal a

syndrome). ovary (e.g., a cell during is in embryogenesis, resulting in streak production B. a organ small in Hypoplasia relatively Turner decrease

Fig. Left 1.1 ventricular hypertrophy. of Fig. (Courtesy esophagus. Barrett 1.2 ------Growth Injury, Adaptations, Cellular Aliya and Cell MD) Death Husa in,

I. BASIC PRINCIPLES

A. to when occurs ability injury Cellular exceeds a adapt. cell's the stress

B. likelihood of the The the of ofinjury its affected. cell type and stress, on type depends severity,

1.

relatively more injury; are highly Neurons muscle skeletal ischemic resistant. to susceptible is whereas,

2.

artery ischemia ischemia atrophy; artery (e.g., atherosclerosis) Slowly renal injury. results renal whereas, developing embolus) acute in results in (e.g.,

Common trauma, causes nutritional C. and or of inflammation, excess, deficiency hypoxia, injury mutations. include genetic cellular

II. HYPOXIA

A. to Low delivery 1. ofcellular important cause oxygen tissue; injury

of final phosphorylation. is electron chain electron in the transport oxidative the Oxygen acceptor

2.

oxygen impairs Decreased oxidative resulting in production. ATP phosphorylation, decreased

3.

to Lack injury. cellular leads ATP (essential of energy source)

B. of decreased include Causes 2-carrying ischemia, and hypoxemia, 0 hypoxia capacity blood. of

decreased blood C. through Ischemia an organ. is flow with 1. Arises

atherosclerosis) (e.g., arterial perfusion Decreased 2.

drainage Budd-Chiari 3. venous (e.g., Decreased syndrome)

90%). blood pressure partial Hypoxemia mm Hg, in 60 < Sao2 a D. (Pao2 low ofoxygen is the < Arises 1. with

2.

3.

pulmonary push 4. (e.g., the as 2 interstitial much able due to barrier defect-PAo2 Diffusion fibrosis) to diffusion thicker into 0 a not blood

mismatch-Blood shunt), problem, e.g., lung cannot reach right-to-left oxygenated e.g., air atelectasis). V/Q bypasses oxygenated blood problem, (ventilation (circulation or

Decreased dysfunction. capacity loss E. or -carrying hemoglobin 0 with arises (Hb)

1.

2.

Fig.1.3 Keratomalacia. Fig. (Courtesy of Ossificans. 1.4 Myositis normal; more from ii. permission CO oxygen-Pao2 i. avidly decreased orthopaedia.com) binds than with Sao2 (Reprinted hemoglobin motherchildnutrition.org) fires heaters. gas cars smoke and exhaust from or include from Exposures

iii. is appearance Classic finding skin. cherry-red of

iv. sign is death. headache; of exposure Early coma and to leads significant exposure

3. Methemoglobinemia i. Iron oxidized cannot in bind to normal; is 11. heme oxygen-Pao FeH, which oxidant sulfa or in nitrate and with drugs) newborns 111. Seen stress (e.g., with chocolate-colored Classic finding cyanosis is blood.

iv. which Treatment state. Fe3+ reduce back helps methylene is Fe2+ intravenous to blue,

III. IRREVERSIBLE INJURY REVERSIBLE CELLULAR AND

Hypoxia resulting oxidative A. impairs in phosphorylation decreased ATP.

B. 1. functions ATP disrupts including key Low cellular

2. resulting buildup sodium the pump, water in cell in Na+-K+ and

in the pump, 3. in the buildup of cell Ca2+ resulting cytosol Ca2+

switch anaerobic glycolysis, Aerobic a resulting in glycolysis. to denatures precipitates acid DNA. results proteins buildup low Lactic and in pH, which

reversible. The C. is phase of injury initial The swelling. hallmark reversible is of cellular injury

1.

microvilli blebbing. in membrane and results of loss swelling Cytosol

2.

the dissociation results protein and in rough reticulum of ribosomes (RER) synthesis. Swelling of endoplasmic decreased

damage Eventually, the irreversible. D. becomes of damage. irreversible The is hallmark injury membrane

1. (e.g., in Plasma ii. the enzymes Cytosolic membrane damage into leaking serum i. troponin) cardiac results 2. cell calcium Additional entering into the damage in results Mitochondrial membrane i. Loss (inner chain transport the mitochondrial electron ii. of membrane) (activates Cytochrome c cytosol leaking 3. into apoptosis) the in by calcium. in intracellular damage into which, membrane the Lysosome are activated leaking results turn, high hydrolytic cytosol, enzymes

cell The result irreversible end injury E. of is death.

Fig. necrosis Coagulative kidney. 1.5 of appearance. A, Gross appearance. Microscopic B, histology C, comparison. for kidney Normal Aliya Husain, Courtesy MD) of {A,

Death Growth Adaptations, and Cell Injury, Cellular

I. PRINCIPLES BASIC

A. (pyknosis), fragmentation The loss hallmark which nucleus, cell occurs and death is (karyorrhexis), of (karyolysis). nuclear via of condensation morphologic dissolution the

B. two of The necrosis mechanisms and death are cell apoptosis.

II. NECROSIS

A. by cells of oflarge Death groups acute inflammation followed

B. to some underlying Due never process; pathologic physiologic

based several gross into on C. types features Divided

III. GROSS PATTERNS NECROSIS OF

Coagulative A. necrosis 1.

remains firm (Fig. tissue that Necrotic and the cell organ by (Fig. proteins, disappears nucleus structure coagulation of are but shape l.SA); preserved l.SB).

2.

the infarction of ischemic 3. Characteristic except brain any organ of

is and infarcted Area (pointing often pale. occlusion) wedge-shaped focus of vascular of to tissue

4.

organized Red pulmonary if infarction arises re-enters Fig. tissue blood infarction, a loosely testicular or (e.g., 1.6).

Liquefactive B. 1. necrosis

and liquefaction. enzymatic liquefied; that tissue protein cells of lysis becomes results Necrotic in

2.

Characteristic of i. from microglial enzymes infarction-Proteolytic brain. Brain the liquefy cells

ii. Abscess-Proteolytic from tissue. liquefy neutrophils enzymes u1. liquefy enzymes parenchyma. pancreas from Pancreatitis-Proteolytic

Gangrenous 1. necrosis C.

mummified that necrosis tissue Fig. gangrene, (dry resembles Coagulative 1.7) 2.

3. of lower tract Characteristic of limb and ischemia GI

ensues occurs, (wet infection necrosis superimposed tissues then of liquefactive gangrene). If dead

Caseous 1. necrosis D.

with cheese-like" appearance and Soft necrotic friable tissue "cottage (Fig. 2. 1.8)

of liquefactive coagulative Combination and necrosis 3.

of Characteristic granulomatous due infection fungal tuberculous or inflammation to

Fig. necrosis Caseous of 1.8 lung. of (Courtesy

Fig. 1 .6 Hemorrhagic testicle. infarction of Fig. 1.7 gangrene. Dry

Rosen, of MD) (Courtesy humpath.com) Yale

necrosis Fat 1. E.

adipose Necrotic with deposition to calcium due tissue chalky-white of (Fig. appearance 1.9) 2.

(e.g., damage pancreatitis-mediated of breast) to of 3. fat and trauma Characteristic peripancreatic fat

released saponification. called to acids (e.g., via or lipase with calcium pancreatitis) a breast) by Fatty (e.g., join process trauma

i. example which calcium dystrophic tissues. in Saponification deposits an is of dead calcification on necrotic phosphate. the normal calcification of as tissue setting serum a In nidus the in for and calcium dystrophic acts calcification,

ii. to nephrocalcinosis). calcification, occurs normal when or (e.g., to leading Metastatic to serum phosphate calcium hyperparathyroidism high lead tissues calcification, in opposed as dystrophic deposition calcium levels

F. Fibrinoid necrosis 1.

Necrotic vessel 2. to blood wall damage

vessel Leaking (Fig. results in microscopically of bright fibrin) proteins staining wall the (including pink wall of into 1.10).

3.

of vasculitis and hypertension malignant Characteristic

IV. APOPTOSIS

A. or death of -dependent, genetically cells involving Energy groups cell single (ATP) cells. programmed small include 1. Examples

2.

during cells 3. Removal of embryogenesis

T cell-mediated infected virally CDs+ cells of killing

1. B. Morphology

more Dying (pink, leading Fig. cell cytoplasm eosinophilic to become shrinks, l.ll).

2.

manner. an and organized condenses in fragments Nucleus

3.

by cell and macrophages; by followed inflammation. from fa bodies are not is removed the ll Apoptotic apoptosis

C. proteases and by that is mediated caspases endonucleases. Apoptosis activate

1.

down break Proteases the cytoskeleton.

2.

DNA. Endonucleases break down

Caspases D. activated by are pathways. multiple

1. pathway mitochondrial Intrinsic i. inactivation DNA damage, of decreased hormonal to Bcl2. injury, leads Cellular stimulation or

ii. cytochrome leak from inner the matrix into the activate caspases. allows to mitochondrial Lack of c and cytoplasm Bcl2

Fig. Fig. of Fat 1.9 peri-pancreatic adipose necrosis Fibrinoid vessel. necrosis of 1.10 Fig. 1.11 Apoptosis. tissue. humpath.com) of (Courtesy

and Cellular Cell Death 2. Adaptations, Injury, Growth thymus). caspases cell, in of thymocytes negative the target FAS Extrinsic death activating on binds (CD95) i. pathway selection receptor FAS receptor-ligand ligand (e.g.,

ii. (TNF) necrosis TNF target cell, the binds activating on caspases. Tumor factor receptor

3. T T by cell target of cell. pathway cell-mediated create i. pores secreted Perforins CDs+ in membrane CDs+ Cytotoxic

ii. enters cell pores and activates from Granzyme CDS+ caspases. T

iii. infected cells ofvirally is example. T-cell CDs+ an killing

I. PRINCIPLES BASIC

A. in outer electron their orbit. are Free species an with unpaired chemical radicals

phosphorylation. Physiologic occurs free generation radicals B. of during oxidative

1.

electrons to (complex oxygen. Cytochrome c oxidase IV) transfers

2.

and hydrogen radicals 0 superoxide hydroxyl Partial (0:), 2 reduction (H2O), ("OH). yields of peroxide

1. of free arises C. Pathologic with generation radicals

2. radical to free hydrolyzed hydroxyl Ionizing radiation-water

during oxidase generates superoxide killing ions oxygendependent Inflammation-NADPH neutrophils. by

3.

hydroxyl radicals (e.g., reaction). iron)-Fe2+ Metals and free generates (Fenton copper

4.

of radicals. drugs metabolizes Drugs chemicals-P450 liver system generating free and acetaminophen), (e.g.,

of aging DNA DNA damage injury and cause lipids and oncogenesis. proteins; D. radicals in of Free oxidation via is cellular and peroxidation implicated

radicals free Elimination via mechanisms. occurs of multiple E.

1.

glutathione (e.g., Antioxidants and E) and C, A 2. , vitamins

(in HP2 co:) i. Superoxide ➔ dismutase mitochondria)-Superoxide ii. + GS-SG radical and H2O ➔ (in free mitochondria)-2GSH peroxidase iii. Glutathione H2O Catalase peroxisomes)-H2O2 3. 2and ➔ (in 0

carrier ceruloplasmin) transferrin proteins and (e.g., Metal

II. FREE EXAMPLES INJURY RADICAL OF

A. tetrachloride 1. (CC1) Carbon

in used 2. solvent Organic the dry cleaning industry

by 3. system hepatocytes Converted of to P450 radical free CC13

detach, in cell consequently, RER; with injury impairing ribosomes Results synthesis. swelling protein of

4.

Decreased fatty change the liver apolipoproteins lead to in (Fig. 1.12).

1. Reperfusion injury B.

which blood ofO2-derived free to Return further radicals, in of tissue. production ischemic tissue damage results

2.

troponin) rise after a Leads enzymes in of (e.g., myocardial to infarcted continued cardiac reperfusion tissue

I. PRINCIPLES BASIC

in misfolded space, deposits thereby extracellular tissues. the is that A. Amyloid damaging protein a

B. proteins Multiple can amyloid. deposit as include features Shared 1.

2.

viewed Congo red when apple-green microscopically light staining (Fig. and under birefringence polarized 1.13)

systemic or can localized. C. Deposition be

II. AMYLOIDOSIS SYSTEMIC

A. into Amyloid divided primary and deposition in organs; secondary amyloidosis multiple

B. from which AL deposition light is amyloid, immunoglobulin amyloidosis derived Primary chain. is systemic of

1. dyscrasias multiple with (e.g., cell plasma Associated myeloma)

protein which of from C. AA amyloid, is systemic amyloid-associated (SAA). Secondary is deposition amyloidosis derived serum

1.

in and malignancy, (FMF). SAA Mediterranean an reactant chronic Familial phase inflammatory states, is increased that acute fever is

2.

(autosomal to origin. occurs a of dysfunction in of recessive) FMF persons neutrophils is Mediterranean and due

or episodes appendicitis, ii. inflammation serosal Presents myocardial mimic arthritis, acute infarction) and with (can i. fever of High amyloid AA tissues. SAA attacks in as deposits during

almost are can tissue D. any since of Clinical diverse findings amyloidosis be systemic involved. Classic findings 1. include

the common most syndrome; involved. Nephrotic kidney is organ

2.

3.

Tongue hepatosplenomegaly malabsorption, enlargement, and

requires tissue Diagnosis biopsy. E. rectum and fat targets. biopsy accessible easily pad are Abdominal

transplanted. Damaged be F. must organs cannot Amyloid be removed.

III. AMYLOIDOSIS LOCALIZED

to Amyloid A. deposition organ. localized usually single a

amyloidosis B. Senile cardiac 1.

the serum Non-mutated deposits in transthyretin heart.

2.

Usually of 25% years in of age individuals > asymptomatic; 80 present

amyloid Familial C. cardiomyopathy

Fig. of 1.12 Fatty change liver. Fig. 1.13 Amyloid. Congo red. A, birefringence. B, Apple-green MD) of (Courtesy Uthman, Ed

Adaptations, Cell 1. and Cellular Injury, Death Growth

cardiomyopathy. to transthyretin restrictive serum deposits the in Mutated heart leading

2.

carry of mutated 5% African the Americans gene.

1. D. diabetes Non-insulin-dependent (type II) mellitus the insulin) from deposits in of islets pancreas. (derived Amylin the

1. Alzheimer disease E.

in precursor plaques. P-amyloid AP (derived amyloid from the brain amyloid deposits forming protein)

2.

present P-APP 21. chromosome Gene is for on syndrome age (trisomy by 21) of with disease 40 Down Most develop Alzheimer the individuals (early-onset).

1. Dialysis-associated F. amyloidosis P2-microglobulin deposits joints. in

of Medullary thyroid 1. G. carcinoma the an (produced by tumor Calcitonin cells the cells) within background'). deposits in amyloid tumor ('tumor

Pathoma for for you choosing Thank studies. your to strive educational keeping materials affordability in highest mind. We the provide while quality time A effort gone developing this materials, so and of we program. legitimate your of tremendous use has appreciate into these amount a future integrity we forth standards when the oath. ourselves and all high your the as physician set taking ethical It speaks Hippocratic to for that of a the a materials and physician contrary training copyright. standards Pathoma of is ethical use is violation Unauthorized to of a current can as basis complete version, are at well on list through regular of videos and your updated account as a be the errata, Pathoma.com. most Pathoma accessed

Sincerely,

MD Dr. Sattar,

Inflammation, Wound Disorders, Inflammatory Healing and

I. INFLAMMATION

A. fluid and plasma and complement), exit interstitial inflammatory (e.g., blood proteins cells, to the Allows vessels enter space

B. acute chronic into inflammation Divided and

I. PRINCIPLES BASIC

A. tissue edema of by (Fig. neutrophils Characterized the in presence and 2.lA)

B. infection to pathogen) (to debris) necrosis eliminate necrotic (to in response tissue Arises or clear

specificity immunity) (innate limited with C. Immediate response

II. MEDIATORS OF ACUTE INFLAMMATION

(TLRs) A. 1. receptors Toll-like

of Present cells dendritic innate (e.g., immune the system on and macrophages cells) 2.

are lipopolysaccharide the pathogen-associated TLR4) (PAMPs) bacteria. PAMP) shared of that on by by microbes outer commonly gram-negative molecular on i. patterns co-receptor CD14 Activated (a membrane macrophages (a recognizes for

3.

upregulation response a activates results immune to leading NF-KB, multiple production activation genes of immune factor of that TLR transcription in mediators. nuclear

4.

lymphocytes) play present on also mediating an of in TLRs adaptive hence, important and, cells (e.g., role are chronic inflammation. immunity

acid 1. metabolites B. Arachidonic (AA) 5-lipoxygenase. A2 cell or and by then released from AA acted phospholipid is membrane upon phospholipase the cyclooxygenase by

Cyclooxygenase i. produces (PG). prostaglandins

a.

permeability. vasodilation PGD2, and vascular increased PGI2, and mediate PGE2

b.

also pain fever. and mediates PGE

ii. (LT). produces 5-lipoxygenase leukotrienes

a.

LTB4 and activates neutrophils. attracts

b.

LTD reacting mediate anaphylaxis) bronchospasm, and of LTE LTC (slow , and vascular increased vasoconstriction, permeability. substances ,

Mast cells 1. C.

2.

i. by complement trauma, cross-linking cell-surface tissue of by proteins (1) IgE (2) and Activated CSa, C3a (3) antigen pathoma.com or which mediate increased of response vasodilation of release vascular permeability. histamine arterioles and Immediate preformed involves granules,

ii. Delayed production arachidonic involves of metabolites, response leukotrienes. acid particularly

1. D. Complement

2.

occurs activation Circulate as inactive i. via precursors; IgM pathway-Cl IgG that to is antigen. binds bound or Classical

ii. products activate directly Alternative pathway-Microbial complement.

iii. binds complement. microorganisms activates on Mannose-binding lectin pathway-MEL (MBL) mannose to and

3.

which, of produces ➔ C3a C3 (mediates C3b), C3 ➔ CSb). production in pathways CS All and in CSa convertase result and (mediates convertase CS turn, (MAC). form to membrane CSb attack with complex C6-C9 complexes the

1. cell C3a (anaphylatoxins)-trigger degranulation, vascular vasodilation permeability and in increased histamine-mediated mast ii. CSa and resulting iii. CSa-chemotactic for neutrophils phagocytosis C3b-opsonin iv. for hole cell MAC-lyses microbes by membrane creating a in the

E. factor XII) (Factor 1. Hageman

2.

subendothelial fibrinolytic Activated to upon ii. in i. collagen; exposure and activates turn, Coagulation tissue systems or Complement iii. mediates to to as as cleaves Kin kininogen in vasodilation system-Kinin and high-molecular-weight permeability pain. histamine), vascular (HMWK) which bradykinin, (similar increased well

III. OF CARDINAL SIGNS INFLAMMATION

A. and (calor) (rubor) warmth 1. Redness

which vasodilation, Due results to increased 2. flow blood in

histamine, via Occurs prostaglandins, of relaxation and key are muscle; arteriolar smooth mediators bradykinin.

B. Swelling (tumor) 1.

space from 2. into Due the to fluid interstitial postcapillary venules (exudate) of leakage

mediators in endothelial tissue damage, and cell endothelial disruption. are contraction histamine, causes resulting cell Key (2) which (1)

(dolor) C. 1. Pain and endings. sensitize nerve Bradykinin sensory PGE

Fig. 2.1 Inflammation. A, inflammation neutrophils. with Acute inflammation with Chronic cells. plasma B, and lymphocytes

and Inflammation, Disorders, Inflammatory Wound Healing

Fever 1. D.

TNF, Pyrogens from macrophages (e.g., increase the activity cells IL-1 of which bacteria) to perivascular cyclooxygenase release in hypothalamus. cause and LPS

2.

temperature point. PGE2 Increased set raises

IV. FUNCTION ARRIVAL AND NEUTROPHIL A. 1-Margination 1. Step flow slows blood venules. postcapillary Vasodilation in

2.

flow marginate the Cells periphery. center to from of B. 2-Rolling Step 1. "speed are cells. on Selectin bumps" endothelial upregulated

release mediated by histamine. bodies P-selectin i. Weibel-Palade from is

ii. E-selectin induced IL-1. and is by TNF

2. bind X Lewis on Selectins sialyl leukocytes.

3.

rolling vessel Interaction leukocytes of results in along wall. C. Step 3-Adhesion 1.

endothelium upregulated Cellular and molecules TNF (ICAM IL-1. VCAM) and on adhesion are by

2.

by • on leukocytes Integrins and 3. LTB4 C5a are upregulated

CA and Ms vessel ofleukocytes firm results the to wall. in integrins adhesion Interaction between

4.

deficiency due of Leukocyte recessive to integrins commonly autosomal an defect (CD18 most is subunit). adhesion

i. of bacterial features separation and (due the of infections formation. to impaired increased lack of pool circulating leukocytes), that include adhesion pus umbilical cord, recurrent neutrophils delayed Clinical marginated

Step Chemotaxis 1. 4-Transmigration D. and

postcapillary transmigrate chemical Leukocytes attractants move endothelium toward the of venules (chemotaxis). across and

2.

are bacterial IL-8, LTB Neutrophils C5a, • attracted and by products,

1. E. 5-Phagocytosis Step

enhanced or (IgG necrotic Consumption is opsonins pathogens by of phagocytosis tissue; and C3b).

2.

from extend phagolysosomes. to phagosomes, Pseudopods produce are with leukocytes lysosomes form to and merge which internalized

3.

recessive) protein phagolysosome by formation. syndrome trafficking (autosomal impaired defect is Chediak-Higashi characterized a Clinical features i. include ii. of infections Increased risk pyogenic iii. to (due death neutrophils) of intramedullary Neutropenia Golgi granules in from granules fusion Giant to apparatus) of (due iv. leukocytes arising the

abnormal granules primary v. to platelets) dense (due Defective hemostasis in

vi. neuropathy Peripheral

material of Step 1. 6-Destruction F. phagocytosed

most the 2-dependent killing effective mechanism. 0 is

2.

HOC! in microbes. burst destroys oxidative by phagolysosomes generated phagocytosed

1. oxidase by 0 NADPH burst). is converted (oxidative 2 too;

ii. o is converted H ; dismutase superoxide to 0 (SOD). by

iii. converted Hp2 HOC! to is by (bleach) (MPO). myeloperoxidase 3. -dependent characterized is poor 0 killing. granulomatous (CGD) disease Chronic by

i. (X-linked ii. defect autosomal Due to recessive) or NADPH oxidase Serratia cepacia, recurrent catalase-positive Leads Pseudomonas and granuloma and organisms, with to particularly infection iii. aureus, marcescens, Staphylococcus Aspergillus Nocardia, formation screen Nitroblue is tetrazolium used test to for CGD. can blue ifNADPH are incubated which NBT with oxidase turns defective. colorless 0 too;, but is Leukocytes oxidase dye, ifNADPH remains convert

4. conversion HOCL MPO 0 deficiency results i. defective to ofH in Candida for are Increased patients risk asymptomatic. most however, infections;

ii. burst to is respiratory intact. normal; Hp2) NBT (02 is

5. than in 0 in and 2 granules enzymes occurs major basic is in and macrophages 2-independent -dependent killing (e.g., 0 via lysozyme secondary less effective protein leukocyte present killing eosinophils).

1. ?-Resolution Step G. the of disappear within after stimulus. undergo 24 inflammatory apoptosis Neutrophils and hours resolution

MACROPHAGES V.

after Macrophages A. predominate and inflammation begins. days after neutrophils 2-3 peak

1. Derived in from blood monocytes

B. and Arrive transmigration in via margination, adhesion, tissue sequence rolling, the

phagocytosis via phagocytosed (02independent lysozyme) in enzymes secondary using Ingest opsonins) by destroy and organisms (augmented granules material C. killing) (e.g.,

the process. step inflammatory D. next Manage of the Outcomes include 1.

and (e.g., macrophages. produced Resolution and IL-10 by TGF-~) healing-Anti-inflammatory cytokines are

2.

recruits from IL-8 macrophages persistent by pus neutrophils. Continued acute additional formation; inflammation-marked

3.

fibrogenic fibrosis; mediate fibrosis via by macrophages and surrounded growth inflammation factors cytokines. Abscess-acute

4.

secrete CD4+ Chronic present cells, cytokines that which helper antigen T inflammation. activate chronic to inflammation-Macrophages promote

I. PRINCIPLES BASIC

A. oflymphocytes presence tissue plasma and (Fig. cells Characterized the by in 2.lB)

B. response, inflammation immunity) (adaptive more Delayed specific acute but than

(4) (3) some viruses, infection infection foreign common include parasites, cause); disease; and (2) with (1) mycobacteria, cancers. persistent autoimmune (most material; Stimuli fungi; (5) and C.

II. LYMPHOCYTES T

A. marrow cells in as T bone Produced progenitor

B. rearrangement receptor in T-cell develop T cells (TCR) CDs+ undergoes T cells the cells or Further the progenitor CD4+ where cytotoxic become 1. and thymus helper use surveillance. cells CD3) complex antigen T TCR (TCR and for

Disorders, Inflammation, 2. Inflammatory Healing Wound and antigen recognizes TCR complex on MHC presented molecules.

ii. i. T CD4+ class II cells-MHC I 3. class T cells-MHC CDS+ ofT binding (2) (1) antigen/MHC requires 2nd and an signal. of cells Activation additional complex

T-cell 1. + helper CD4 C. activation

phagocytosed, Extracellular MHC cells foreign (APCs). (e.g., antigen is and presented presenting by antigen processed, II, is which protein) class on expressed

2.

cells T helper activation binds 2nd CD4+ providing B7 on APC signal. CD2S on

3.

"help" subsets. cytokines are secrete into Activated that inflammation T two + CD4 cells divided and helper

T to secretes macrophage, TH2 promotes promotes T1) phenotype). B-cell from IFN-y (activates IgG, class phenotype IgM and inhibits Hl switching subset i.

ii. IgE), subset switching IL-4). and TH2 (eosinophil IL-4 to secretes B-cell to IL-13 (function chemotaxis IgA), class to activation, and similar switching and class IL-5 (facilitates

1. cytotoxic activation CDs+ T-cell D.

antigen proteins class processed and nucleated cytoplasm) which cells is the I, expressed all MHC (derived Intracellular presented is in by and platelets. from on

2.

cell provides THl from signal. CD4+ IL-2 activation 2nd

3.

Cytotoxic T killing. activated cells for are

4.

1. target cell, pores of perforin perforin Secretion activating enter allow that creates to apoptosis. granzyme; granzyme the and

ii. FasL, Expression cells, on Fas activating binds which apoptosis of target

III. B LYMPHOCYTES

are cells A. become IgM and na'ive and that express bone Immature in B IgD. surface B cells marrow rearrangements immunoglobulin the to produced undergo

occurs B. activation 1. via B-cell

by IgD; cells surface IgDsecreting 2. plasma results in binding IgM-or IgM maturation Antigen or to

antigen CD4+ class presentation MHC via T B-cell II. helper cells to

signal. CD40L helper 2nd cell, receptor activation cell providing T on B CD40 on i. binds

ii. T Helper isotype switching, B-cell then and (mediate hypermutation, to cells). IL-4 and IL-5 cell secretes maturation plasma

IV. GRANULOMATOUS INFLAMMATION

inflammation of Subtype chronic A.

B. a which is abundant pink with a cells of collection usually epithelioid surrounded by by (macrophages cytoplasm), and lymphocytes giant histiocytes Characterized of granuloma, rim

into subtypes noncaseating caseating and Divided C. 1.

lack granulomas Noncaseating necrosis (Fig. central 2.2A). disease, scratch sarcoidosis, cat Crohn disease. include and reaction Common foreign material, to etiologies exposure, beryllium

2.

granulomas are of central infections and exhibit characteristic fungal (Fig. necrosis Caseating tuberculosis and 2.2B).

in granuloma formation Steps involved D. 1.

class II T Macrophages process present and helper via MHC antigen to cells. CD4+

2.

Interaction TH to into subtype. IL-12, macrophages differentiate CD4+ inducing T cells 1 to leads secrete helper

3.

epithelioid 1 giant cells TH secrete converts which IFN-y, and macrophages to histiocytes cells.

I. DIGEORGE SYNDROME

of A. pouches and the pharyngeal third fourth failure Developmental 1. 22qll to microdeletion Due

great Presents abnormalities heart, vessels, (lack parathyroids); (lack deficiency with of face of thymus); and and B. of hypocalcemia T-cell

II. COMBINED (SCIO) IMMUNODEFICIENCY SEVERE

A. humoral cell-mediated and immunity Defective

1. B. Etiologies include

is cells. T defects-Cytokine signaling maturation proliferation Cytokine for of and and B receptor necessary

2.

buildup deoxyadenosine and deficiency-ADA is waste adenosine lymphocytes. deaminate to to Adenosine as excretion deaminase is of toxic products; for and deoxyadenosine adenosine (ADA) necessary

3.

is necessary deficiency-MHC cytokine T production. cell CD4+ for II and helper class MHC activation II class

to protozoa! bacterial, Characterized and by susceptibility viral, C. fungal, opportunistic vaccines live including infections, and infections

and baby') D. sterile stem transplantation. cell ('bubble Treatment isolation is

III. X-LINKED AGAMMAGLOBULINEMIA

A. due maturation B-cell Complete lack to 1. of disordered immunoglobulin pro-B cannot cells mature. Pre-and

B. Bruton Due mutated tyrosine to kinase; X-linked

enterovirus are antibodies protective. life present after bacterial, 6 the first (e.g., and Presents of with months lamblia coxsackievirus), oflife months during maternal 6 infections; Giardia and recurrent C. polio

be Live avoided. (e.g., D. vaccines must polio)

IV. (CVID) COMMON VARIABLE IMMUNODEFICIENCY

A. or B-cell defects to immunoglobulin helper T-cell due Low

Fig. 2.2 Granuloma. Noncaseating. A, Caseating. B, Fig. Angioedema. 2.3 of (Courtesy James Heilman, MD, Wikipedia)

Inflammation, Disorders, Healing Inflammatory Wound and

B. late usually for enterovirus, and lamblia infections, childhood Giardia in risk Increased bacterial,

C. lymphoma disease and for autoimmune risk Increased

V. DEFICIENCY IgA

A. serum and Low mucosa! most immunoglobulin IgA; deficiency common

B. Increased risk mucosa! for infection, viral; most are asymptomatic. especially patients however,

VI. SYNDROME HYPER-IgM

A. elevated IgM Characterized by

B. helper cells) CD40 receptor T or cells) B Due mutated to CD40L (on 1. (on

during activation. signal B-cell delivered cannot Second be helper to T cells

2.

class switching are for immunoglobulin necessary produced. not Consequently, cytokines

opsonization), and (due IgG, recurrent especially result poor infections Low IgA, mucosa! pyogenic in IgE at C. to sites.

VII. SYNDROME WISKOTT-ALDRICH

A. death cellular bleeding humoral and cause and of recurrent major infections (defective by thrombocytopenia, a immunity); eczema, is Characterized

B. in to X-linked the mutation WASP Due gene;

VIII. COMPLEMENT DEFICIENCIES

gonorrhoeae deficiencies-increased infection (N C5-C9 and risk Neisseria for N A. meningitidis)

Fig. which (especially edema angioedema, by B. periorbital, in skin is of hereditary Cl the deficiency-results inhibitor characterized mucosa! and 2.3) surfaces

I. PRINCIPLES BASIC

A. Characterized self of by 1. tissues damage immune-mediated is prevalence US 1%-2%.

B. self-tolerance of Involves loss 1.

but central lymphocytes peripheral or develop Self-reactive bone regularly marrow) and tolerance. generated are (thymus

2.

or regulatory (thymocyte) apoptosis Central of in cells. leads to tolerance generation T-cell T thymus

polyendocrine AIRE autoimmune i. result in syndrome. mutations

3.

Central marrow receptor to bone leads editing in or apoptosis. B-cell tolerance

4.

Peripheral cells. to tolerance B ofT apoptosis leads and anergy or

1. pathway (ALPS). lymphoproliferative apoptosis Fas in result autoimmune mutations syndrome

5.

cytokines T-cell Regulatory autoimmunity T blocking TGF-~). cells anti-inflammatory (IL-10 suppress activation by producing and and

1 i. type CD25 polymorphisms DM). autoimmunity with and associated are (MS

ii. FOXP3 Enteropathy, to (Immune lead IPEX mutations Polyendocrinopathy, X-linked). syndrome dysregulation,

classically C. women; More in 1. common affects ofchildbearing age women apoptosis reduce cells. self-reactive Estrogen may B of

likely Etiology in trigger genetically-susceptible is individuals. an environmental D.

1. in Increased incidence twins 2.

with types (e.g., certain polymorphisms 3. HLA Association HLA-B27) PTPN22 and

triggers to or bystander mimicry. molecular Environmental lead activation

partially spreading are show Autoimmune remissions often explained features; with and by disorders relapses clinically and E. overlapping epitope progressive

II. SYSTEMIC ERYTHEMATOSUS LUPUS

A. autoimmune 1. systemic Chronic, disease remissions are common. and Flares

in 1. arises B. middle-aged and Classically American females, especially women Hispanic African adults in arise (less gender May and children bias) older dramatic also

(type Antigen-antibody complexes damage tissues multiple C. HSR). III

1.

Poorly-cleared UV host produce to self-reactive which apoptotic (e.g., antigens. activates then from nuclear antibodies damage) debris lymphocytes,

2.

complexes generated up cells. are levels at and by taken dendritic Antigen-antibody low

3.

immune DNA TLRs, (IFN-a). amplifying response antigens activate

4.

deposit generated causing are subsequently multiple and complexes disease. Antigen-antibody levels tissues higher at in

5.

of early (Clq, associated SLE. Deficiency and is proteins C2) C4, complement with

can tissue involved. D. be Almost any Classic 1. findings include

loss, fatigue, lymphadenopathy, Fever, phenomenon 2. weight Raynaud and

(Fig. rash 'butterfly' Malar 2.4A) or rash discoid (Fig. 2.4B), sunlight especially 3. upon to exposure

4.

(usually ?. Arthritis involving 5. 2 joints)

6.

7.

injury. glomerulonephritis of common i. is form severe Diffuse and most most the proliferative

ii. injury Other also glomerulonephritis) (e.g., of occur. patterns membranous

8.

(type leukopenia 9. or HSR) II Anemia, thrombocytopenia,

10.

sensitive, antibody (ANA; Antinuclear but not specific) 11.

E. antibody with (one-third patients). Antiphospholipid associated SLE of is

1. phospholipids against bound to directed proteins Autoantibody

Fig. 2.4A SLE. Malar rash, 'butterfly' Fig. Discoid rash, SLE. 2.4B

and Inflammatory Inflammation, Healing Wound 2. Disorders, antibodies I, Important antiphospholipid tests), VDRL include screening PTT). syphilis RPR anticardiolipin anticoagulant and (false-positive anti-02-glycoprotein and lupus (falsely-elevated

by syndrome hypercoagulable due anticoagulant). antibodies antiphospholipid characterized state Antiphospholipid antibody lupus is (especially to F.

1.

2. (stroke) including venous vein, and cerebral placental loss), (recurrent thrombosis thrombosis venous, arterial pregnancy Results hepatic and in deep

3.

SLE; disorder commonly a primary as more with occurs however, Associated

drug-induced Antihistone G. lupus. characteristic of antibody is

1.

common are isoniazid hydralazine, causes. Procainamide, and

2.

by positive definition. ANA is

3.

rare. and renal CNS involvement are

4.

of results remission. in usually drug Removal

flares; treatment severe glucocorticoids refractory or agents useful sunlight exposure includes are First-line for immunosuppressive H. disease. in other to and avoiding direct

I. accelerated (occurs late) death. 5-year infection, of is are > 90%; coronary common failure, atherosclerosis and renal survival causes

III. SYNDROME SJOGREN

destruction Autoimmune A. lacrimal glands and salivary of 1. with HSR) fibrosis Lymphocyte-mediated (type IV damage

as B. an sicca), woman my a (keratoconjunctivitis (50-60 eyes" (xerostomia), in mouth presents 1. dry chew older cracker, in caries recurrent and dry dirt eyes Classically years)-"Can't dental progress of May and corneal epithelium ulceration to oral mucosa

(sicca Can disorder, rheumatoid associated autoimmune 1. syndrome) another especially with C. arthritis be primary or present when absent. is is Rheumatoid even rheumatoid arthritis factor often

(anti-SSA/Ro ANA and antibodies 1. anti-ribonucleoprotein and by D. Characterized anti-SSB/La)

neuropathy). manifestations associated with (e.g., anti-SSB Anti-SSA are extraglandular and

2.

lupus heart risk at block. with Pregnant women with and for delivering babies neonatal are anti-SSA congenital

3.

and with of also pregnant patients) anti-SSB SLE seen patients Anti-SSA (screen a are subset in

E. criterion (Fig. biopsy Lymphocytic additional sialadenitis glands) lip is (minor diagnostic an salivary on 2.4C).

as parotid disease enlargement Increased the B-cell risk course presents which (marginal F. late lymphoma, in unilateral for zone) gland of

IV. SYSTEMIC SCLEROSIS (SCLERODERMA)

Autoimmune and visceral disorder by characterized 1. of organs skin sclerosis A. presents years) in middle-aged females (30-50 Classically

of to Fibroblast leads B. deposition collagen. activation

1.

Autoimmune initiating to damage event. is possible mesenchyme

2.

of (TGF-0 growth adhesion and endothelin molecules), factors Endothelial decreased secretion PDGF). NO), to (increased dysfunction leads (increased vasoconstriction inflammation and and

3.

damage. and perivascular, causes Fibrosis, progresses organ initially

V.

I.

II.

and limited involvement. with is type-Skin face) C. visceral involvement (hands late Limited

1. phenomenon, dysmotility, Raynaud (Fig. antibodies, Calcinosis/anti-Centromere Esophageal Sclerodactyly Prototype syndrome: CREST is the of skin. 2.4D), and Telangiectasias

involvement Diffuse D. diffuse early type-Skin visceral involvement. is with

1.

involved. organ Any can be

2.

i. phenomenon) (Raynaud Vessels ii. and GI (esophageal iii. dysmotility reflux) tract iv. pulmonary hypertension) and (interstitial fibrosis Lungs renal Kidneys 3. (scleroderma crisis)

topoisomerase I DNA (anti-Scl-70). antibodies with associated to Highly

ofSLE, sclerosis, features mixed damage Autoimmune-mediated polymyositis with and A. tissue systemic

B. ribonucleoprotein with to ANA antibodies along by serum Characterized Ul

is A. when begins. Healing initiated inflammation

B. repair combination a and regeneration of Occurs via

A. Replacement with tissue; of tissue on dependent capacity regenerative native of damaged tissue

are regenerative permanent. based divided into three and types labile, Tissues capacity: B. on stable,

cells that possess continuously the Labile tissues cycle to C. stem tissue. regenerate

1.

(stem bowel in and Fig. crypts, Small large cells mucosa] 2. 2.5)

cells Fig. basal layer, in (stem Skin 3. 2.6)

can necessary. quiescent comprised ), are tissues cells cycle D. that the but when regenerate of to tissue reenter Stable cell are (G

1. liver compensatory after resection. partial Classic of by regeneration example hyperplasia is cells then reenters additional quiescence. hepatocyte and produces Each

Fig. Fig. sialadenitis, Lymphocytic Sjogren 2.4C Sclerodactyly, scleroderma. 2.4D Fig. crypts. 2.5 Intestinal syndrome.

Disorders, Healing Wound and Inflammation, Inflammatory

regenerative and E. neurons). myocardium, tissues lack muscle, skeletal (e.g., significant potential Permanent

III. REPAIR

A. with damaged tissue Replacement of scar fibrous

B. or healing deep are stem regenerative lost regenerative a when cells when a skin myocardial after capacity (e.g., infarction, lacks cut) Occurs tissue Fig. (e.g., 2.7)

repair (Fig. of the is C. phase formation initial Granulation tissue 2.8).

1. III (provide fibroblasts (contract (deposit Consists nutrients), and of wound) type capillaries myofibroblasts collagen),

replaced type I in with Eventually results in which III 1. collagen formation, D. collagen is scar type

in Type embryonic III tissue, collagen keloids. tissue, and granulation uterus, pliable and is present

2.

is present I most skin, strength high has bone, and tensile in organs. collagen Type and tendons,

3.

removes a as Collagenase zinc III cofactor. requires and type collagen

IV.

factors target secrete signaling via growth paracrine growth Mediated by macrophages factors fibroblasts) (e.g., that A.

gene receptors (e.g., with growth B. growth. receptor) factor Interaction expression of factors cellular in growth results factor and epidermal with growth

Examples 1. include of mediators C.

2.

3.

4. growth muscle, fibroblasts for and endothelium, factor Platelet-derived smooth factor-growth

5.

V.

or intention. via primary secondary Cutaneous occurs healing A.

1.

of to (e.g., are scar brought edges together intention-Wound leads formation 2. incision); surgical a Primary suturing minimal

approximated. not are intention-Edges Secondary tissue myofibroblasts the wound, the Granulation defect; forming a contract then scar. fills

B. healing 1. occurs Delayed in wound most Infection S the common is offender) (most aureus cause; common

Fig. 2.6 of Basal skin. layer Fig. scarring. 2.7 Myocardial (Courtesy Fig. Aliya of 2.8 Granulation tissue. MD) Husa in, 2. in and the of for deficiency procollagen collagen residues; an zinc copper, Vitamin hydroxylation important lysine Vitamin C i. cross-linking. is is hydroxylation eventual proline necessary cofactor or C,

ii. cofactor cross-links Copper stable for is and collagen. hydroxylysine which form lysyl to lysine a oxidase,

iii. stronger Zinc collagenase, is replaces granulation a I collagen cofactor of type the III for collagen. type which tissue with

3. include malnutrition. and Other foreign body, ischemia, diabetes, causes

surgery is rupture most commonly abdominal Dehiscence seen wound; of after C. a

of (Fig. is wound localized production to that is the excess D. scar tissue scar Hypertrophic 2.9).

production (Fig. to E. wound of out scar the is tissue proportion that excess is Keloid of 2.10).

1.

2.

3.

earlobes, Classically face, upper extremities affects and

Fig. Hypertrophic scar. 2.9 . Fig (Reprinted with Keloid. 2.10 1128404-overview) http://emedicine.medscape.com/ article/ permission,

Principles of Neoplasia

I. BASIC PRINCIPLES

features that Neoplasia A. irreversible, unregulated, it and and these monoclonal; growth repair. new is from is distinguish hyperplasia tissue

B. the cells from a means derived neoplastic cell. single that mother are Monoclonal

enzyme by dehydrogenase (G6PD) Clonality historically glucose-6-phosphate determined was C. isoforms.

1.

(e.g., from parent. exist; is isoform one each isoforms G6PDc) G6PDA, only Multiple inherited G6PDB, and

2.

(G6PD by lyonization one on In in females, present isoform the X each is randomly chromosome). cell is inactivated

3.

(e.g., 50% G6PD8) G6PDA, cells tissue and ratio isoforms of 50% Normal 1:1 in of cells of is of . active cells any have have

4.

multiple are which is maintained derived from ratio hyperplasia, 1:1 (cells polyclonal is cells). in

5.

neoplasia, in is present which one isoform monoclonal. Only is

6.

the isoforms, Clonality receptor determined chromosome. present on which by also be X androgen also can are

lymphocytes (Ig) by immunoglobulin phenotype. determined D. light is Clonality chain ofB

1.

of comprised and chains. lg heavy light is

2.

or is chain that light B lambda. either expresses cell Each kappa

3.

light lambda to kappa is 3:1. ratio chain Normal

4.

This is maintained which ratio hyperplasia, is in polyclonal.

5.

1:3) (e.g., kappa monoclonal. which in to to Ratio > or ratio= inverted lambda increases is is lymphoma, 6:1

or benign malignant. are tumors E. Neoplastic

1.

localized remain tumors not metastasize. and do Benign

2.

invade and locally to metastasize. have the potential Malignant (cancer) tumors

of malignant lineage Tumor or F. differentiation (Table nomenclature whether benign of the tissue is is 3.1). tumor and based produced) on (type

Table Tumor Examples of Nomenclature pathoma.com 3.1:

II. EPIDEMIOLOGY

A. is of Cancer cause adults in leading and children. death 2nd the both

1.

chronic death are (3) cardiovascular disease, (1) causes respiratory adults The leading of disease. cancer, and in (2)

2.

in children accidents, death of defects. (2) (3) cancer, causes and The are congenital leading (1)

B. are breast/prostate, colorectal. adults incidence common by (1) The in and lung, most (3) cancers (2)

and (3) C. colorectal. are adults in causes cancer (1) prostate, The most mortality of breast/ lung, common (2)

III. SCREENING ROLE OF

A. cell. Cancer single a begins as mutated

B. Approximately divisions 30 occur clinical before arise. earliest symptoms the

increased division (doubling Each mutations. C. results time) in

1.

have late that symptoms mutations. additional and, in not hence, will until produce do additional disease undergone divisions Cancers

2.

detected have tend Cancers are to a poor late prognosis. that

3.

mortality. it carcinoma in requires becomes a carcinoma of arise; before dysplasia before (precancerous to clinical symptoms or catch change) Screening efficacy screening, decrease seeks however, cancer-specific

include 1. Common D. screening methods

2.

before it clinically invades cancer 3. palpable or in Mammography-detects carcinoma (e.g., before becomes DCIS) breast invasive situ it

4.

I. PRINCIPLES BASIC

A. initiated DNA Cancer of to by cells. damage stem is formation mechanisms, damage The DNA is lethal. repair not overcomes but

1. DNA, the Carcinogens damage that are agents risk increasing for cancer. carcinogens viruses, Important include radiation (Table oncogenic and 3.2). chemicals,

mutations progression (growth) for disrupt promotion key systems, and B. (spread). tumor DNA allowing eventually regulatory

1. systems regulators include and of tumor Disrupted apoptosis. suppressor genes, proto-oncogenes,

II. ONCOGENES

and essential unregulated growth differentiation; are lead of oncogenes form for cell A. growth. cellular proto-oncogenes that mutations to Proto-oncogenes

B. include signal of cell growth factors, receptors, regulators, Categories nuclear oncogenes and (Table growth 3.3). transducers, factor regulators cycle

1.

cellular factors astrocytoma). Growth (e.g., in growth PDGFB induce

2.

signals from cancer). mediate breast factor (e.g., factors Growth growth [HER2/neu] receptors ERBB2 in

3.

transducers ras). Signal (e.g., relay receptor activation nucleus the to

Principles of Neoplasia

Carcinogens Cancers Associated Table Important and 3.2:

chromium, Nitrosamines Vinyl or Nickel, Naphthylamine silica chloride beryllium,

common 16, source) HTLV-1 is subtypes HPV most 33) sunlight High-risk (e.g., 31, 18, HBVandHCV

upper carcinoma and oropharynx cell esophagus, carcinoma of and Squamous hepatocellular

angiosarcoma liver and of cell Squamous lung skin, cancer, carcinoma of

kidney, of esophagus, bladder, and oropharynx, pancreas Carcinoma lung,

Urothelial carcinoma bladder of

liver of Angiosarcoma

carcinoma, CNS lymphoma AIDS lymphoma, Burkitt in and Nasopharyngeal

Squamous ofvulva, and cervix; cell adenocarcinoma of vagina, cervix anus, carcinoma

papillary carcinoma AML, CML, of the thyroid and

melanoma squamous cell skin cell and Basal of carcinoma, carcinoma,

rice stored from can grains Derived Aspergillus, contaminate and which

Side chemotherapy effect of

present cigarette in smoke. Arsenic is

to Exposure asbestos mesothelioma. to cancer than likely to is lung lead more

carcinogen carcinogen worldwide; particularly common are hydrocarbons polycyclic ic. Most

carcinoma responsible in foods; of Japan in for smoked Found stomach high rate

pipes used to in chloride (PVC) make polyvinyl use Occupational for exposure;

pyrimidine -,--~---------FUNDAMENTALS in which formation normally of dimers Results OF are in restriction excised endonuclease by DNA, 1. PA_T_H_O_L_O_G_Y_______ GDP-bound in an associated factor growth state. with receptors inactive Ras is

ii. GDP with binding be ras. activating replaced causes Receptor to GTP,

iii. Activated growth sends the nucleus. to signals ras

iv.

GTP activating protein. is cleaving by inactivates GTPase itself Ras this to GDP; augmented by

v.

Mutated protein. of activity activating inhibits GTPase ras the increased signals. the resulting growth state ras, This of prolongs in activated

4. Cell (e.g., the cyclin-dependent mediate regulators cycle cyclin through and kinase). cycle progression cell

the proteins Cyclins cell the complex cycle. through which and cyclin-dependent a cell that kinases form (CDKs) phosphorylates i. drive

ii. which S retinoblastoma promotes the example, complex protein, For the cyclinD/CDK4 the checkpoint. G/ through phosphorylates progression

III. GENES TUMOR SUPPRESSOR

A. Rb risk hence, cell decrease examples. of p53 (retinoblastoma) the tumor ("suppress") classic Regulate growth and, are and formation;

the to cell phase. G S progression regulates from p53 of B. cycle

Important Table Tumors and 3.3: Oncogenes Associated

PDGFB autocrine Overexpression, growth factor Platelet-derived loop Astrocytoma

neu] of MEN carcinoma breast Neural factor thyroid RET growth carcinomas Point Subset mutation receptor medullary 2A, sporadic Amplification MEN and of 2B receptor

melanoma, Carcinomas, and

CML with kinase t(9;22) of some Tyrosine types ABL and BCR ALL

Principles 1. Neoplasia of

DNA to cycle slows p53 upregulates repair damage, the cell In DNA response and enzymes.

2.

not apoptosis. is IfDNA possible, repair induces p53

disrupts BAX, upregulates Bcl2. 1. which p53

ii. from activating leaks the c Cytochrome apoptosis. mitochondria

3.

hypothesis). Both gene the two-hit out for (Knudson formation copies tumor knocked of must p53 be

i. in seen 50% > is cancers. Loss of

ii. and propensity sarcomas. in of Germline is carcinomas the to somatic), hit mutation multiple Li-Fraumeni by develop (2nd characterized syndrome results types

G1 regulates S Rb phase. to also from C. progression

1.

Rb the necessary phase. which is E2F transcription for "holds" S transition factor, the to

2.

is complex. the kinase RB by phosphorylated released is (CDK4) when cyclinD/cyclin-dependent 4 E2F

3.

constitutively and progression cycle E2F, the results cells. mutation of in through growth allowing uncontrolled cell free Rb

4.

(Knudson formation hypothesis). Rb of be tumor copies must twohit for gene Both knocked out

i. characterized hits by mutation somatic) is are retinoblastoma unilateral (Fig. Sporadic (both 3.1).

11. familial osteosarcoma. results is Germline and retinoblastoma characterized by hit somatic), mutation in (2nd bilateral retinoblastoma

IV. OF APOPTOSIS REGULATORS

A. DNA apoptosis promote (e.g., Bcl2) c. cells cells, whose l. of normal Bcl2 be apoptosis cannot mitochondrial stabilizes mutated in membrane, normally blocking repaired the Prevent cytochrome release but in

2. c to Disruption the leave apoptosis. of and cytochrome allows activate mitochondria Bcl2

lymphoma. follicular Bcl2 B. overexpressed in is

1.

lg 18) chain t(l4;18) resulting the Bcl2. heavy (chromosome increased in 14), moves to locus Bcl2 (chromosome

2.

is apoptosis. Mitochondrial membrane prohibiting further stabilized,

3.

B to apoptosis lymph node somatic normally accumulate, germinal the center in during lymphoma. that leading cells hypermutation would undergo

Fig. 3.1 Retinoblastoma. Fig. of (Courtesy Jerome Carcinoma lymph 3.2 node. involving Fig. omentum 3.3 by the carcinoma. Seeding of MD) of Jerome (Courtesy MD) Taxy, Taxy,

OF TUMOR V. IMPORTANT DEVELOPMENT OTHER FEATURES

necessary for immortality. Telomerase cell A. is

1.

resulting cell in serial senescence. with cellular Normally, eventually shorten divisions, telomeres

2.

preserves telomeres. which upregulated often telomerase, have Cancers

vessels) is blood necessary growth. new for B. and (production Angiogenesis tumor of survival

1. factors) commonly cells. tumor and produced by FGF (angiogenic are VEGF

survival. Avoiding necessary C. for is surveillance tumor immune

1.

Mutations I. of which often production on class expressed abnormal result are proteins, MHC in

2.

cells. cells T mutated detect such CDS+ and destroy

3.

class surveillance evade Tumor downregulating can of cells I. immune MHC by expression

4.

primary Immunodeficiency risk cancer. and (both increases for secondary)

I. AND TUMOR SPREAD INVASION

and tumor Accumulation mutations spread. eventually results of A. in invasion

1.

to attached Epithelial cellular cells are (e.g., by tumor one normally molecules adhesion E-cadherin). another

2.

attached of E-cadherin dissociation to Downregulation cells. leads of

3.

basement Cells to membrane (collagen IV) collagenase. attach and destroy via type laminin

4.

attach extracellular Cells matrix fibronectin the to and locally. spread in

5.

allows or vascular metastasis spaces Entrance spread). lymphatic (distant for into

II. METASTASIS ROUTES OF

Lymphatic spread of A. characteristic is carcinomas.

1. spread is Initial lymph nodes draining regional to (Fig. 3.2).

carcinomas. spread sarcomas of is B. Hematogenous some and characteristic

1.

2.

3.

4. Follicular carcinoma thyroid the of

of Fig. ovarian of which the carcinoma, characteristic Seeding body caking', ('omental is often C. cavities peritoneum involves 3.3).

Fig. of features 3.4 Histologic neoplasia. thyroid. Well adenoma A, follicular of differentiated, B, Fig. differentiated, anaplastic thyroid. lmmunohistochemical 3.5 of Poorly for stain carcinoma keratin cells marking epithelial brown). (in

I. FEATURES CLINICAL

slow well Benign to A. tend circumscribed, mobile. and be distinct, tumors growing,

and infiltrative, tissues rapid usually structures. poorly are local tumors surrounding growing, B. to circumscribed, and fixed Malignant

is be excision before required tumor a Biopsy generally certainty. or or as can benign malignant with classified C.

1. grow a in malignant-like fashion. benign can Some in tumors some can benign-like and malignant a fashion, grow tumors

are Benign A. usually tumors well differentiated (Fig. 3.4A). include Characteristics 1.

2.

3.

4. to cytoplasmic ratio Low nuclear

5.

membrane 6. tissue) basement local or Lack invasion of (of

B. poorly are Fig. classically Malignant differentiated (anaplastic, tumors 3.4B). Characteristics 1. include

(loss polarity) of Disorganized 2. growth

3.

to cytoplasmic nuclear ratio 4. High

mitotic activity with 5. mitosis atypical High

metastasize. Metastatic the C. of is hallmark potential malignancy-benign never tumors

lmmunohistochemical Cell Types Target Stains and Common 3.4: Table

Neuroendocrine cell cells (e.g., small

and Schwannoma cell histiocytosis Melanoma, Langerhans

______________ IBll, F_U_N_D_A_M_E_N_T_A_L_S_O_F_P_A_T_H_O_L_O_G_Y_______

classify to characterize Immunohistochemistry that difficult tumors used D. to are (Fig. on is histology Table 3.5, 3.4).

III. MARKERS SERUM TUMOR

tumor A. serum PSA) (e.g., by into Proteins released

B. monitoring screening, and recurrence to for monitoring response Useful treatment,

levels biopsy of biopsy require diagnosis of tissue PSA). prostate Elevated carcinoma elevated with (e.g., C. for

IV.

A. (i.e., Microscopic grows); much account of 1. in the resembles differentiation it tissue architectural nuclear how a takes features assessment into and cancer which

2.

B. cancers. for better Important cancers have well-differentiated determining than poorly-differentiated prognosis; prognosis

V.

A. and size of Assessment of a cancer spread

B. than factor; prognostic more grade important Key

C. final surgical ofthe after resection Determined tumor

TNM staging Utilizes D. 1. system

T-tumor (size and/or of invasion) 2. depth

prognostic N-spread 3. factor most important nodes; regional to lymph second

I. HEMOSTASIS

A. tissues. carry blood Integrity necessary is the vessel to blood to of

1. repaired (clot) involves a to thrombus vessel the site is formation at which Damage injury. wall of hemostasis, by of the

B. Hemostasis in two and primary occurs secondary. stages:

1.

and hemostasis forms a weak and platelet interaction mediated between plug is wall. vessel by platelets the Primary

2.

cascade. hemostasis Secondary coagulation the the platelet plug stabilizes and mediated is by

I. HEMOSTASIS PRIMARY

A. damaged vessel vasoconstriction Step of 1-Transient 1. Mediated reflex from neural cells endothelial and release stimulation endothelin by

B. adhesion surface 1. vessel Step 2-Platelet disrupted of to the

factor Von Willebrand binds exposed subendothelial collagen. (vWF)

2.

using vWF bind GPib Platelets receptor. the

3.

cells Weibel-Palade from vWF is platelets. derived the of of and endothelial a-granules bodies

degranulation C. Step 3-Platelet 1. and in induces change with Adhesion release mediators. shape degranulation of platelets multiple

i. platelet of exposure released Illa ADP is receptor platelets. granules; dense GPilb/ on promotes from

11. synthesized released; aggregation by promotes platelet is TXA2 cyclooxygenase (COX) platelet and

D. 4-Platelet Step 1. aggregation

via in of GPIIb/llla fibrinogen plug site molecule; of using Platelets injury aggregate the plasma) as at (from linking a platelet results 2. formation

plug (secondary hemostasis) is cascade stabilizes Platelet coagulation it. weak;

II. HEMOSTASIS DISORDERS OF PRIMARY

A. into or due divided disorders to quantitative in Usually abnormalities qualitative platelets;

B. mucosa! Clinical features include and bleeding. skin

1.

Symptoms mucosa! of and symptom), hemoptysis, GI bleeding, epistaxis (most include hematuria, common bleeding overall menorrhagia. Intracranial with severe bleeding occurs thrombocytopenia.

2.

Fig. of Symptoms bleeding (1-2 skin include mm, petechiae mm), 3 4.1), of are 1 easy bruising; thrombocytopenia usually are and qualitative and petechiae sign with cm), ecchymoses (> (> seen purpura disorders. a not

pathoma.com

C. laboratory 1. include Useful studies

K/µL; symptoms. to leads count-normal 50 K/µL < 150-400 Platelet

2.

quantitative 2-7 minutes; prolonged 3. qualitative and Bleeding with platelet time-normal disorders

assess number platelets of Blood 4. size to and smear-used

marrow to assess biopsy-used which produce Bone platelets megakaryocytes,

III. PURPURA IMMUNE THROMBOCYTOPENIC (ITP)

antigens GPIIb/IIIa) against A. Autoimmune (e.g., 1. production oflgG platelet cause children adults and in common of thrombocytopenia Most

are B. by spleen. in cells produced Autoantibodies the plasma

by C. platelets resulting macrophages, consumed are thrombocytopenia. Antibody-bound splenic in

Divided into forms chronic 1. and D. acute

presentation in within resolving viral infection selflimited, a after weeks or children Acute of 2. arises usually form weeks immunization;

in arises adults, age. women form of childbearing Chronic usually primary secondary (e.g., SLE). or May be can thrombocytopenia cause offspring in the IgG placenta. cross since May short-lived antiplatelet

E. findings include Laboratory 1.

platelet 2. 50 K/µL ..J.. count, often <

not are Normal factors affected. PT/PTT-Coagulation

3.

corticosteroids. F. is treatment Initial show but well; may relapse. response, early adults Children respond often

1.

short-lived. platelet IVIG raise the is count bleeding, used is its effect symptomatic to but in

2.

primary source of the (performed refractory the site in cases). and of destruction antibody platelet Splenectomy eliminates

IV. ANEMIA MICROANGIOPATHIC HEMOLYTIC

platelet A. formation Pathologic 1. small vessels in of microthrombi

formation in microthrombi. consumed the of are Platelets

2.

with are hemolytic in anemia resulting microthrombi, as cross RBCs "sheared" they schistocytes (Fig. 4.2).

B. Seen purpura uremic hemolytic thrombocytopenic and (TTP) (HUS) in syndrome thrombotic

due cleaves enzyme an normally multimers TTP is smaller monomers vWF for decreased degradation. ADAMTS13, to that eventual into C.

Fig. involving skin. 4.1 Petechiae Fig. Schistocyte. 4.2

1.

uncleaved microthrombi. adhesion, multimers lead to platelet Large, abnormal in resulting

2.

commonly usually acquired an to due most ADAMTS13 adult in seen autoantibody; Decreased is females

HUS drugs by damage to is due infection. endothelial D. or

1.

children coli with Classically seen 0157:H? in E results which from dysentery, beef to exposure 2. undercooked

resulting E damages endothelial platelet verotoxin in cells coli microthrombi.

include and TTP) 1. findings E. (HUS Clinical

2.

3.

4.

Renal common insufficiency in of (more HUS)-Thrombi involve kidney. the vessels

5.

of abnormalities common (more in CNS. TTP)-Thrombi the vessels involve CNS

F. Laboratory findings 1. include

time Thrombocytopenia t 2. bleeding with

(coagulation 3. is activated) Normal cascade not PT/PTT

4. Anemia schistocytes with

and TTP. involves corticosteroids, G. in particularly Treatment plasmapheresis

PLATELET V. DISORDERS QUALITATIVE

GPib due platelet adhesion Bernard-Soulier impaired. genetic A. syndrome a is deficiency; to is

1. smear thrombocytopenia enlarged shows Blood platelets. mild with

impaired. aggregation B. platelet Glanzmann to a is deficiency; is due genetic thrombasthenia GPIIb/IIIa

irreversibly C. cyclooxygenase; of TXA aggregation. Aspirin inactivates lack impairs

D. and impaired. disrupts adhesion Uremia both platelet are aggregation function;

I. SECONDARY HEMOSTASIS

cascade 1. via the weak coagulation plug A. Stabilizes platelet the

fibrin. converts to thrombin, fibrinogen cascade platelet in Coagulation generates plug which the

2.

is thrombus. yielding Fibrin then stable cross-linked, platelet-fibrin a

B. Factors of by the cascade inactive in the an are coagulation produced state. liver 1. requires Activation to Exposure activates factor Tissue pathway). VII i. thromboplastin substance an (extrinsic activating

ii. factor activates collagen pathway). (intrinsic XII Subendothelial

2.

3. surface of platelets Phospholipid

II. HEMOSTASIS OF SECONDARY DISORDERS

A. factor due to Usually abnormalities

B. features and muscles include surgical tooth (e.g., joints extraction). procedures (hemarthrosis) rebleeding Clinical into circumcision wisdom and and bleeding deep after tissue

Laboratory include 1. C. studies

extrinsic VII) cascade (PT)-measures V, Prothrombin fibrinogen) coagulation of (factors common II, 2. the X, and pathways (factor time and

IX, Partial thromboplastin intrinsic time XII, (factors (PTT)-measures XI,

of the coagulation VIII) and II, (factors common and X, fibrinogen) cascade V, pathways

III. HEMOPHILIA A

A. deficiency Genetic (FVIII) 1. VIII factor

2.

and 1. tissue, Presents postsurgical B. deep joint, bleeding with depends of deficiency. the severity Clinical on degree

1. findings include C. Laboratory

2.

FVIII 3. ,I,

recombinant involves FVIII. D. Treatment

IV.

A. Genetic 1. IX factor deficiency Resembles instead except hemophilia of FVIII levels are decreased FIX A,

V.

A. factor Acquired a antibody impaired anti-FVIII most resulting function; against in common. is factor coagulation

1.

A. Clinical are lab hemophilia to and findings similar

2.

mixing normal correct PTT A. not does hemophilia study) PTT upon in with plasma inhibitor; to does correct patient's due plasma (mixing

VI. VON DISEASE WILLEBRAND

A. 1. Genetic deficiency vWF inherited Most common coagulation disorder

B. the vWF autosomal common Multiple and levels. is with type quantitative decreased most exist, dominant defects; qualitative causing subtypes

C. Presents mucosa! with mild bleeding; low vWF skin and impairs platelet adhesion.

findings Laboratory 1. include D.

2.

half-life bleeding however, and seen. tissue, are not usually t PT-Decreased normally stabilizes FVIII); postsurgical FVIII joint, normal PTT; deep (vWF

3.

of agglutination agglutination test. lack causing by ➔ impaired ➔ to induces vWF GPib; vWF test-Ristocetin platelet Abnormal ristocetin platelet bind abnormal

vWF Weibel-Palade is release (ADH endothelial desmopressin Treatment analog), of increases which bodies from E. cells.

VII. VITAMIN K DEFICIENCY

A. Disrupts of multiple factors 1. coagulation function

in K liver. activated reductase by epoxide the is Vitamin

2.

necessary IX, gamma proteins carboxylation X, C vitamin II, for function. carboxylates K factors and VII, is factor S; Activated gamma and

B. 1. Deficiency occurs in

K; by to prophylactically that prevent lack to GI bacteria Newborns-due newborn. vitamin the disease normally birth newborns given synthesize vitamin injection K is of to all of colonization at hemorrhagic

2.

vitamin Long-term the antibiotic 3. GI tract therapy-disrupts in bacteria K-producing

Malabsorption-leads vitamin K including vitamins, fat-soluble deficiency to of

VIII. HEMOSTASIS SECONDARY CAUSES OF ABNORMAL OTHER

Liver decreased effect ofvitamin production on liver coagulation K using and failure factors PT. reductase; activation of is epoxide by failure-decreased coagulation of followed A.

a factors, Large-volume B. resulting coagulation relative transfusion-dilutes deficiency in

HEPARIN-INDUCED THROMBOCYTOPENIA I.

arises A. therapy Platelet heparin destruction that to secondary

remaining thrombosis. may platelets B. platelets, Fragments leading activate to destroyed of

II. INTRAVASCULAR DISSEMINATED COAGULATION

the coagulation Pathologic activation cascade of A. 1.

ischemia result and microthrombi Widespread in infarction.

2.

mucosa! factors of Consumption results and from and bleeding, platelets in sites especially IV surfaces from orifices). body (bleeding

B. process Almost secondary disease 1. always to another

in activates the Obstetric fluid thromboplastin coagulation. complications-Tissue amniotic

2.

tissue IL-1) bacterial (especially cytokines or cells endothelial the from factor. E and and induce make with Sepsis to (e.g., N TNF wall meningitidis)-Endotoxins Coli

3.

activates Adenocarcinoma-Mucin coagulation.

4.

granules coagulation. promyelocytic Acute activate leukemia-Primary

5.

coagulation. Rattlesnake activates bite-Venom

findings 1. include Laboratory C.

j,. platelet 2. count

3.

j,. 4. fibrinogen

5.

DIC. the best particularly D-dimer Elevated is screening for split fibrin test D-dimer Elevated i. products,

ii. Derived fibrinogen. not splitting cross-linked produced of fibrin; from of D-dimer is from splitting

coagulation and blood factors), as D. necessary. products transfusing cryoprecipitate underlying and addressing the Treatment involves (contains cause

III. FIBRINOLYSIS DISORDERS OF

A. thrombus damaged Normal vessel after heals. fibrinolysis removes

1.

to plasminogen activator plasmin. Tissue converts plasminogen (tPA)

2.

fibrin cleaves destroys blocks coagulation and fibrinogen, platelet aggregation. serum and Plasmin factors,

3.

inactivates a2-antiplasmin plasmin.

B. to in due cleavage resulting plasmin of excessive of Disorders serum fibrinogen. overactivity are fibrinolysis Examples include 1.

activates Radical urokinase plasmin. of prostatectomy-Release

2.

production Cirrhosis a2-antiplasmin of ofliver-reduced

(resembles increased with C. Presents bleeding DIC)

include 1. Laboratory findings D.

PT/PTT-Plasmin coagulation destroys t factors.

2.

count-Plasmin platelet with normal aggregation. blocks time t bleeding platelet

3.

split is formed fibrinogen products because Increased are fibrin not fibrinogen however, D-dimers absent. thrombi without D-dimers-Serum are lysed;

plasminogen. blocks is E. activation which acid, Treatment aminocaproic of

I. PRINCIPLES BASIC

intravascular an A. Pathologic blood (thrombus) 1. clot formation of

2.

of the below the (DVT) common the leg knee. Most deep veins location is

B. Characterized lines Zahn (alternating layers of RBCs, platelets/fibrin of (1) and Fig. by 4.3) attachment wall vessel 1. to and (2) postmortem distinguish clot. features thrombus from Both

cell disruption endothelial risk damage, C. factors major (Virchow and in Three triad). flow, hypercoagulable blood thrombosis are state for

II. BLOOD NORMAL IN DISRUPTION FLOW

for and thrombosis. flow A. blood of risk Stasis increases turbulence

1. and dispersed factors is Blood normally platelets continuous and laminar; keeps flow and inactivated

B. include 1. Examples

2.

myocardial arrhythmia dysfunction wall Cardiac 3. or (e.g., infarction)

III. CELL ENDOTHELIAL DAMAGE

the cells, thrombosis. risk disrupts damage for increasing endothelial A. protective Endothelial the of function

thrombosis by mechanisms. several prevent Endothelial cells B.

1.

to underlying collagen 2. tissue factor Block subendothelial exposure and

(PGI of NO-vasodilation and and inhibition prostacyclin platelet Produce )

by of 4.3 RBCs. Lines alternating and layers of characterized Zahn platelets/fibrin Fig,

3.

antithrombin heparin-like 4. and III thrombin factors molecules-augment coagulation Secrete which inactivates (ATIII),

(3) factors, activator plasminogen and which Secrete aggregation (tPA)-converts platelet fibrin blocks fibrinogen, plasminogen tissue serum (2) to plasmin, destroys coagulation 5. and cleaves (1)

inactivates protein and factors VIII V which thrombomodulin-redirects Secrete C, activate thrombin to

levels of endothelial and atherosclerosis, high homocysteine. Causes include of vasculitis, damage cell C.

1. the risk deficiency for Vitamin mildly and increasing Bl2 levels, elevated result in folate thrombosis. homocysteine

in the THF) circulates acid serum. i. methyl-THF as (tetrahydrofolate, Folic

11. (vitamin to participate DNA transferred of allowing cobalamin Methyl to precursors. the is in synthesis THF Bl2),

iii. methionine. homocysteine resulting to transfers Cobalamin in methyl

iv. Lack or conversion to methionine homocysteine Bl2 resulting homocysteine. folate leads of to buildup decreased ofvitamin of in

2. deficiency (CBS) in homocystinuria. Cystathionine beta high levels with results homocysteine synthase

1. buildup. CBS enzyme to to leads converts homocysteine cystathionine; homocysteine deficiency

ii. and long dislocation, mental thrombosis, Characterized by vessel fingers. lens slender retardation,

A. inherited excessive defective acquired to or procoagulant proteins may be anticoagulant Due or proteins;

B. Classic at or young is age. presentation DVT a DVTs recurrent

1. the in leg; veins. occurs and sites deep other hepatic cerebral the of include veins Usually

coagulation (autosomal the cascade. on feedback C. or negative Protein S deficiency decreases dominant) C

1.

Proteins inactivate and VIII. C S and V factors normally

2.

i. IX, (due X proteins relative C shorter factors temporary VII, a deficiency and half-life) in warfarin S and to ii. results Initial of therapy stage to of II, for deficiency therapy of seen risk deficiency, severe preexisting warfarin increasing S the skin. thrombosis, especially C In a or the onset in at is

deactivation V the Leiden of a C V Factor cleavage form by factor S. lacks site proteins for that mutated and is D.

1. inherited Most cause of hypercoagulable state common

Prothrombin that increased 20210A expression. is in inherited results gene prothrombin an E. mutation point in

1. thrombus increased prothrombin formation. results in Increased thrombin, promoting

deficiency of F. thrombus. molecules the effect protective TIII by produced A decreases heparin-like risk for the endothelium, increasing the

1.

ATIII, which factors. inactivates Heparin-like activate normally and thrombin molecules coagulation

2.

with standard heparin In deficiency, rise PTT ATIII dosing. does not

1. activating heparin works by Pharmacologic binding and ATIII.

11. High an heparin of to activate ATIII; then limited anticoagulated maintain state. given is doses coumadin

I.

II.

with G. state. associated are hypercoagulable contraceptives a Oral

1. coagulation of production thrombosis. risk induces Estrogen thereby increasing for factors, increased the

travels downstream vessels; vessel on depend A. the occludes involved. and Intravascular mass that symptoms

most B. a (>95%) common type Thromboembolus embolus of to is due thrombus that dislodges;

due C. Atherosclerotic to an dislodges. atherosclerotic that is embolus plaque

1. cholesterol clefts embolus by of the (Fig. presence in the Characterized 4.4A)

long associated fractures, bones, bone tissue is and trauma. D. soft embolus Fat with particularly

1.

still repair fracture is after present shortly 2. while Develops or

often with marrow elements, bone by (fat, vessels, Fig. Characterized dyspnea is in seen pulmonary overlying and petechiae the skin on the chest 4.4B)

sickness. classically decompression Gas embolus seen in is E.

1.

Nitrogen precipitates due out of gas by blood ascent rapid a diver. to

2.

joint ('chokes'). ('bends') with symptoms Presents and respiratory and pain muscle

3.

is multifocal form characterized disease) by ischemic Chronic bone. (Caisson of necrosis

4.

into also the abdomen). during surgery occur (air may Gas embolus pumped laparoscopic is

F. 1. during Amniotic delivery embolus labor fluid or circulation enters maternal

breath, neurologic 2. (due the Presents nature amniotic and thrombogenic with of to of fluid) symptoms, shortness DIC

by Characterized cells keratin embolus squamous (Fig. skin, in fetal and debris, from 4.4C)

A. the most is (DVT) the of extremity, the due femoral, deep source thrombus usually involving lower or Usually popliteal to venous thromboembolus; veins. common iliac,

B. supply is has lung bronchial the Most a the small because and clinically and arteries) pulmonary (via usually blood (1) (selfresolves) dual silent often (2) embolus

Fig. Emboli. 4.4 bolus characterized em by A, Atherosclerotic clefts. cholesterol bone with Fat embolus B, elements. marrow bolus cells keratin fetal with em from debris squamous and C, Amniotic skin. fluid Courtesy (A, A. of Garfia. Professor MD) Teas, Shakuntala C, Courtesy of

10% medium-sized if obstructed cause PEs cardiopulmonary pre-existing of occurs patients infarction. only compromise; with is artery Pulmonary C. infarction in large-or a

1.

with pleuritic hemoptysis, breath, pain, pleural shortness 2. and of Presents effusion chest

V/Q perfusion abnormal. mismatch; scan shows is lung

3.

Spiral CT shows vascular filling the in defect a lung.

4.

ultrasound Doppler detect is Lower to useful extremity DVT.

5.

elevated. D-dimer is

6.

infarct. hemorrhagic, Gross wedge-shaped a reveals examination

right with D. pulmonary a (Fig. arteries or Sudden pulmonary large embolus artery that occurs death large both blocks of significant and with left a occlusion saddle dissociation. is to death 4.5); due electromechanical

with Pulmonary hypertension reorganized over that arise may E. emboli time. are chronic

III. EMBOLISM SYSTEMIC

A. to Usually thromboembolus due

B. commonly heart left Most the arise in

flow organs, to occlude to most Travel the C. systemic commonly down circulation extremities lower

Fig. involving bolus em artery. Saddle 4.5 pulmonary of MD) Yale Rosen, (Courtesy

I. PRINCIPLES BASIC

A. cell mass blood circulating (RBC) red Reduction in

Presents of and symptoms B. signs 1. hypoxia with

Weakness, dyspnea and fatigue, 2.

3.

4.

with coronary Angina, especially disease preexisting artery

(Hb), RBC count surrogates C. for difficult as to and used hematocrit Hemoglobin mass, which measure. is RBC (Hct), are

1. in males and is g/dL 13.5-17.5 females 12.5-16.0 < defined g/dL is as 13.5 in in < Hb g/dL g/dL Anemia (normal 12.5 females). in and Hb males

D. = as > corpuscular classified normocytic µm3), 80 mean microcytic 100 macrocytic Based anemia on < or µm (MCV), µm volume 3). (MCV 3), (MCV (MCV can 80-100 be

I. PRINCIPLES BASIC

A. Anemia µm 3 80 < MCV with

are of decreased production due B. to Microcytic anemias hemoglobin.

1.

marrow mature progenitor = to divide large multiple the 80-100 µm smaller 3). cells cells normally bone produce times and RBC are (MCV in

2.

"extra" occurs hemoglobin division which to is Microcytosis due to an concentration. maintain

made globin; Hemoglobin of iron heme of heme is and composed is C. and protoporphyrin. any microcytic leads in these decrease anemia. of to components A

anemia, anemia include thalassemia. anemias sideroblastic Microcytic anemia, chronic (2) (3) (4) (1) iron disease, D. of and deficiency

II. IRON ANEMIA DEFICIENCY

A. decreased 1. iron to of Due levels microcytic ..I.-heme ..I.-iron ➔ anemia ➔ ➔ ..I.-hemoglobin

B. type 1. of anemia common Most of affecting the world, 1/3 most common deficiency is roughly Lack world's the iron nutritional of in population.

(meat-derived) C. heme (vegetable-derived) and consumed is in forms. Iron non-heme

1.

the occurs duodenum. Absorption in heme Enterocytes have is non-heme transporters; the more heme and (DMTl) readily absorbed. form

2.

transport via cell blood membrane iron Enterocytes into across the ferroportin.

3.

it blood and iron macrophages storage. Transferrin bone to transports and for in delivers the liver marrow

4.

free bound the reaction. radicals intracellular iron Stored iron Fenton which from is forming ferritin, prevents via to

pathoma.com

measurements iron D. Laboratory 1. status of

in blood Serum 2. of the iron iron-measure

blood transferrin Total in iron-binding molecules the 3. capacity of (TIBC)-measure

% saturation-percentage transferrin is bound iron 33%) molecules of 4. are (normal that by

the iron Serum in stores macrophages ferritin-reflects liver and

deficiency by usually loss. dietary lack caused Iron or E. blood is

1.

2. in iron) milk is low Infants-breast-feeding (human

3.

4.

hookworm Necator duodenale 5. americanus) in polyps/carcinoma and developing in world; Elderly-colon the Western world the (Ancylostoma

by causes absorbed include Other readily iron than Fe2+ and Fe3+). is absorption maintaining gastrectomy more aids state, malabsorption, (acid malnutrition, which the

Stages 1. F. of deficiency iron

is iron 2. ferritin; Storage depleted--J.. t TIBC

Serum iron; iron % depleted--J.. is serum 3. -J.. saturation

Normocytic RBCs. but fewer, normal-sized, marrow makes anemia-Bone

4.

anemia-Bone Microcytic, hypochromic RBCs. makes fewer marrow smaller and

iron pica. anemia, Clinical and of include deficiency G. koilonychia, features

include 1. findings H. Laboratory

width red Fig. distribution t with cell Microcytic, RBCs (RDW, hypochromic 2. 5.1)

saturation % serum 3. -J.. TIBC; ferritin; -J.. t iron; -J..

I. Treatment involves (ferrous iron supplemental sulfate).

beefy-red iron anemia, presents as esophageal dysphagia, deficiency Plummer-Vinson and anemia tongue J. with is atrophic web and glossitis; syndrome

III. DISEASE OF ANEMIA CHRONIC

A. most endocarditis anemia inflammation type cancer; or with common hospitalized (e.g., in Anemia of chronic autoimmune or associated conditions) patients

B. hepcidin. acute including production of phase results disease Chronic the liver, reactants from in

1. sites suppressing iron macrophages precursors to (2) in limiting Hepcidin erythroid and by (1) (EPO) from iron transfer erythropoietin storage sequesters

Fig. of 5.1 Fig. hypochromic iron Microcytic, RBCs blue 5.2 stain). sideroblasts Ringed (Prussian anemia. deficiency

prevent aim accessing their is from iron, production; survival. for necessary to which is bacteria

2. ➔ iron ➔ ..l.-hemoglobin ..l.-available ➔ ..l.-heme anemia microcytic

Laboratory C. findings 1. include

..l.-serum saturation t ..l.-% ..l.-TIBC, ferritin, 2. iron, and

addressing underlying D. involves cause. Treatment the

IV.

A. Anemia synthesis 1. to due protoporphyrin defective ..l.-protoporphyrin ➔ ➔ microcytic anemia ..l.-hemoglobin ..l.-heme ➔

Protoporphyrin synthesized of is via a reactions. series B.

1.

vitamin acid cofactor as CoA converts (ALAS) synthetase step). a (ALA) to aminolevulinic acid succinyl B6 (rate-limiting Aminolevulinic using

2.

dehydratase ALA acid porphobilinogen. (ALAD) to Aminolevulinic converts

3.

to reactions protoporphyrin. porphobilinogen Additional convert

4.

the heme (final make Ferrochelatase attaches to protoporphyrin mitochondria). in reaction; occurs iron to

and Iron precursors the transferred mitochondria heme. C. form to enters to erythroid is If protoporphyrin in is deficient, iron trapped mitochondria. remains

1. are the called around (hence, of term erythroid anemia, the nucleus Iron-laden these form a ring sideroblasts mitochondria precursors; Fig. sideroblastic ringed cells 5.2).

acquired. Sideroblastic can be anemia or D. congenital

1.

defect ALAS (rate-limiting enzyme). most Congenital commonly involves

2.

1. ii. Alcoholism-mitochondrial poison iii. ALAD ferrochelatase and Lead poisoning-inhibits tuberculosis as Vitamin commonly treatment side of B6 deficiency-required effect ALAS; isoniazid most seen for a cofactor for

include serum iron, t saturation and t -1, E. ferritin, (iron-overloaded TIBC, Laboratory % findings state). t

V.

A. Anemia globin 1. synthesis due hemoglobin the to of chains decreased of ➔ hemoglobin ➔ -1, globin -1, microcytic anemia

B. protected are against carriers falciparum Inherited Plasmodium malaria. mutation;

beta into production globin based P-thalassemia on or decreased of Divided C. a-and chains. alpha

1. HbA2 types Normal are HbF of (a2y), HbA (a2p), and (a/\). hemoglobin

Anemia Findings 5.1: in Table Laboratory Microcytic

Low High Low Chronic Anemia Low Disease of

D.

E.

present due a-Thalassemia usually is are gene 16. to alpha chromosome deletion; genes on 4 normally,

1.

2.

deleted-mild associated severe genes increased an deletion with cis count; thalassemia of offspring. in is anemia RBC with risk Two t

deletions chromosome; Asians on seen both when is in the deletion i. same occur ii. Cis including on when in African seen is Americans deletion deletion each 3. occurs one Trans chromosome; Africans,

seen chains on HbH (HbH) is Three that anemia; RBCs; electrophoresis. genes tetramers deleted-severe p damage form

4.

RBCs; damage seen on Barts Hb electrophoresis. that (Hb Barts) is of P-Thalassemia is in gene 1. or and in mutations sites); to individuals mutations African promoter descent usually Mediterranean (point seen due splicing

diminished the genes or present on mutations production in chromosome chain. of p-globin absent p (p+) are Two (P0) 11; result

2.

is with and is of increased (PIP+) mildest P-Thalassemia disease an usually form RBC asymptomatic count. minor the

i. are on smear target and (Fig. Microcytic, seen RBCs hypochromic blood cells 5.3).

ii. with HbA decreased electrophoresis HbA Hemoglobin 1%). (2%, normal (5%, slightly shows and normal increased HbF 2.5%)

3. HbF a disease temporarily birth; (a2y) severe presents (P form protective. is P-Thalassemia of most anemia few with months at high birth major the is severe after and 0!pa)

precipitate hemolysis erythropoiesis ineffective (removal resulting by damage and the and in a membrane, RBCs circulating RBC of i. Unpaired spleen). chains extravascular

ii. to erythroid formation the skull bone 'crewcut' on in leads expansion hyperplasia appearance Fig. (reactive into hematopoiesis of (1) resulting x-ray, ensues Massive facial with 5.4) precursors. extramedullary (3) hematopoiesis and erythroid risk aplastic infection with ('chipmunk parvovirus Bl9 crisis of bones facies'), (2) hepatosplenomegaly, and of

iii. transfusions often secondary hemochromatosis for necessary; to iv. risk Chronic leads are

hypochromic RBCs red blood cells. with target and Smear microcytic, shows cells nucleated

v.

Electrophoresis with HbA. and or HbF little no shows HbA

Fig. 5.3 Target cells. Fig. 5.4 'Crewcut' appearance. Fig. (Reproduced with in www.orthopaedia.com/x/xgGvAQ) Hypersegmented 5.5 permission, neutrophil anemia. macrocytic

I. BASIC PRINCIPLES

A. due 100 to most or commonly (megaloblastic folate MCV deficiency µm3; with Bl2 > Anemia vitamin anemia)

are vitamin Folate DNA for necessary synthesis Bl2 B. and of precursors.

1.

Folate serum removal DNA group of the circulates the as precursors. allows methyl in (methyl for the methyltetrahydrofolate participation in of THF); synthesis

2.

to transferred is Bl2 vitamin (cobalamin). group Methyl

3.

then transfers it homocysteine, Bl2 producing to Vitamin methionine.

precursors. folate C. of Bl2 vitamin of DNA Lack or synthesis impairs

1.

Impaired megaloblastic leads and precursors anemia. RBC to enlargement division of

2.

Impaired leads precursors hypersegmented to granulocytic division neutrophils. of

3.

rapidly-dividing epithelial intestinal) (e.g., in also cells. change seen is Megaloblastic

change) (e.g., and causes 5-FU). liver disease, (without include drugs megaloblastic alcoholism, anemia of D. Other macrocytic

II. FOLATE DEFICIENCY

Dietary and green vegetables from A. is obtained some folate fruits.

1. the jejunum Absorbed in

as deficiency stores within minimal. Folate B. develops body are months,

increased which and hemolytic diet C. and dihydrofolate alcoholics demand include cancer, reductase). elderly), folate inhibits (e.g., (e.g., antagonists methotrexate, and Causes (e.g., poor anemia), pregnancy,

1. findings Clinical and laboratory D. include

Macrocytic (> Fig. 5 neutrophils lobes, hypersegmented RBCs and 2. 5.5)

3.

.,J., 4. serum folate

5.

DEFICIENCY Ill. Bl2 VITAMIN

to Dietary Bl2 animal-derived proteins. vitamin A. is complexed

1.

is gland salivary (e.g., Salivary (also from then and the carried enzymes which bound liberate 2, R-binder Bl by amylase) gland) the stomach. vitamin through

2.

duodenum detach proteases in Pancreatic the Bl2 vitamin from R-binder.

3.

absorbed in is Vitamin cells) the ileum. parietal the by factor-vitamin (made in small gastric bowel; intrinsic intrinsic factor the Bl2 binds complex Bl2

develop vitamin B. Vitamin common and of large is due hepatic than to Bl2 2. to folate less takes stores deficiency Bl deficiency years

anemia the Bl2 cause most common C. of is deficiency. vitamin Pernicious

1. intrinsic factor of of cells parietal stomach) (body deficiency to destruction Autoimmune leads

vegans. vitamin rare, insufficiency except (e.g., dietary latum pancreatic disease or in [fish deficiency Other causes terminal Diphyllobothrium and damage the Crohn to deficiency tapeworm]); Bl2 ileum D. of include is

findings and 1. E. Clinical laboratory include

hypersegmented neutrophils 2. with Macrocytic RBCs

3.

the degeneration for metabolism). methylmalonic combined the B12 of acid CoA Vitamin a (important cord Subacute cofactor i. fatty acid is conversion in of spinal succinyl to

ii. impairs of levels deficiency methylmalonic which myelinization. in acid, Vitamin cord results increased spinal B12

iii. in spastic column) Damage results poor (lateral tract). proprioception and corticospinal vibratory (posterior sensation paresis and

4.

vitamin -.J, B12 5. serum

deficiency), for serum t increases homocysteine 6. to risk (similar folate which thrombosis

I. PRINCIPLES BASIC

A. = Anemia normal-sized RBCs (MCV µm3) with 80-100

B. increased Due to peripheral destruction or 1. underproduction helps etiologies. between two Reticulocyte these count distinguish to

II. RETICULOCYTES

A. 1. Young bone marrow RBCs the from released with larger smear bluish blood cells Identified cytoplasm (due RNA, Fig. as on residual to 5.6)

B. is reticulocyte 1-2%. count Normal (RC)

1. and 120 are removed roughly circulation from is by each day lifespan 1-2% ofRBCs RBC days; reticulocytes. replaced

the to anemia A properly C. 3%. by to responds increasing marrow RC > functioning

falsely however, is anemia. in D. RC, elevated

1. RBCs RBCs; RC percentage falsely reticulocytes. as in measured decrease total is total of of elevates percentage

E. corrected multiplying count reticulocyte Hct/45. by RC is by

1.

and count indicates Corrected good > peripheral suggests response marrow 3% destruction.

2.

suggests underproduction. Corrected count indicates < 3% and response poor marrow

III. PERIPHERAL RBC (HEMOLYSIS) DESTRUCTION

A. extravascular in a anemia and response. good result into both intravascular Divided marrow with hemolysis;

system reticuloendothelial lymph involves nodes). and hemolysis Extravascular the by spleen, RBC destruction (macrophages B. liver, of the

Fig. 5.6 Reticulocyte. Fig. 5.7 Spherocytes.

1. consume hemoglobin. RBCs break and Macrophages down

i. is acids. broken Globin into down amino

ii. iron broken is iron Heme protoporphyrin; down into is recycled. and

111. into bound and delivered conjugation excretion to the unconjugated albumin for which down is Protoporphyrin bile. serum and into to liver bilirubin, is broken

2. laboratory i. Clinical include and findings splenomegaly, with unconjugated bilirubin increased gallstones Anemia ii. and to due jaundice for bilirubin, risk count> 3% reticulocyte hyperplasia corrected with Marrow

destruction of hemolysis involves C. vessels. Intravascular RBCs within

1. Clinical include laboratory and findings 1. 11. Hemoglobinemia iii. Hemoglobinuria filtered iron, cells that in resulting hemoglobin into the urine of which the down tubular accumulates as cells hemosiderinuria. are it is Hemosiderinuria-Renal break hemosiderin; shed eventually up into and some pick tubular

iv. haptoglobin serum Decreased

I. HEREDITARY SPHEROCYTOSIS

A. proteins defect cytoskeleton-membrane Inherited ofRBC 1. tethering involves Most band ankyrin, spectrin, commonly or 3

B. time. Membrane and over formed are lost blebs

1.

(spherocytes) disc-shaped. of Loss cells of membrane renders round instead

2.

splenic resulting able anemia. through by to sinusoids macrophages, in maneuver splenic and less consumed Spherocytes are are

and laboratory C. include Clinical 1. findings

of central pallor (Fig. with Spherocytes loss 5.7) 2.

3.

unconjugated (extravascular 4. with hemolysis) for risk Splenomegaly, bilirubin, and jaundice bilirubin increased gallstones

risk a infection erythroid for Bl9 plastic of parvovirus Increased precursors with crisis

which by Diagnosed D. osmotic in fragility increased test, hypotonic solution fragility reveals spherocyte

and of nuclear in E. is Howell-Jolly spherocytes resolves, splenectomy; persist (fragments emerge blood (Fig. RBCs) Treatment but bodies anemia material on smear 5.8).

II. SICKLE ANEMIA CELL

single A. change (hydrophobic). in~ a amino Autosomal valine hemoglobin; chain with mutation acid glutamic acid of (hydrophilic) recessive normal replaces

against individuals to of of by Gene falciparum protective likely descent, 10% role carried is malaria. due African B.

cell are HbS >90% results abnormal in ~ arises two present; disease C. genes RBCs Sickle when in

cells resulting D. into structures, HbS when in polymerizes deoxygenated; aggregate (Fig. needle-like polymers sickle 5.9).

1.

Increased and occurs of with risk sickling dehydration, acidosis. hypoxemia,

2.

life. birth high is first protective against protects months the at few of for HbF sickling; HbF hydroxyurea increases with levels Treatment ofHbF.

E.

F.

G.

H.

passing and Cells sickle complications de-sickle through microcirculation, damage. continuously related while RBC to resulting the membrane in

1.

to leading risk membranes, bilirubin damaged anemia, Extravascular increased system removes hyperbilirubinemia, jaundice hemolysis-Reticuloendothelial gallstones. with unconjugated and with RBCs for

2.

decreased haptoglobin leading damaged cells to blood hemolysis smear. target Intravascular and membranes with dehydrate, with on hemolysis-RBCs

3.

i. l Expansion of facies') facia the appearance into ('crewcut' skull on 11. x-ray) hematopoiesis bones and ('chipmunk hematopoiesis iii. with Extramedullary hepatomegaly crisis of with Extensive sickling leads vaso-occlusion. precursors aplastic of Risk of parvovirus complications B19 erythroid to infection

1.

feet due infarcts vaso-occlusive 2. hands bones; Dactylitis-swollen in to common presenting infants sign in and

fibrotic spleen. Autosplenectomy-shrunken, include Consequences i. risk such cause be death of vaccinated 5 and of affected children); age. years Streptococcus encapsulated Increased with in by organisms should influenzae common of Haemophilus as pneumoniae infection children (most

ii. iii. Salmonella paratyphi osteomyelitis of Increased risk smear on blood Howell-Jolly 3. bodies

Presents breath, with ii. shortness chest i. lung and pain, of infiltrates Often precipitated iii. by pneumonia cause death patients common of in adult Most 4.

5.

proteinuria of papillary in more one pchain; slightly Renal and hematuria in normal 50% HbS) < 1. HbS one presence than results trait and the (HbA gross RBCs efficiently is produced is mutated Sickle cell necrosis-results in HbS in vivo asymptomatic medulla. Generally 50% with renal < no not RBCs do in with sickle except the anemia;

1. to microscopic in decreased hematuria which microinfarctions sickling, concentrate the urine. ability hypoxia leading eventually, hypertonicity to cause and medulla and, Extreme results of

1.

sickle cells blood trait. target in on Sickle but cell cell seen and smear in cells disease, are not sickle

2.

sickle; positive any Metabisulfite in to HbS amount causes and of 3. both screen with cells trait disease

electrophoresis amount ofHbS. presence the confirms Hb and

Fig. Fragment (HowellFig. 5.8 of nuclear remnant Sickle 5.9 cell disease. Fig. 5.10 crystal. Hemoglobin C within body) RBC. Jolly

Red Blood Cell _,... Disorders

HbS, (no HbA) Disease-90% HbF, HbA 8% ii. 2% i. Trait-55% 43% HbS, HbA, 2% HbA2

III. C HEMOGLOBIN

Autosomal of 1. recessive mutation hemoglobin in ~ chain A.

Normal acid is replaced lysine. glutamic by

2.

Presents extravascular hemolysis due B. to anemia with mild

(Fig. C. smear seen on HbC crystals blood RBCs are Characteristic in 5.10).

I. HEMOGLOBINURIA PAROXYSMAL NOCTURNAL (PNH)

A. Acquired 1. defect resulting in to susceptible (GPI); renders cells glycosylphosphatidylinositol destruction by in cells myeloid absent stem complement

complement. with cells coexist Blood

2.

(DAF) against the factor by protects of on accelerating complement-mediated Decay convertase. damage surface cells inhibiting C3 blood

3.

anchoring to is membrane the DAF by glycolipid). cell (an GPI secured

4.

susceptible of Absence leads absence complement-mediated of to damage. to rendering cells DAF, GPI

B. episodically, night occurs often hemolysis during at Intravascular sleep.

1.

breathing respiratory complement. sleep activates acidosis shallow and Mild with during develops

2.

platelets and are lysed. RBCs, WBCs,

3.

hemoglobinuria the hemoglobinemia leads in morning); and hemolysis seen after days hemolysis. Intravascular to hemosiderinuria (especially is

test Sucrose is screen of the is to blood test acidified CDSS flow (DAF) cytometry to on test confirmatory serum C. cells. or for lack disease; used detect

hepatic, of cerebral death the veins. Main or portal, D. cause is thrombosis of

1. inducing circulation, release thrombosis. Destroyed platelets cytoplasmic into contents

to develops deficiency hemoglobin in of leukemia myeloid 10% Complications loss (due acute E. urine) (AML), chronic include in patients. of which and the anemia iron

II. GLUCOSE-6-PHOSPHATE DEFICIENCY (G6PD) DEHYDROGENASE

A. stress susceptible oxidative G6PD; recessive half-life renders disorder 1. to in reduced resulting X-linked of cells

H20 stress, particular 2• in 2. normally RBCs are oxidative exposed to

oxidized antioxidant) 0 , becomes but process. neutralizes in (an the H Glutathione

3.

needed glutathione. to G6PD, NADPH, by-product of a reduced regenerate is

4.

NADPH glutathione ➔ ➔ ,J, G6PD ➔ oxidative intravascular ,J, by hemolysis ,J, 2 reduced ➔ injury H20

has variants. G6PD deficiency B. two major

1.

to oxidative leading hemolysis mild stress African G6PD variant-mildly half-life of reduced with 2. intravascular

hemolysis intravascular G6PD with marked variant-markedly reduced to oxidative 3. half-life stress leading Mediterranean of

in protective is frequency populations to malaria. carrier High against due likely falciparum role both

stress C. Heinz Oxidative precipitates bodies. as Hb

1.

primaquine, drugs, of and beans. drugs dapsone), (e.g., include stress infections, and oxidative Causes sulfa fava

2.

from (Fig. are RBCs Heinz by bodies resulting macrophages, removed bite splenic in cells 5.11).

3.

predominantly hemolysis to intravascular Leads

exposure hemoglobinuria pain after to Presents oxidative and hours back with D. stress

(precipitated a stain, be for is Fig. seen screen special hemoglobin to preparation only Heinz Heinz disease with can E. used studies deficiency 5.12); (performed enzyme confirm episode after resolves). hemolytic weeks

III. IMMUNE ANEMIA HEMOLYTIC (IHA)

A. IgM) ofRBCs destruction (IgG Antibody-mediated or

disease hemolysis. involves IgG-mediated B. usually extravascular

1.

resulting is agglutinin); RBCs binds of the splenic (warm temperature in by IgG body the central in consumed antibody-coated relatively RBC membrane warm macrophages, of spherocytes.

2.

Associated CLL, with cephalosporins) i. (most penicillin cause), and SLE drugs common and (classically, certain drug-membrane membrane binding to to of Drug RBC complex attach (e.g., penicillin) ii. antibody with subsequent may RBCs 3. on a-methyldopa) induce Drug (e.g., may bind production of self autoantibodies that antigens

if splenectomy. cessation IVIG, involves necessary, steroids, offending Treatment and, drug, the of

lead C. IgM-mediated disease can to hemolysis. intravascular

1.

fixes the complement temperature of cold and binds the agglutinin). RBCs IgM in (cold extremities relatively

2.

hemolysis. for an complement, serves activation but to macrophages in splenic resulting residual RBCs intravascular opsonin lead complement can C3b of extreme as spherocytes; inactivate

3.

pneumoniae infectious Associated Mycoplasma with mononucleosis. and

can is Coombs test or used IHA; direct diagnose testing D. be indirect. to

1.

presence antibody-or Direct Coombs the confirms of complement-coated test RBCs. added anti-IgG/complement agglutination coated patient IgG with if or are occurs already When is RBCs to RBCs, complement. for This is most the test IHA. important

2.

antibodies Coombs serum. the Indirect confirms presence of patient in test the are AntiIgG present. mixed test occurs antibodies are patient serum; agglutination if and serum with RBCs

Fig. Bite 5.11 cell. Fig. (Heinz 5.12 Heinz preparation). bodies Fig. Schistocyte. 5.13

IV.

pathology; destroyed circulation. are through they vascular hemolysis A. pass that as from the RBCs results Intravascular

1. chronic anemia hemolysis. deficiency with Iron occurs

B. present, with microthrombi heart HELLP), and on microthrombi schistocytes DIC, valves, blood when (TTP-HUS, smear Occurs stenosis; produce (Fig. aortic prosthetic 5.13).

V.

A. (Fig. liver ofRBCs Infection Plasmodium with and female 5.14); the transmitted by mosquito Anopheles

RBCs the of in intravascular a fever. part as B. resulting rupture odium hemolysis Plasm life cycle, and cyclical

1.

2.

results splenomegaly also C. extravascular mild RBCs; in infected hemolysis with consumes some Spleen

I. PRINCIPLES BASIC

A. production by RBCs count bone characterized of marrow; by corrected low Decreased reticulocyte

Etiologies B. 1. include

Causes anemia 2. of macrocytic and microcytic

3. EPO by Renal of cells failure-decreased interstitial production peritubular

Damage in result anemia to bone (may marrow pancytopenia) cells or precursor

II. PARVOVIRUS Bl9

significant of cells temporarily and anemia leads the (e.g., setting sickle stress cell marrow red erythropoiesis; in to progenitor A. Infects anemia). preexisting halts

B. is is Treatment (infection self-limited). supportive

III. APLASTIC ANEMIA

A. thrombocytopenia, in pancytopenia hematopoietic leukopenia) with stem Damage resulting low (anemia, count to and reticulocyte cells,

viral drugs Etiologies include chemicals, infections, and damage. or B. autoimmune

fatty empty, C. reveals an marrow (Fig. Biopsy 5.15).

Fig. falciparum. 5.14 P infected Erythrocytes with Fig. Aplastic anemia. 5.15 MD) Mourao, Paulo of (Courtesy

marrow-stimulating D. supportive Treatment erythropoietin, GM-CSF, and with includes factors any and transfusions (e.g., of care cessation G-CSF). and causative drugs

1.

may to of with cases release Immunosuppression due are abnormal be as cytokines. helpful activation T-cell some idiopathic

2.

as resort bone May transplantation a require last marrow

IV. PROCESS MYELOPHTHISIC

resulting is that metastatic in process A. impaired, bone cancer) Pathologic (e.g., hematopoiesis replaces pancytopenia. marrow;

I. PRINCIPLES BASIC

Hematopoiesis stepwise occurs hematopoietic a of CD34+ (Fig. via A. maturation stem cells 6.1).

B. released into Cells bone the and the blood. marrow mature are from

white cell is count (WBC) K/µL. 5-10 A blood normal approximately C.

called is low l. leukopenia. A K) WBC 5 count(<

2.

K) called is high WBC leukocytosis. count(> A 10

3.

WBC or high one count decrease low A increase in lineage. due or a usually to cell particular is

II. LEUKOPENIA

Neutropenia a decreased of to refers neutrophils. number A. circulating of in cells to decreased with include chemotherapy neutrophils. (e.g., alkylating especially production agents)-Damage l. Causes stem WBCs, toxicity Drug results

2.

Severe (e.g., in sepsis)-Increased into neutrophils. decreased infection tissues circulating of neutrophils results movement gram-negative

3.

granulocyte may to patients. As or neutropenic a in thereby boost used G-CSF infection be production, GM-CSF treatment, decreasing risk of

of lymphocytes. Lymphopenia decreased number circulating to refers B. a Immunodeficiency 2. HIV) or Di l. syndrome Causes (e.g., include George

exogenous (e.g., 3. Cushing corticosteroids or syndrome)induces state lymphocytes of High cortisol apoptosis

(e.g., systemic erythematosus) 4. destruction lupus Autoimmune

lymphopenia earliest emerge are body highly sensitive change to radiation-Lymphocytes the radiation; to Whole body after radiation. is whole

III. LEUKOCYTOSIS

A. Neutrophilic circulating leukocytosis increased refers to neutrophils. Causes immature immature of and cells including marrow receptors bone by or (CD16). (left release tissue include are shift); pool infection forms characterized necrosis-induces l. Bacterial decreased neutrophils, Fe marginated

Fig. Hematopoiesis. 6.1

pathoma.com 2. leukocyte cortisol release of pool High state-impairs of neutrophils to marginated adhesion, leading

monocytes. to circulating B. Monocytosis increased refers inflammatory chronic Causes infectious) autoimmune and and (e.g., malignancy. states include

refers circulating to eosinophils. increased C. Eosinophilia parasitic Hodgkin (type allergic and reactions lymphoma. infections, Causes hypersensitivity), include I is driven Eosinophilia factor. increased eosinophil by chemotactic

leukemia classically to refers myeloid Basophilia in increased basophils; seen chronic circulating D.

increased Lymphocytic refers to leukocytosis E. lymphocytes. circulating include 1. Causes

virally response infections-T lymphocytes hyperplasia to in undergo cells. infected Viral

2.

lymphocytosis-promoting from pertussis infection-Bacteria enter produce node. Bordetella the to which the circulating lymphocytes blood leaving blocks lymph factor,

IV. INFECTIOUS (IM) MONONUCLEOSIS

a reactive results CDs+ infection comprised that leukocytosis A. cells; in T lymphocytic EBV cause. of common a less CMV is

1. is transmitted by teenagers classically affects disease"); saliva EBV ("kissing

1. infects EBV B. primarily

2. resulting in Oropharynx, pharyngitis

enzymes elevated and 3. resulting liver hepatitis with in Liver, hepatomegaly

leads 1. response T-cell CDs+ to C.

lymphadenopathy lymph (LAD) due in 2. hyperplasia paracortex node to the T-cell Generalized

to hyperplasia T-cell due (PALS) in periarterial Splenomegaly 3. lymphatic sheath the

CDs+ High T count atypical WBC (Fig. (reactive with the in lymphocytes cells) blood 6.2)

The for test is screening. monospot used D.

1.

antibodies) red cells that horse IgM cross-react or Detects (heterophile blood sheep with 2. antibodies

3.

of as monospot A negative suggests a cause possible IM. test CMV

4.

diagnosis capsid EBV testing the serologic antigen. for is Definitive made viral by

Fig. Atypical lymphocyte, 6.2 Fig. infectious 6.3 rupture. Splenic K.V. (Courtesy of mononucleosis. MD) Santosh,

Complications E. 1.

Increased (Fig. splenic risk rupture for patients advised for 6.3); avoid one month. contact generally are to sports

2.

ampicillin if 3. Rash exposed to

for and risk lymphoma, of immunodeficiency HIV) both cells in Dormancy develops. (e.g., virus recurrence increased leads to B-cell especially B if

I. PRINCIPLES BASIC

of blasts bone the A. of in defined accumulation blasts; marrow. as > 20% proliferation the Neoplastic

B. with in Increased neutropenia (bleeding), anemia (fatigue), resulting an or normal (infection). "acute" "crowd-out" thrombocytopenia blasts presentation hematopoiesis,

WBC a blood resulting in Blasts stream, high usually the C. count. enter

1. Blasts cells, (Fig. immature nucleoli with out are large, punched often 6.4).

acute myelogenous phenotype (ALL) lymphoblastic subdivided leukemia leukemia leukemia acute on the into Acute based the (AML) D. or is of blasts.

II. ACUTE LEUKEMIA LYMPHOBLASTIC

marrow accumulation (> Neoplastic the 20%) bone 1. oflymphoblasts A. in

DNA characterized TdT, staining positive polymerase. for by a Lymphoblasts nuclear are

2.

lymphocytes. TdT in blasts myeloid and mature absent is

B. after 5 Most children; in syndrome arises years) age with of associated commonly the Down (usually arises

C. Subclassified on and markers B-ALL based surface into T-ALL

most B-ALL of ALL. type common the D. is

1.

and characterized that CD19, express Usually lymphoblasts CDlO, by CD20. (TdT+)

2.

and Excellent response CSF to chemotherapy; (Fig. requires to scrotum prophylaxis 3. 6.5)

Prognosis based abnormalities. is cytogenetic on

i. prognosis; in children t(l2;21) seen has commonly more ii. a good (Philadelphia+ more prognosis; ALL) adults a poor seen in has t(9;22) commonly

CD2 markers CDS (e.g., E. ranging CD3, (TdT+) express T-ALL is by that CD4, lymphoblasts characterized to from CD7). blasts do The express CDlO. not

Fig. acute leukemia. of Blasts 6.4 Fig. meninges. involving lymphoblastic 6.5 leukemia Acute

1. acute Usually as teenagers because mass) in a (called form lymphoma lymphoblastic (thymic) the mass cells presents malignant a mediastinal

III. MYELOID LEUKEMIA ACUTE

Neoplastic bone cells (> marrow of immature in 20%) accumulation myeloid the A.

myeloperoxidase B. by usually are cytoplasmic (MPO). staining Myeloblasts positive characterized for

1. Crystal be may (Fig. MPO aggregates as of seen Auer rods 6.6).

is years) commonly C. older 50-60 in age adults (average Most arises

Subclassification lineage myeloid abnormalities, D. surface on of markers. and cytogenetic immature cells, based include 1. subtypes High-yield (APL) i. promyelocytic Acute leukemia maturation Characterized (RAR) chromosome of chromosome translocation promyelocytes 17 by which and receptor retinoic 15; acid to blocks accumulate. involves the t(l5;17), disruption RAR (blasts) on

ii. Abnormal primary DIC. that the promyelocytes numerous contain for granules increase risk

iii. vitamin mature acid the die). eventually the is causes and to with altered all-trans-retinoic (and A Treatment which (ATRA, receptor derivative), a blasts binds

2. i. Acute leukemia monocytic monoblasts; lack MPO of ii. Proliferation usually characteristically gums Blasts (Fig. infiltrate 6.7).

3. megakaryoblastic i. Acute leukemia megakaryoblasts; MPO ii. lack of Proliferation of 5) arises the with Down age before (usually Associated syndrome

AML (myelodysplastic arise alkylating exposure radiotherapy. pre-existing may to prior agents from or also syndromes), dysplasia with especially E.

1.

syndromes usually Myelodysplastic with increased marrow, abnormal present 20%). bone maturation and blasts(< ofcells, cytopenias, hypercellular

2.

die though from progress bleeding, or to Most leukemia. some infection acute patients

I. BASIC PRINCIPLES

count Neoplastic by high proliferation lymphocytes; circulating characterized a WBC of mature A.

B. adults seen insidious older and onset in in Usually

II. CHRONIC LEUKEMIA LYMPHOCYTIC (CLL)

Neoplastic leukemia co-express that and A. common CDS proliferation CD20; naive overall B most of cells

B. and smudge seen lymphocytes blood Increased are smear cells (Fig. on 6.8).

of and generalized small lymphoma. nodes lymphocytic lymph Involvement called lymphadenopathy leads is C. to

Complications D. 1. include

most of common CLL. cause Hypogammaglobulinemia-Infection in death the is

2.

3.

to large transformation)marked spleen diffuse clinically or B-cell an lymph lymphoma node (Richter Transformation by enlarging

III. HAIRY LEUKEMIA CELL

A. Neoplastic mature characterized proliferation by B (Fig. cells of cytoplasmic hairy processes 6.9)

B. tartrate-resistant acid phosphatase (TRAP). positive are Cells for

accumulation to aspiration marrow pulp) Clinical and to bone in of red cells (due C. hairy splenomegaly include "dry features marrow on fibrosis). tap" (due absent. usually is Lymphadenopathy

to cells. levels 2-CDA Excellent D. in (cladribine), deaminase accumulates to response toxic neoplastic adenosine B inhibitor; an adenosine

IV.

mature T cells A. Neoplastic of CD4+ proliferation

B. seen HTLV-1; Associated in and Japan with Caribbean the most commonly

with bone lesions with infiltration), and (punched-out) lytic include rash hypercalcemia. (skin lymphadenopathy features C. generalized hepatosplenomegaly, Clinical

V.

Neoplastic infiltrate rash, and skin mature cells A. the T nodules. of proliferation skin, plaques, that producing CD4+ localized Pautrier Aggregates in the microabscesses. called cells epidermis neoplastic of are

B. involve producing spread Sezary blood, the to syndrome. can Cells

1. (Fig. (Sezary lymphocytes cerebriform blood Characteristic with nuclei cells) smear are seen on 6.10).

Fig. 6.9 Hairy cell leukemia. (Courtesy of Paulo Fig. Sezary cells. 6.10 Mourao, MD) MD) Mourao, Paulo of (Courtesy

I. PRINCIPLES BASIC

disease 50-60 of Neoplastic proliferation (average mature is A. of cells adulthood myeloid lineage; of years) late age

B. 1. with count WBC high marrow Results in bone hypercellular increased; cell myeloid produced classified myeloid of on the all based are lineages dominant Cells

include C. 1. Complications

to of cells turnover for hyperuricemia gout 2. due risk and high Increased

marrow to to fibrosis Progression leukemia acute or transformation

II. LEUKEMIA CHRONIC (CML) MYELOID

basophils are and precursors; myeloid their (Fig. especially of proliferation granulocytes characteristically cells, A. Neoplastic increased mature 6.11).

B. BCR-ABL with tyrosine chromosome) Driven a activity. increased protein kinase fusion t(9;22) (Philadelphia which generates by

1. which kinase blocks line activity. imatinib, treatment tyrosine First is

C. common. is Splenomegaly shortly to spleen transformation phase thereafter. Enlarging progression suggests acute to follows of accelerated leukemia disease; usually

1. stem pluripotent cases) Can (2/3 cases) of transform a (1/3 to cell. in since of is AML ALL or mutation

a CML 1. neutrophilic (reactive reaction from by is distinguished D. leukocytosis) leukemoid

stain leukocyte LAP (granulocytes reaction a leukemoid 2. positive) in are Negative (LAP) alkaline phosphatase

reaction) Increased 3. leukemoid basophils (absent with

III. (PV) VERA POLYCYTHEMIA

especially myeloid 1. cells, A. of RBCs Neoplastic mature proliferation and platelets also are increased. Granulocytes

B. mutation Associated JAK2 kinase with

due symptoms hyperviscosity are to mostly of blood. Clinical C.

1.

2.

sinus) hepatic portal thrombosis dural and risk vein, 3. of Increased venous vein, (e.g.,

4. due face Flushed congestion (plethora) to

after mast increased histamine from release to Itching, (due cells) especially bathing

D. therapy is is second-line hydroxyurea. Treatment phlebotomy;

Fig. leukemia. Chronic 6.11 myelogenous Fig. Essential thrombocythemia. 6.12

1. Without treatment, year. occurs death within one usually

E. must PV be polycythemia. distinguished reactive from

1.

are erythropoietin (EPO) PV, levels Sao decreased, In and is normal.

2.

increased. EPO to and is disease, due In high is reactive Sao2 lung altitude low, polycythemia or

3.

EPO polycythemia Sao2 EPO carcinoma, and to cell from ectopic is production high, due normal. reactive is In renal

IV.

especially of cells, (Fig. mature Neoplastic platelets myeloid proliferation A. 1. 6.12) RBCs also increased. granulocytes are and

B. with mutation JAK2 kinase Associated

Symptoms of to are C. and/or risk thrombosis. related an increased bleeding

1.

fibrosis Rarely marrow to 2. or acute leukemia progresses

V.

A. mature megakaryocytes especially cells, of 1. Neoplastic proliferation myeloid kinase with (50% mutation of cases) Associated JAK2

(PDGF) (Fig. causing factor Megakaryocytes marrow B. growth excess platelet-derived fibrosis produce 6.13).

C. 1. features include Clinical

to Splenomegaly due extramedullary hematopoiesis 2.

smear granulocytes, (tear-drop and RBCs, Leukoerythroblastic immature nucleated Fig. RBCs, 3. 6.14)

Increased infection, bleeding thrombosis, and of risk

I. PRINCIPLES BASIC

A. nodes. to lymph LAD enlarged refers

1.

that acute lymphadenitis). seen in is nodes LAD are infection lymph draining (acute usually a region of Painful

2.

lymphadenitis), lymphoma. carcinoma, seen or can metastatic Painless chronic LAD (chronic inflammation with be

B. particular of of (Fig. lymph hyperplasia node the is to regions inflammation, node In enlargement due lymph 6.15).

1. example. rheumatoid infection, region) of hyperplasia arthritis with seen (B-cell HIV Follicular for stages early and is

Fig. Myelofibrosis. 6.13 Fig. Tear-drop 6.14 RBC. Fig. node. 6.15 lymph Normal

2.

region) with (e.g., (T-cell mononucleosis). viral Paracortex hyperplasia is seen infectious infections

3.

is that draining in of a cancer. are with tissue sinus histiocytes seen Hyperplasia nodes lymph

I. BASIC PRINCIPLES

node that arise a Neoplastic cells may proliferation forms A. a lymph tissue in in oflymphoid extranodal mass; or

B. lymphoma (NHL, into non-Hodgkin (HL, 6.1) 60%) and 40%) Divided (Table Hodgkin lymphoma

classified of on growth, T), cell translocations. type of NHL based further markers, pattern surface expression cell C. versus and cell size, cytogenetic (e.g., is B

1.

marginal B lymphoma involve cells that CLL and cell lymphocytic mantle lymphoma, 2. cells-follicular small Small lymphoma, (i.e., tissue) lymphoma, zone

3.

Hodgkin Differences Non-Hodgkin Between Table Lymphoma and 6.1: Lymphoma

cells Lymphoid mass of Composition

usually arises lymphadenopathy, Painless

young usually 'B' symptoms, Clinical with arises in

the mainstay Guides therapy; treatment. of is radiation

Fig. Follicular lymphoma. 6.16 Disruption of architecture A, neoplastic normal by follicles. lymph node follicles B, Neoplastic body tingible macrophages. lacking Reactive macrophages C, follicular for tingible hyperplasia comparison. body with

II. FOLLICULAR LYMPHOMA

form nodules proliferation follicle-like of small A. (Fig. (CD20+) Neoplastic that cells B 6.16A)

painless adulthood in late Presents with B. lymphadenopathy

to 18 Driven the translocates l. heavy on 14. locus chain t(l4;18) C. chromosome lg on BCL2 chromosome by

2. Results Bcl2, apoptosis which overexpression of inhibits in

rituximab D. involves who reserved (anti-CD20 low-dose Treatment and symptomatic are chemotherapy antibody). patients for or is

important E. is an presents node complication; lymph enlarging Progression an large diffuse B-cell as lymphoma to

distinguished from Follicular lymphoma follicular is hyperplasia F. by 1. reactive

Disruption 2. node lymph follicular architecture of (maintained in hyperplasia) normal

macrophages Fig. tingible in body centers (tingible in germinal macrophages are Lack hyperplasia, of present follicular body 6.16B,C) 3.

4.

is polyclonal) hyperplasia (follicular Monoclonality

III. LYMPHOMA CELL MANTLE

expands B small of mantle (CD20+) cells the Neoplastic proliferation zone that A.

in late lymphadenopathy with B. Presents adulthood painless

t(ll;l4) Driven by 1. C.

Cyclin to chain chromosome heavy 14. locus 11 gene lg on chromosome translocates on Dl

2.

Gl/S the transition cell proliferation. Overexpression cyclin promotes Dl cycle, facilitating in of neoplastic

IV.

of B A. expands zone cells proliferation the that Neoplastic (CD20+) marginal small

B. Hashimoto chronic Sjogren such states thyroiditis, as with and gastritis 1. H inflammatory pylori syndrome, Associated zone B cells. center formed The by post-germinal is marginal

in marginal sites. is zone lymphoma C. mucosal MALToma

1. treatment of with Pylori. MALToma may Gastric H regress

V.

cells proliferation of Neoplastic A. with associated B EBV intermediate-sized (CD20+);

a in mass as adult extranodal child Classically an B. or young presents

Fig. Burkitt lymphoma. 6.17 Involvement A, of jaw. B, 'Starry-sky' appearance. (A, 1. Blyth) Courtesy Mike

African (Fig. involves form the usually jaw 6.17A).

2.

form usually Sporadic abdomen. the involves

c-myc 8) Driven 1. of translocations C. (chromosome by

t(8;14) lg of common, chain most 14. heavy translocation chromosome c-myc locus the is resulting on in to

2.

Overexpression cell oncogene of promotes growth. c-myc

microscopy D. appearance on (Fig. Characterized mitotic index by and high 'starry-sky' 6.17B)

VI. DIFFUSE B-CELL LARGE LYMPHOMA

A. that cells (CD20+) oflarge diffusely sheets 1. in B Neoplastic grow proliferation

common form Most 2. of NHL

low-grade from of lymphoma or (e.g., transformation a lymphoma) Arises B. sporadically 1. follicular an or mass lymph Presents late as an enlarging adulthood in extranodal node

I. PRINCIPLES BASIC

proliferation Reed-Sternberg Fig. multilobed which of nucleoli prominent large with nuclei', and A. (RS) Neoplastic B cells ('owl-eyed cells, nuclei are positive and classically for CD30 6.18); CD15

cytokines. RS cells B. secrete

1.

Occasionally results loss, weight and symptoms chills, in 'B' sweats) (fever, night 2.

and reactive eosinophils macrophages, 3. Attract lymphocytes, plasma cells,

to fibrosis lead May

the of Reactive C. form bulk cells tumor for make of HL. classification and the a basis up inflammatory include 1. Subtypes

2.

3.

4.

cases). subtype of (70% HL most is common the all Nodular of D. sclerosis

1.

a in young female. presentation node an Classic usually is enlarging lymph or cervical adult, mediastinal

2.

of bands is node divided Lymph sclerosis (Fig. by Fig. are cells lake-like in spaces (lacunar present 6.19A); RS cells, 6.19B).

other subtypes E. 1. Important regarding of HL considerations all the types. has best Lymphocyte-rich prognosis of

Fig. 6.18 cell. Reed-Sternberg Fig. sclerosis Hodgkin type. nodular 6.19 lymphoma, lymph of node. A, Sclerosis spaces. B, cells in lacunar Reed-Sternberg

2.

IL-5). often is produce cells associated with (RS cellularity Mixed abundant eosinophils

3.

usually of HIV-positive in the individuals Lymphocyte-depleted elderly and seen types; all the is most aggressive

I. MULTIPLE MYELOMA

Malignant 1. proliferation A. in bone marrow cells of plasma the

malignancy cancer, however, malignant Most bone; overall. bone lesion most of common primary metastatic of common is the

2.

B. features Clinical include 1.

osteoclasts, leading plasma to on the pain with bone receptor destruction. RANK activate hypercalcemia-Neoplastic Bone cells seen skeletal 'punched-out' x-ray on Lytic, are lesions (Fig. 6.20A), for skull; the in increased and vertebrae fracture especially risk 2.

or M (SPEP), Elevated protein commonly cells monoclonal IgA. spike immunoglobulin; serum most serum plasma due to produce protein-Neoplastic present is IgG on electrophoresis

3.

antigenic risk antibody infection of in myeloma. death of Increased infection-Monoclonal most cause lacks multiple the common diversity; is

4.

protein blood charge RBCs serum on between formation (Fig. Rouleaux decreases smear-Increased ofRBCs 6.20B).

5.

and in chains serum amyloidosis-Free circulate AL light deposit tissues. in Primary

6.

risk tubules kidney the as renal excreted to protein; Proteinuria-Free is (myeloma chain failure Jones Bence light kidney). leads in for urine in deposition

II. OF GAMMOPATHY (MGUS) SIGNIFICANCE UNDETERMINED MONOCLONAL

A. serum proteinuria). spike other amyloid, SPEP; absent multiple Bence no of bone lytic M AL or lesions, (e.g., features Increased myeloma protein on with hypercalcemia, are Jones

B. of 1 % in patients myeloma MGUS in year. each with 5% of (seen develop elderly individuals); multiple 70-year-old Common

III. WALDENSTROM MACROGLOBULINEMIA

monoclonal with A. IgM lymphoma production B-cell

B. include features Clinical

Fig. 6.20 Multiple myeloma. 'Punched-out' x-ray. lesions A, skull, involving Rouleaux formation of B, Fig. microscopy. granule, electron Birbeck 6.21 RBCs. (Courtesy of humpath.com) 1.

lymphadenopathy; are Generalized lesions lytic absent. bone

2.

serum spike 3. M protein Increased oflgM) with (comprised

(e.g., pentamer) retinal deficits neurologic or causes hyperviscosity. Visual and (large serum hemorrhage stroke)-IgM

4.

defective platelet Bleeding-Viscous in serum aggregation. results

C. serum. with treated Acute from which plasmapheresis, the removes complications IgM are

I. BASIC PRINCIPLES

specialized the are found Langerhans predominantly skin. A. cells dendritic in cells

1.

2.

Present antigen to cells T nai:ve

Langerhans is Langerhans cells. B. neoplastic proliferation a histiocytosis of cell

1. are on (tennis racket) granules seen (Fig. Characteristic Birbeck electron microscopy by cells S-100+ CDla+ immunohistochemistry. are 6.21); and

II. DISEASE LETTERER-SIWE

A. of proliferation Langerhans cells Malignant

B. old). an skeletal skin rash cystic years defects in infant(< presentation 2 and is Classic

Multiple be rapidly involved; organs C. may fatal

III. GRANULOMA EOSINOPHILIC

proliferation A. bone of Benign cells in Langerhans

B. presentation is skin an in pathologic adolescent; fracture is Classic not involved.

with cells, mixed Langerhans including Biopsy shows eosinophils. inflammatory C. cells numerous

IV. HAND-SCHULLER-CHRISTIAN DISEASE

proliferation Malignant Langerhans cells of A.

B. lytic is skull and rash, scalp exophthalmos child. defects, in Classic insipidus, presentation diabetes a

I. BASIC PRINCIPLES

Inflammation of blood vessel wall 1. the A. layers: adventitia tissue connective three comprised muscle is media, endothelial and (Fig. intima, Arterial wall smooth of 7.1).

Etiology usually unknown; B. are most infectious. is not cases

C. features Clinical include 1.

myalgias) loss, symptoms inflammation fatigue, 2. of fever, Nonspecific weight and (e.g.,

narrowing vessels Symptoms to of organ ischemia-due inflamed of thrombosis the luminal or

into vasculitides small-vessel Divided large-, D. 1. and medium-,

major the aorta involves Large-vessel vasculitis its and branches.

2.

Medium-vessel muscular that vasculitis supply involves organs. arteries

3.

involves arterioles, capillaries, and venules. Small-vessel vasculitis

II. VASCULITIS LARGE-VESSEL

A. Arteritis Cell) Temporal (Giant 1.

involves carotid branches artery classically of 2. Granulomatous the vasculitis that

3.

involvement), visual artery Presents disturbances artery (ophthalmic (temporal and claudication. jaw as involvement), headache are symptoms pain Flu-like (polymyalgia present. joint muscle and rheumatica) with often elevated. is ESR

4.

(Fig. and giant cells with reveals intimal vessel Biopsy inflamed wall fibrosis 7.2).

and of diagnosis segmental; exclude negative vessel, of long requires does i. a a Lesions not disease. biopsy biopsy are segment

5.

without high of risk is treatment blindness Treatment corticosteroids;

Takayasu Arteritis 1. B.

points at the branch aortic involves classically that Granulomatous vasculitis 2. arch

with 50 in the symptoms as neurologic upper ('pulseless years visual pulse absent or extremity Presents a (classically, < Asian disease'). females) in young adults old weak and is ESR elevated.

3.

is Treatment corticosteroids.

III. MEDIUM-VESSEL VASCULITIS

1. Polyarteritis Nodosa A.

lungs Necrotizing spared. are multiple vasculitis organs; involving

2.

in young lesions. as with disturbances, hypertension pain and neurologic Classically artery (mesenteric artery abdominal involvement), (renal melena skin involvement), presents adults Associated with pathoma.com HBsAg 3. serum

of are present. Lesions stages varying transmural fibrinoid of Early (Fig. necrosis inflammation lesion with consists 'string-of-pearls' heals fibrosis, with imaging a appearance on 7.3); 4. producing eventually

and is not if fatal treated cyclophosphamide; corticosteroids Treatment

1. B. Disease Kawasaki

2.

with fever, of rash conjunctivitis, and nodes 3. signs and palms erythematous enlarged lymph nonspecific soles, Presents cervical including

Coronary thrombosis and with rupture. with (2) risk is for involvement and leads aneurysm infarction to myocardial common (1) artery

4.

aspirin self-limited. and disease is is IVIG; Treatment

1. C. Buerger Disease

2.

and of phenomenon present. autoamputation Presents Raynaud fingers with often toes; is gangrene, and ulceration,

3.

associated smoking is Highly with cessation. heavy treatment smoking;

IV. SMALL-VESSEL VASCULITIS

A. 1. Wegener Granulomatosis

involving nasopharynx, 2. Necrotizing granulomatous lungs, kidneys and vasculitis

middle-aged to Classic or nodular bilateral and due hemoptysis lung hematuria is sinusitis rapidly with infiltrates, a nasopharyngeal presentation glomerulonephritis. male ulceration, with progressive

3.

correlate disease c-ANCA activity. levels with Serum

4.

(Fig. granulomas Biopsy reveals vasculitis adjacent large with necrotizing necrotizing 7.4).

5.

common. is relapses steroids; and are cyclophosphamide Treatment

B. 1. Polyangiitis Microscopic

kidney lung organs, multiple especially 2. Necrotizing and vasculitis involving

granulomatosis, but similar nasopharyngeal granulomas Wegener to and involvement Presentation absent. are is

3.

levels with Serum disease activity. correlate p-ANCA

4.

common. are cyclophosphamide; is and relapses corticosteroids Treatment

Churg-Strauss 1. Syndrome C.

with Necrotizing organs, and eosinophils lungs granulomatous especially involving inflammation multiple heart 2.

often present. Asthma eosinophilia are peripheral and

3.

levels with p-ANCA activity. Serum disease correlate

Fig. Normal muscular artery. 7.1 Fig. Temporal cell) 7.2 (giant arteritis. Fig. necrosis, nodosa. polyarteritis 7.3 Fibrinoid

Purpura Henoch-Schonlein 1. D.

children Vasculitis IgA due to most deposition; immune vasculitis common complex 2. in

Presents 3. palpable purpura tract bleeding, pain (IgA hematuria buttocks and occurs GI respiratory infection usually an upper on nephropathy); following legs, and with and

recur; severe Disease treated may steroids, but self-limited, with is if

I. BASIC PRINCIPLES

A. systemic chapter pressure; may Increased circulation pulmonary 9) or (see blood involve

B. as :2'. is pressure HTN defined Systemic or 140/90 types mm on ~ based Hg etiology (normal 120/80 divided secondary mm primary into Hg);

II. HTN PRIMARY

HTN cases) (95% A. of of unknown etiology

B. race obesity, include physical in lack and in Americans, age, Risk stress, risk risk diet. factors decreased high-salt African of (increased activity, Asians),

III. SECONDARY HTN

ofcases) etiology A. an (5% identifiable HTN to due

hypertension). artery stenosis is Renal common cause B. (renovascular a

1.

to Stenosis decreases flow blood glomerulus.

2.

apparatus converts by to secreting renin, which angiotensinogen responds Juxtaglomerular angiotensin I. (JGA)

3.

(ATII) to Angiotensin converting I converted angiotensin angiotensin enzyme (ACE). is II by

4.

(2) by of which plasma volume). release aldosterone, arteriolar smooth (expanding resistance sodium (1) in promoting tubule ATII total raises increases adrenal the increasing muscle, convoluted blood peripheral of resorption distal contracting and pressure

5.

in neither Leads seen primary atrophy flow) hypertension. unilateral to and kidney; blood (due low increased feature HTN to with is of the renin affected plasma

include (elderly of (young fibromuscular dysplasia Important C. causes females). atherosclerosis and males) stenosis

Fig. granulomatosis. Wegener 7.4 granuloma. Necrotizing A, granuloma. edge Giant B, cells of at Fig. Atherosclerosis. 7.5

1. medium-sized resulting the of blood developmental especially is arteries, Fibromuscular irregular thickening artery. of vessel in defect dysplasia large-and wall, the renal a

IV. BENIGN AND MALIGNANT HTN

also A. can classified or as HTN be malignant. benign

B. in HTN HTN elevation a cases pressure; are Benign benign. or moderate most of mild blood is

1. are damaged Clinically vessels organs time. and silent; slowly over

comprises pressure of is cases mm Malignant Hg); 180/120 severe blood < HTN C. (> 1. in elevation 5%

2.

acute papilledema) medical is end-organ and a headache, (e.g., emergency acute and Presents with renal damage failure,

I. PRINCIPLES BASIC

A. blood of vessel the to "hard due arteries;" wall Literally, thickening

B. pathologic and sclerosis arteriolosclerosis, Three patterns-atherosclerosis, medial calcific Monckeberg

II. ATHEROSCLEROSIS

obstructs 1. Intimal that A. blood flow plaque (Fig. (mostly Consists a core necrotic of with cholesterol) fibromuscular a cap lipid undergoes calcification often dystrophic 7.5);

B. medium-sized aorta, coronary Involves popliteal internal artery, artery, commonly abdominal arteries; and large-and carotid are affected. artery

and factors divided are Risk atherosclerosis modifiable into C. nonmodifiable. for

1.

diabetes. smoking, risk Modifiable hypercholesterolemia factors hypertension, include risk; HDL risk), increases decreases and (LDL

2.

females; in increase is (multifactorial, postmenopausal include males risk with factors (number risk). and and highly (increased severity of gender risk history predictive family estrogen lesions of genetics age protective), and is but age), Nonmodifiable

D. 1. Pathogenesis

intima. Damage to lipids leak allows to endothelium into the

2.

by in foam cells. are resulting macrophages consumed receptors, oxidized Lipids then via scavenger and

Fig. 7.6 em bolus. Atherosclerotic Fig. of (Courtesy arteriolosclerosis. Hyaline 7.7 Fig. Arteriolonephrosclerosis. 7.8 Jerome Taxy, (Courtesy A. of Professor Garfia) 3. MD) muscle. healing proliferation smooth and leads and extracellular to matrix deposition of of Inflammation

Morphologic stages E. 1.

the as (present (flat most Begins early in 2. oflipid-laden streaks fatty intima arise consisting in macrophages); yellow lesions life teenagers) of

Progresses atherosclerotic to plaque

Western > for F. atherosclerosis of 50% disease Complications in countries. account of

1. i. to blood and medium-sized in of leading ischemia impaired vessels flow Stenosis results disease extremity arteries, Peripheral vascular ii. e.g., popliteal) (lower arteries) iii. Angina (coronary disease Ischemic 2. arteries) bowel (mesenteric

myocardial infarction arteries) stroke results in (e.g., Plaque and with cerebral thrombosis rupture artery). (coronary middle

3.

the with cholesterol in within (Fig. embolus crystals characterized Plaque by embolization results rupture emboli, atherosclerotic 7.6).

4.

in (e.g., vessel of wall results aneurysm Weakening aorta). abdominal

III. ARTERIOLOSCLEROSIS

A. small Narrowing divided types hyaline into and hyperplastic arterioles; of

on vascular is (Fig. the arteriolosclerosis Hyaline are B. pink leaking seen thickening; proteins as producing wall, by hyaline caused vessel into proteins microscopy 7.7).

1.

2.

end-organ caliber classically Results produces reduced in Fig. ischemia; (arteriolonephrosclerosis, glomerular with vessel scarring chronic slowly failure progresses renal 7.8) that to

appearance, of of involves hyperplasia Fig. C. ('onion-skin' arteriolosclerosis vessel thickening muscle wall Hyperplastic smooth by 7.9).

1.

hypertension of Consequence malignant 2.

caliber end-organ Results with reduced 3. ischemia in vessel

characteristic acute vessel the a May lead of with fibrinoid necrosis wall 'flea-bitten' with appearance to classically failure renal causes hemorrhage;

IV. MEDIAL SCLEROSIS CALCIFIC MONCKEBERG

nonobstructive (Fig. of (medium-sized) of media arteries; Calcification muscular A. the 7.lOA)

B. clinically incidental significant; on as Not an or seen (Fig. mammography x-ray finding 7.lOB)

Fig. arteriolosclerosis. 7.9 Hyperplastic Fig. medial calcific 7.10 sclerosis. Monckeberg Microscopic A, appearance. B, Mammogram.

DISSECTION AORTIC I.

the A. of aortic Intimal with blood through dissection tear wall media of (Fig. 7.11)

B. 10 the weakness region) (high media aorta of Occurs in the the with cm proximal stress of preexisting

defects is of hypertension (older tissue connective also individuals) common inherited C. adults); Most with (younger 1. associated cause

decreased media. atrophy vasorum; arteriolosclerosis the vasa flow results causes of of the Hypertension hyaline in

2.

tissue to classically media syndrome syndrome weakness of (cystic and Ehlers-Danlos lead connective Marfan the medial in necrosis). the

pain the to back D. that chest radiates sharp, tearing Presents as

E. Complications pericardia! include resultant and or branching (most with coronary fatal tamponade (e.g., end-organ of of ischemia. common hemorrhage, cause with renal) death), rupture obstruction arteries

II. THORACIC ANEURYSM

of thoracic A. the aorta Balloon-like dilation

B. Due the to wall. in aortic weakness flow, Classically narrowing, syphilis; of the vasa in atrophy vessel vasorum luminal in of the wall. tertiary seen results decreased endarteritis and in 'tree-bark' (Fig. the of aorta Results appearance a 7.12)

valve aortic aortic is insufficiency. the C. root, Major of complication valve in resulting dilation

1. and structures thrombosis/embolism. mediastinal compression or of Other include (e.g., esophagus) complications airway

III. ANEURYSM AORTIC ABDOMINAL

the the dilation usually abdominal arteries, (Fig. Balloon-like aortic aorta; below the A. renal above but arises bifurcation of 7.13)

B. hypertension due 1. atherosclerosis; smokers with male 60 old classically to in Primarily > seen years vessel weakness resulting of wall. the and media, Atherosclerosis atrophy the the diffusion barrier increases to in

Presents as mass abdominal grows pulsatile time C. that with a

and cm > Major diameter; presents in when triad of D. especially rupture, hypotension, pulsatile 5 complication is flank with mass, pain abdominal 1. and complications oflocal Other structures compression thrombosis/embolism. ureter) include (e.g.,

Fig. dissection. Aortic 7.11 humpath. of (Courtesy Fig. aortic aneurysm. of due 7.13 to Fig, aorta 'Tree-bark' 7.12 appearance Abdominal (Courtesy com) lis. syphi of MD) Husain, MD) (Courtesy Aliya Husain, of Aliya

HEMANGIOMA I.

of (Fig. blood A. tumor Benign comprised vessels 7. 14)

B. Commonly during regresses present at birth; childhood often

C. liver Most often and involves skin

II. ANGIOSARCOMA

of aggressive A. proliferation highly endothelial cells; Malignant

B. liver. Common skin, include sites breast, and

1. to Thorotrast. and polyvinyl with is chloride, exposure associated angiosarcoma arsenic, Liver

III. SARCOMA KAPOSI

endothelial cells; HHV-8 Low-grade of A. malignant associated with proliferation

purple as on and B. patches, skin nodules the plaques, (Fig. Presents organs may involve also visceral 7.15);

1. in seen Classically C.

to removal. surgical European remains Older males-tumor skin; Eastern involves localized treatment

2.

agents system). spreads immune is treatment antiretroviral (to boost AIDS-tumor early;

3.

Transplant early; treatment involves decreasing recipients-tumor spreads immunosuppression.

Fig. 7.14 Hemangioma. Fig. 7.15 Kaposi sarcoma.

I. BASIC PRINCIPLES

A. of cause IHD US. Group syndromes death ischemia; the of is myocardial leading the related in to

B. myocardium blood to Usually flow arteries, of due coronary 1. to the decreases atherosclerosis which to similar Risk age. IHD those increases of atherosclerosis; factors are incidence for with

II. ANGINA

A. with angina that pain chest is arises exertion stress. Stable or emotional

1.

during > of with arteries is flow myocardium blood the stenosis; decreased the to able meet to demands metabolic not atherosclerosis 70% of coronary exertion. Due

2.

injury to reversible myocytes Represents 3. (no necrosis)

radiates or that chest pain and < diaphoresis, of breath the 4. left 20 to as Presents shortness (lasting minutes) jaw, arm

subendocardial shows due EKG ischemia. ST-segment depression to

5.

pain Unstable B. angina chest at is that rest. occurs

1.

due thrombosis artery to of rupture incomplete an with plaque atherosclerotic Usually a (Fig. occlusion coronary and of 8.lA).

2.

injury myocytes 3. to necrosis) (no reversible Represents

depression due ischemia. ST-segment to shows subendocardial EKG

4.

5.

progression High to risk of myocardial infarction

exertion. Prinzmetal pain unrelated to chest angina C. is episodic

1.

2. to Due coronary artery vasospasm

Represents reversible necrosis) myocytes 3. (no injury to

due shows elevation transmural to ST-segment EKG ischemia.

4.

III. INFARCTION MYOCARDIAL

of A. myocytes Necrosis cardiac

B. a plaque thrombosis of artery of (Fig. complete and with rupture to an due Usually atherosclerotic occlusion coronary 8.lB) 1. causes include angina and Prinzmetal Other (due or to artery cocaine emboli, vasculitis disease). coronary use), (e.g., Kawasaki vasospasm

radiates chest (lasting or 20 nitroglycerin. include are relieved C. Clinical minutes) jaw, pain the features and dyspnea; diaphoresis, by not crushing that arm left > severe, to symptoms

both and spared. (RV) are involves left Infarction the ventricle atria ventricle usually generally right (LV); D.

1. pathoma.com

anterior septum to (LAD) artery LAD the involved most infarction commonly in anterior of Occlusion the (45% leads and LV; ofleft of anterior descending artery of MI cases). is the wall

2.

leads most infarction right commonly the LV; in of to septum, RCA involved artery posterior the posterior 2nd muscles coronary of artery (RCA) papillary wall, of the and Occlusion is MI.

3.

of Occlusion wall leads of of to left L lateral the circumflex infarction V. artery

infarction, Initial necrosis phase leads involving infarction E. Fig. 50% of < the myocardial (subendocardial of thickness to subendocardial shows depression. 8.2); EKG ST-segment

1. Continued elevation. necrosis wall EKG infarction); ischemia the myocardial (transmural leads most severe shows of or ST-segment involving transmural to

F. elevated cardiac detect enzymes. Laboratory tests

1.

standard) for marker Troponin MI. (gold sensitive specific and is most I the and by normal after peak days. 7-10 rise hours to Levels infarction, 24 2-4 hours, return at

2.

after at normal MB useful hours 72 that by an initial after return hours, kinase reinfarction rise peak 24 CK-MB levels days for Ml; 4-6 and infarction, (CK-MB) to occurs detecting is creatine hours.

G. includes 1. Treatment 2. Aspirin heparin-limits and/or thrombosis ischemia 3. 0 2-minimizes Supplemental

4.

for risk heart 5. demand arrhythmia 0 ~-blocker-slows and rate, decreasing

6.

results of necrosis, i. cells leading (contraction Reperfusion hypercontraction in irreversibly-damaged calcium Fig. myofibrils band of to influx, 8.3).

ii. (reperfusion inflammatory to injury). radical further free Return may damaging of and oxygen lead generation, cells myocytes

infarction of to (Table microscopic Complications myocardial closely related 8.1). and changes are H. gross

Changes in Morphologic ~~~::c~;~N Infarction MICROSCOPIC CHANGES COMPLICATIONS Table CHANGES GROSS Myocardial 8.1:

and failure, infarction), (massive Cardiogenic shock heart arrhythmia congestive

Coagulative (Fig. necrosis

8.4A)

Fibrinous pericarditis (Fig. Neutrophils presents days as pallor 8.SA); 1-3 Yellow (Fig. pain with rub chest friction 8.4B)

wall free of ventricular (Fig. Rupture Yellow 4-7 Macrophages leads to papillary interventricular or muscle (Fig. cardiac pallor 8.SB; shunt), tamponade), days to septum (leads leads insufficiency) mitral to 8.SC;

tissue tissue collagen, weeks from 1-3 as emerges Red of with border Granulation granulation edge enters fibroblasts, plump infarct. blood and vessels

(Fig. Aneurysm or thrombus, 8.7), mural

Months White scar (Fig. 8.6A) (Fig. Fibrosis 8.6B)

Fig. 8.3 band Contraction necrosis. Fig. Myocardial 8.4 infarction. necrosis A, Coagulative of myocardium. B, infiltrate. Neutrophilic

Fig. Complications infarction. 8.5 of myocardial pericarditis. A, Fibrinous free Rupture B, of wall. ventricular muscle. C, Rupture of papillary of MD) (Courtesy Aliya Husain,

Fig. 8.6 scar. Myocardial A, Gross appearance. Microscopic B, appearance. Fig. Ajit of (A, Paintal, Courtesy Ventricular aneurysm. 8.7 MD)

IV.

A. < without cardiac or occurs disease; symptoms due 1 symptoms death arise Unexpected to 1. after hour to ventricular arrhythmia fatal due Usually

B. preexisting ischemia; acute common severe is Most atherosclerosis. 90% of etiology have patients

1. include cardiomyopathy, prolapse, abuse. causes cocaine mitral Less common valve and

V.

A. progresses function infarction); (with (CHF) due ischemic heart or myocardial congestive to without failure damage chronic to Poor

I. BASIC PRINCIPLES

A. Pump divided failure right-and into left-sided failure;

II. LEFT-SIDED FAILURE HEART

A. hypertension, cardiomyopathy, infarction, Causes cardiomyopathy. myocardial include restrictive dilated and ischemia,

B. due Clinical decreased pulmonary congestion. forward are perfusion features and to

1. Pulmonary leads pulmonary congestion to edema.

i. crackles lying and increased (due venous dyspnea, orthopnea, Results ii. return dyspnea to nocturnal when paroxysmal in flat), leading to congested hemosiderin-laden capillaries may hemorrhage; macrophages Fig. Small, intraalveolar by ('heart-failure' burst, marked cells, 8.8) 2. activation to flow renin-angiotensin Decreased of kidneys to leads system.

retention CHF. exacerbates i. Fluid

C. Mainstay treatment ACE is inhibitor. of

III. HEART RIGHT-SIDED FAILURE

A. heart important lung include leftto-right pulmonale). chronic commonly disease (cor due failure; left-sided causes other and to Most shunt

B. are congestion. Clinical to due features

1.

2.

Painful 'nutmeg' hepatosplenomegaly with (Fig. characteristic liver 8.9); cirrhosis cardiac 3. may lead to

pitting pressure) (due to hydrostatic increased Dependent edema

Fig. Hemosiderin-laden 8.8 Fig. macrophages ('heart 'Nutmeg' congestive 8.9 failure. liver, heart Fig. of heart, 'Boot-shaped' 8.10 tetralogy Fallot. failure' cells).

I. BASIC PRINCIPLES

of weeks 1% Arise in 1. A. embryogenesis through 3 (usually 8); births live during seen Most sporadic. defects are

B. in left between (pulmonary) circulations. (systemic) and right Often result shunting

relatively C. shunting be can eventually shunt Defects with birth, left-to-right the but reverse. at may asymptomatic

1.

results the through pulmonary Increased pulmonary circulation vessels flow hypertrophy hypertension. in and pulmonary of

2.

shunt, results reversal clubbing. polycythemia, cyanosis and (Eisenmenger eventually with resistance to leading Increased ventricular of hypertrophy, late pulmonary in right syndrome)

present D. usually shunting Defects birth. after shortly right-to-left cyanosis with as

II. VENTRICULAR (VSD) AL SEPT DEFECT

A. in Defect left ventricles and right septum 1. the that the divides

2.

syndrome alcohol fetal Associated with

B. age extent of and presentation. determines shunting at defect in of shunt; size Results left-to-right asymptomatic; to defects are defects Eisenmenger Small lead often syndrome. can large

small may surgical involves spontaneously. close closure; C. defects Treatment

III. (ASD) DEFECT ATRIAL SEPTAL

A. left type and that common the ostium in of divides atria; Defect is most (90% right secundum cases). septum

with Ostium syndrome. type Down is B. associated primum

in shunt delays and blood closure of Results right in pulmonary on C. heart valve) split S2 left-to-right auscultation (increased

Paradoxical an D. are complication. emboli important

IV.

A. to rubella congenital close; Failure with ductus of associated arteriosus

B. aorta the artery between and Results pulmonary left-to-right 1. shunt the in lungs. ductus pulmonary the artery the During development, to from normally the blood aorta, shunts the arteriosus bypassing

to 'machine-like' may cyanosis resulting in Eisenmenger lower murmur; extremity Asymptomatic syndrome, with birth C. continuous lead at

patency of D. PDA indomethacin, closure resulting arteriosus). (PGE maintains in decreases ductus which Treatment the PGE, involves

V.

A. outflow the (1) tract, that (4) ventricular VSD, (3) of the VSD stenosis an (2) and by Characterized ventricular overrides right aorta right hypertrophy,

B. shunting leads of Right-to-left extent to degree shunt the cyanosis; and of early determines cyanosis. stenosis

more the reach shunting response arterial and allows in squat to a Patients lungs. learn cyanotic decreases spell; increased resistance to to blood C.

'Boot-shaped' heart x-ray D. on (Fig. 8.10)

VI. OF THE GREAT TRANSPOSITION VESSELS

A. B. artery the pulmonary and Characterized left ventricle by right ventricle aorta the arising arising from from diabetes Associated maternal with

mix. and C. with do circuits cyanosis; pulmonary not Presents early systemic

1.

after Creation blood survival. birth required for is to (allowing of shunt mix)

2.

PDA repair be is a maintain to PGE can performed. definitive surgical until administered

in and atrophy ventricle of Results D. left hypertrophy right the the of ventricle

VII. TRUNCUS ARTERIOSUS

A. both Characterized a large 1. single ventricles arising by vessel from Truncus fails divide. to

from ventricle separate. blood pulmonary deoxygenated B. and Presents oxygenated aortic early from blood circulations with ventricle before right mixes cyanosis; left with

VIII. TRI CUSPID ATRESIA

to orifice Tricuspid hypoplastic. ventricle is valve A. develop; fails right

B. with a Often presents right-to-left in ASD, with resulting cyanosis. associated shunt; early

IX. OF THE COARCTATION AORTA

A. aorta Narrowing (Fig. of the classically forms into divided and 8.llA); adult infantile

the arch, but a lies (proximal Infantile associated PDA. B. to) coarctation PDA; the is form with before after aortic (distal to)

1.

as cyanosis in lower extremity birth often 2. Presents infants, at

syndrome Associated Turner with

with the aortic after lies to) PDA; Adult form a coarctation associated arch. not (distal C. is

1.

hypotension extremities; in hypertension the discovered pulses classically extremities and in upper the Presents in adulthood as weak lower 2. with

(Fig. across arteries of cause 'notching' engorged arteries; the ribs Collateral x-ray develops circulation intercostal on 8.llB), 3.

with aortic valve Associated bicuspid

I. PRINCIPLES BASIC

A. pulmonary, has The (tricuspid, aortic) mitral, that four valves and backflow. heart prevent

or in generally the valve Valvular caliber lesions result (backflow). B. stenosis regurgitation (decreased orifice) of

Fig. the of 8.11 Coarctation aorta. specimen. Gross A, B, 'Notching on ribs' x-ray. of Aliya (A, of MD. Husain, Courtesy 2009;38:7-9) Images Courtesy Cardio/ Paediatr B, of

II. ACUTE FEVER RHEUMATIC

A. complication ~-hemolytic pharyngitis streptococci; an group pharyngitis 2-3 children episode after affects A of weeks to throat") due Systemic ("strep ofstreptococcal

B. protein resembles human mimicry; in tissue. molecular Caused M by proteins bacterial

is based criteria. Jones on C. Diagnosis

1.

the B group A titers) and of presence or major 2. infection criteria (e.g., Evidence anti-DNase with ~-hemolytic prior elevated of ASO streptococcal minor

are and include criteria nonspecific Minor elevated fever and ESR.

3.

in a i. days to polyarthritis-swelling involve knees, joint (e.g., large another resolves and "migrates" wrist, 11. large and pain joint ankles) Migratory that within a. Pancarditis

is more commonly the valve. aortic valve involved than Endocarditis-Mitral vegetations small to that by regurgitation (Fig. Characterized lead closure lines of along 8.12A) b.

with with histiocytes (Anitschkow inflammation, giant cells, foci are Myocarditis chronic Aschoff reactive nuclei fibrinoid cells), that bodies of and (Fig. material slender, characterized by wavy common is the the of cause most acute during myocarditis 8.12B,C); phase. death

c.

Pericarditis-leads pain iii. chest friction and to rub iv. nodules Subcutaneous

Erythema v. borders, marginatum-annular, trunk and commonly with limbs erythematous rash nonpruritic involving

chorea involuntary muscle Sydenham (rapid, movements)

disease. to Acute increases resolves, A the chronic in disease; ~-hemolytic phase risk and to results acute of streptococci D. group for relapse exposure may chronic but rheumatic usually progress repeat heart attack

III. RHEUMATIC CHRONIC DISEASE HEART

A. fever arises as of scarring rheumatic Valve that consequence a

B. Results with 1. a appearance ' in stenosis classic 'fish-mouth

chordae thickening Almost the cusps valve; leads involves to tendineae mitral always of 2. and

fusion valve; leads (Fig. to of Occasionally the aortic involves commissures the 8.13) 3.

commonly less Other are valves involved.

C. include Complications endocarditis. infectious

Fig. 8.12 disease. Acute rheumatic heart Mitra! A, vegetations. valve body involving Aschoff B, myocardium. Anitschkow cells. C, Husain, Aliya MD. of Courtesy (A, B, Uthman, MD) Ed of Courtesy

IV.

A. aortic (Fig. valve Narrowing orifice of the 8.14)

B. and calcification due to and "wear 1. from tear" Usually fibrosis

2.

aortic hastens onset. risk disease Bicuspid increases valve and A and valve "wear on aortic three normal each increased fewer cusp. in tear" has results cusps; cusps

distinguish mitral and coexisting from rheumatic fusion disease May tear." also arise C. valve of rheumatic as and aortic "wear valve chronic the stenosis commissures a consequence disease; of

Cardiac compensation ejection a which crescendo-decrescendo murmur click during systolic asymptomatic heard. prolonged stage is a a by followed D. leads to

1. include E. Complications

cardiac hypertrophy-may left to failure Concentric progress ventricular 2.

flow to myocardium with and to leads across exercise-Limited Angina the and increase syncope ability stenotic blood the valve perfusion of decreased brain.

3.

crossing calcified Microangiopathic hemolytic schistocytes) while the anemia-RBCs are valve. (producing damaged

F. of after valve Treatment is complications. replacement onset

V.

aorta of ventricle during diastole the the into from Backflow A. blood left

due aortic valve endocarditis); common damage root dilation (e.g., to (e.g., root Arises aneurysm aortic infectious dilation or isolated dissection) and is cause most syphilitic B.

C. include features Clinical 1.

2. diastolic murmur Early, blowing

pressure pulse Pulse Hyperdynamic systolic the i. difference increased to diastolic between and is due circulation pressure pressures.

ii. to pressure systolic while increased stroke decreases volume. regurgitation, due due to Diastolic pressure increases

iii. pulse), (water-hammer pulsating with nail 3. (Quincke Presents and head bobbing pulse bounding pulse), bed

volume to Results dilation (due overload) in hypertrophy and LV eccentric

dysfunction D. Treatment LV replacement once is valve develops.

VI. MITRAL VALVE PROLAPSE

A. into left Ballooning of mitral during valve systole atrium 1. US 2-3% Seen of in adults

B. of (Fig. to myxoid (accumulation Due degeneration the floppy substance) it ground making valve, of 1. 8.15) Etiology in unknown; be is syndrome seen syndrome Marfan Ehlers-Dantos may or

regurgitation murmur; with usually mid-systolic followed incidental 1. click a Presents C. an asymptomatic by Click squatting murmur ventricular emptying). systemic decreases softer resistance and (increased with left become

endocarditis, infectious arrhythmia, regurgitation. mitral Complications but D. severe rare, include and are

is Treatment E. valve replacement.

VII. MITRAL REGURGITATION

A. the left into blood from Reflux left the during atrium of ventricle systole

B. rupture acute complication failure), muscle disease, infarction. a LV endocarditis, after myocardial other arises prolapse; of infective Usually rheumatic and dilatation mitral include heart causes a cardiac as papillary (e.g., left-sided valve

features C. 1. Clinical

with decreases louder return ventricular atrium) left left and expiration systemic 2. resistance Holosystolic (increased squatting (increased murmur; emptying) to "blowing"

STENOSIS VIII.MITRAL

A. valve Narrowing mitral the orifice of 1. chronic to Usually valve rheumatic due disease

B. Clinical 1. features

2.

in leads the left Volume of overload to atrium, dilatation resulting i. ii. congestion with and hemorrhage Pulmonary edema alveolar failure hypertension and heart eventual right-sided iii. Pulmonary associated Atrial with thrombi risk (Fig. for mural fibrillation 8.16)

I. PRINCIPLES BASIC

the lines A. surface to usually endocardium that bacterial of Inflammation due valves; infection cardiac of

cause. viridans most is the Streptococcus overall common B. rheumatic is infects low-virulence organism a It that (e.g., damaged valves chronic heart previously

Fig. hrombus involving atrium. Mural left t 8.16 Fig. vegetations involving tricuspid Fig. Large 8.17A lesions. 8.17B Janeway MD) of valve. (Courtesy Aliya Husain, Husain, MD) Aliya of (Courtesy

I.

disease and valve mitral prolapse). do not in valve destroy vegetations 1. endocarditis) that small (subacute Results the

thrombotic fibrin). (platelets endocardial and surface develops Damaged vegetations

2.

antibiotics to of in of decrease leads bacteria Transient prophylactic bacteremia endocarditis. trapping the risk vegetations;

C. the common most IV abusers. drug is aureus Staphylococcus in cause

1.

High-virulence commonly the normal valves, tricuspid. that most infects organism

2.

(acute Fig. in vegetations valve destroy that endocarditis, Results large the 8.17A)

D. endocarditis epidermidis is valves. with prosthetic Staphylococcus of associated

endocarditis patients bovis colorectal in carcinoma. E. associated Streptococcus is underlying with with

Eikenella, Cardiobacterium, organisms with cultures. with HACEK are associated F. (Haemophilus, endocarditis blood Kingella) Actinobacillus, negative

of Clinical bacterial G. 1. features include endocarditis

2. to Fever-due bacteremia

Murmur-due 3. vegetations on heart valve to

(erythematous lesions on palms lesions Janeway nontender and soles, Fig. nail fingers or splinter 8.17B), nodes in hemorrhages (tender bed Osler (Fig. lesions toes), on (Fig. 8.17C) spots Roth and septic 4. of vegetations 8.17D)-due embolization to

inflammation to chronic of Anemia chronic disease-due

Laboratory H. 1. findings

2.

3. disease(-!-Hb, and t saturation) ferritin,-!-TIBC,-!-serum -!-% chronic Anemia of -!-MCV; iron,

useful valves. detecting lesions Transesophageal on echocardiogram for is

a to vegetations due endocarditis adenocarcinoma. sterile arise underlying hypercoagulable in I. is state thrombotic with Nonbacterial that or association Vegetations the regurgitation. in mitral result on valve arise of closure mitral lines and along

due J. to arise endocarditis sterile association in with is SLE. Libman-Sacks vegetations that valve mitral the of mitral on Vegetations surface undersurface regurgitation. and the and in present result are

A. of myocardial cardiac dysfunction result that in diseases Group

Fig. 8.17C hemorrhages. Splinter Fig. Roth 8.17D spots. Fig. cardiomyopathy. Dilated 8.18 ____________c_a_r_d_i_a_c_P_a_th_o_l_o...g...y_ (Courtesy Jamie ---~---~----~----- Steinmetz, of MD)

II. DILATED CARDIOMYOPATHY

heart chambers A. of (Fig. the all Dilation of four cardiomyopathy common 8.18); form of most

B. biventricular to in pump), dysfunction include arrhythmia. valve Results systolic (ventricles complications CHF; cannot leading regurgitation mitral tricuspid and and

1. include C. idiopathic; commonly Most causes other

2.

A (usually (Fig. due B)-characterized to the by infiltrate or coxsackie in a Myocarditis myocardium lymphocytic with pain, arrhythmia chest in death, 8.19); sudden heart results failure. or cardiomyopathy Dilated late complication. is a

3.

4.

doxorubicin) Drugs (e.g., 5.

Pregnancy-seen late during 6. after or months) (weeks soon childbirth to pregnancy

is Treatment heart transplant. D.

III. HYPERTROPHIC CARDIOMYOPATHY

A. the Massive of left ventricle hypertrophy

B. autosomal sarcomere most in mutations to due Usually genetic form dominant. common is proteins;

1. C. Clinical features include

to cardiac cannot hypertrophy leads (ventricle dysfunction output-Left fill). diastolic ventricular Decreased

2.

cause athletes. arrhythmias; due in a hypertrophic ventricular is Sudden of death to death common cardiomyopathy young sudden

3.

the Syncope exercise-Subaortic aortic of in functional hypertrophy ventricular with septum stenosis. results

shows (Fig. with disarray D. myofiber Biopsy hypertrophy 8.20).

IV. RESTRICTIVE CARDIOMYOPATHY

A. of compliance filling endomyocardium ventricular the Decreased that during restricts diastole

B. include amyloidosis, sarcoidosis, Fig. Causes endocardial (children, fibroelastosis and (endomyocardial syndrome with eosinophilia). infiltrate and fibrosis an eosinophilic Loeffler 8.21),

Presents is with congestive EKG amplitude. classic finding as failure; QRS C. heart diminished low-voltage

Fig. 8.19 Myocarditis. Fig. 8.20 disarray, Fig. hypertrophic Myofiber 8.21 Endocardial fibroelastosis. (Courtesy cardiomyopathy. of humpath.com)

I. MYXOMA

1. A. gelatinous abundant substance Benign and mesenchymal with appearance a ground histology tumor on adults common in cardiac primary tumor Most

B. valve a causes to that the mass the forms syncope obstruction in of due pedunculated atrium mitral Usually left

II. RHABDOMYOMA

Benign cardiac 1. of muscle hamartoma A. tumor Most primary children; sclerosis associated tuberous with in cardiac common

B. arises ventricle the Usually in

III. METASTASIS

heart than Metastatic A. common the tumors. tumors are more in primary

1. and metastases lung the lymphoma. carcinoma, heart melanoma, breast and to include Common

B. in the pericardium, Most commonly resulting a pericardia! involve effusion

I. RHINITIS

is Inflammation the common A. rhinovirus of cause. mucosa; nasal the most

runny with B. (common Presents sneezing, nose congestion, cold) and

of 1. a a Allergic hypersensitivity is C. type subtype (e.g., rhinitis I to reaction to due rhinitis pollen)

an inflammatory 2. with infiltrate Characterized by eosinophils

Associated eczema asthma and with

II. NASAL POLYP

nasal mucosa of inflamed edematous, Protrusion A.

B. bouts 1. and repeated rhinitis; fibrosis secondary cystic asthma also aspirin-intolerant of occurs to Usually in nasal of 10% triad asthma the polyps; Aspirin-intolerant adults aspirininduced and characterized asthma, of asthmatic in by seen is bronchospasms,

III. ANGIOFIBROMA

nasal tissue; vessels blood in and tumor seen A. fibrous males large of Benign adolescent composed classically mucosa of

Presents with B. profuse epistaxis

IV. PHARYNGEAL NASO CARCINOMA

epithelium A. Malignant tumor of nasopharyngeal

B. and in Chinese African EBY; seen adults children classically Associated with

Biopsy a reveals in carcinoma) lymphocytes. background C. cell (poorly differentiated usually squamous cells of pleomorphic epithelial keratin-positive

with Often lymph presents of involvement cervical nodes D.

I. EPIGLOTTITIS ACUTE

the epiglottis Inflammation of (Fig. A. in cause, 9.1); b type common H the influenzae most children. especially is nonimmunized

with drooling Presents ofairway and muffled inspiratory high dysphagia, sore obstruction voice, risk stridor; B. fever, throat, with

II. LARYNGOTRACHEOBRONCHITIS (CROUP)

common upper virus the Inflammation airway; most the A. is of parainfluenza cause.

inspiratory and cough "barking" with hoarse, stridor a B. Presents

III. CORD (SINGER'S NODULE) NODULE VOCAL

that cord on vocal arises A. Nodule true the

B. of use vocal (Fig. cords; usually excessive Due bilateral to 9.2A) 1. connective Composed of (Fig. degenerative tissue (myxoid) 9.2B) pathoma.com

Presents with resting ofvoice with hoarseness; C. resolves

IV.

the A. Benign papillary vocal tumor of cord

B. 11; usually to are and children. Due HPV single in 6 adults papillomas in and multiple

C. hoarseness Presents with

V.

the from A. of carcinoma usually cord cell arising Squamous the epithelial lining vocal

B. and arise from tobacco; a can rarely are papilloma alcohol Risk laryngeal factors

and other Presents include cough hoarseness; C. stridor. with signs

I. PNEUMONIA

A. the Infection lung parenchyma of

B. when damage cough impaired organism impaired highly plugging) reflex, escalator, or or mucus are is Occurs mucociliary normal to (e.g., defenses virulent.

decreased breath (bloody) sounds, chills, count. tachypnea dullness Clinical productive chest percussion, fever with C. with or crackles, include and WBC cough to pain, rusty features sputum, yellow-green elevated (pus) pleuritic and

made and sputum and is stain Diagnosis blood chest culture, gram D. x-ray, cultures. by

Three interstitial patterns seen E. bronchopneumonia, x-ray: are lobar pneumonia. pneumonia, and chest classically on

Fig. 9.1 Acute epiglottitis. of Fig. (Courtesy Stephanie 9.2 cord Vocal nodules. A, appearance. Gross Microscopic appearance. B, Rozell, wikipedia.org, (B, MD) Reproduced from 3.0) CCBY-SA . • ( ~;"I. ~:;: • "' , . ❖ . • '• •~~ •. r,;.

·:£;1« ·"fl:

Fig. pneumonia. 9.3 Lobar appearance. X-ray A, Red B, hepatization. involving C, Acute sacs. alveolar inflammation Wikipedia. (A, James Courtesy MD, Heilman, of Courtesy MD) Yale Rosen, B, of

II. PNEUMONIA LOBAR

A. by of (Fig. entire an the consolidation lobe lung of Characterized 9.3A)

B. most Usually causes common bacterial; are pneumoniae Streptococcus (Table Klebsiella pneumoniae (95%) and 9.1)

pneumonia phases gross 1. C. oflobar Classic

edema and 2. congested Congestion-due vessels to

Red to the a (Fig. hemorrhage and spongy solid consistency giving exudate, the lung hepatization-due filling normally spaces, air alveolar neutrophils, 3. 9.3B,C)

hepatization-due red the within to 4. of cells degradation Gray exudate

Ill. BRONCHOPNEUMONIA

A. Characterized scattered often patchy centered bronchioles; by and (Fig. around consolidation bilateral multifocal 9.4)

B. of a 9.2) variety by Caused (Table bacterial organisms

IV.

A. interstitial infiltrates (Fig. Characterized diffuse by 9.5)

'atypical' symptoms relatively and presentation B. with sputum low mild respiratory fever); upper (minimal Presents

or bacteria 9.3) by (Table C. Caused viruses

V.

A. patients) alcoholics for and risk Seen aspiration patients comatose in (e.g., at

B. in and Bacteroides, the (e.g., Peptococcus) oropharynx due often bacteria Fusobacterium, to Most anaerobic

Fig. Bronchopneumonia. 9.4 A, X-ray appearance. B, Gross appearance. Rosen, Yale (B, of MD) Courtesy

Fig. pneumonia. 9.5 Interstitial appearance. X-ray A, interstitium. involving B, Inflammatory infiltrate

or pneumonia; complicated 2nd most often by cause secondary 9.2: empyema abscess Causes of Table common of Bronchopneumonia

(leads Common COPD) superimposed secondary to of exacerbation cause COPD pneumonia of on and pneumonia

pneumonia COPD (leads on superimposed and pneumonia to Community-acquired COPD) of exacerbation

that by superimposed Intracellular transmitted is pneumonia in states; on best immunocompromised visualized stain COPD, water pneumonia, organism pneumonia or from silver Community-acquired source

9.3: Causes Table (Atypical) Pneumonia Interstitial of

dormitory). living of or young atypical college adults a recruits military cause usually students common Most (classically, in affects pneumonia, anemia cold RBCs I (IgM anemia) hemolytic erythema against multiforme. Complications and hemolytic antigen include on autoimmune causes lack gram on stain wall ofcell visible due to Not

pneumonia young atypical Second most common cause in of adults

of in Most infants cause common pneumonia atypical

Atypical posttransplant with or chemotherapy immunosuppression pneumonia

pneumonia disease. and elderly, Atypical preexisting in those lung with immunocompromised, the for Also superimposed aureus influenzae pneumonia H or bacterial the increases S risk

placentas). are Atypical deposited fever high are farmers in present seen in pneumonia (Q (Coxiella veterinarians ticks with by and or cattle fever); on cattle spores does from (1) causes transmission highly (survives and does but pneumonia, it heat-resistant a arthropod vector not a rash. is rickettsial Coxiella for it organism, most (3) produce because endospores), skin as require not rickettsiae distinct is (2)

lobe a lower results Classically abscess 1. C. in right main Anatomically, branches than angle the acute right stem less at bronchus a left. the

VI. TUBERCULOSIS (TB)

A. tuberculosis aerosolized to of inhalation Mycobacterium Due

B. initial Primary with TB exposure. arises

1.

the undergoes lobe necrosis caseating focal, lung and in that and in a of lower complex (Fig. forming fibrosis lymph the Ghon nodes calcification, Results hilar 9.6A) 2.

asymptomatic, positive a but TB generally leads PPD. Primary to is

with C. arises Secondary tuberculosis. TB reactivation ofMycobacterium

1.

also may with be aging seen 2. AIDS; to Reactivation due is commonly

3.

cavitary lead pulmonary or to may necrosis; caseous of Forms also 4. TB foci tuberculous miliary bronchopneumonia

and sweats, include Clinical with fevers loss. hemoptysis, features night weight cough and

5.

reveals bacilli (Fig. stain reveals caseating Biopsy acid-fast AFB granulomas; 9.6B,C).

6.

meninges often occurs pyuria), lumbar (Pott nodes, cervical sites involve any tissue; Systemic (meningitis), can kidneys (sterile common include vertebrae and and lymph spread disease).

I. PRINCIPLES BASIC

A. lung by characterized not diseases is trapped. of empty, air Group obstruction; does and airway

1. is expired in ofexpiration first especially during -.I, Volume forcefully be the (-.I, :FVC results ratio FEV); decreased can second FVC), (-.l,-.l, that FEV ofair 2. air Total is increased lung capacity to usually (TLC) due trapping.

II. BRONCHITIS CHRONIC

A. associated smoking productive of cough months 2 minimum least highly lasting 3 years; a over with at Chronic

B. bronchial hypertrophy of by glands Characterized (Fig. mucous 9.7)

Fig. Tuberculosis. 9.6 Ghon focus. A, B, Caseating granuloma. staining M tuberculosis. C, AFB of Ya MD) (A, le of 1. Rosen, Courtesy normal wall increases of bronchial thickness to glands is mucus > thickness 50%; 40%). to (Reid to < increased index Leads relative

features Clinical 1. C.

production mucus due 2. to Productive excessive cough

t ('blue ..I.-Pao2 Paco2 bloaters')-Mucus carbon 3. dioxide; plugs and Cyanosis trap

Increased pulmonale infection risk cor and of

III. EMPHYSEMA

(Fig. air Destruction sacs alveolar A. of 1. 9.8) obstruction airways of during air elastic trapping. results in and Loss of collapse recoil and exhalation

B. and Due to of proteases imbalance proteases 1. anti

and in Inflammation neutrophils macrophages. to of leads lung normally proteases the release by

2.

a trypsin neutralizes -anti proteases. (Al AT)

3.

of AlAT Excessive leads to or sacs. the alveolar lack of destruction air inflammation

common Smoking emphysema. most C. is of cause the

1.

smoke in to Pollutants lead inflammation protease-mediated and excessive damage.

2.

in Results centriacinar is in that emphysema severe upper most lobes the

AlAT D. a of deficiency emphysema. cause rare is

1.

protease-mediated leaves the Lack sacs of damage. vulnerable to antiprotease air

2.

panacinar lower that in Results in lobes severe emphysema most the 3. is

also cirrhosis may Liver be present.

due AT is the i. misfolding to mutated protein. Al deficiency of

ii. Mutant accumulates in liver damage. endoplasmic in the resulting ofhepatocytes, reticulum AlAT

111. in globules Biopsy reveals (Fig. hepatocytes pink, PAS-positive 9.9).

4.

the of on AlAT is based degree severity Disease deficiency.

(PiMM). the copies two expressed is i. PiM normal usually allele; are

ii. levels most results the significantly clinically relevant AlAT PiZ in low is common of circulating mutation; iii. decreased for PiMZ are emphysema however, circulating asymptomatic AlAT; levels risk usually exists. of with with significant smoking heterozygotes

iv. are cirrhosis. significant homozygotes risk PiZZ panacinar and for at emphysema

Fig. Chronic 9.7 bronchitis. Fig. Emphysema. 9.8 appearance. Gross A, appearance. Microscopic B, Yale MD) of Rosen, Courtesy (A,

emphysema of E. Clinical include 1. features

and Dyspnea sputum cough minimal with 2.

('pink-puffer') 3. lips pursed Prolonged expiration with

4.

Fig. chest of diameter ('barrel-chest,' anterior-posterior Increased 5. 9.10)

cor (due pulmonale of capillaries alveolar destruction complications. are Hypoxemia the sac) late in to and

IV.

to airway allergic often stimuli A. asthma) most bronchoconstriction, Reversible due (atopic

eczema, rhinitis, a with in Presents atopy and family allergic often of associated childhood; B. history

1. Pathogenesis (type I hypersensitivity) C.

Allergens H2 in individuals. cells of genetically CD4+ induce T T susceptible phenotype

2.

T (mediates eosinophils), H2 (attracts IL-4 cells T (stimulates to cells class switch and secrete IL-10 IgE), H2 IL-5 T and inhibits Hl).

3.

Reexposure leads cells. to activation to IgE-mediated mast allergen of

i. (earlyphase inflammation, bronchoconstriction, ofleukotrienes reaction). C4, of D4, Release and lead granules edema E4 preformed to generation and histamine and

ii. and (late-phase cells especially basic eosinophils, major protein from damages derived reaction). perpetuates bronchoconstriction Inflammation,

exposure. and D. are features to episodic related allergen Clinical

1.

2.

spirals) Fig. crystals, and eosinophil-derived (Charcot-Leyden mucus classically (Curschmann spiral-shaped crystals with Productive cough, plugs 9.11).

3.

unrelenting status and can attack asthmaticus in Severe, result death.

as aspirin asthma) arise intolerant also (e.g., from asthma), E. and viral causes exercise, nonallergic may such infection, exposures. Asthma (non-atopic occupational aspirin

V.

A. of dilatation Permanent (Fig. bronchi results air of loss trapping. in 9.12); airway tone

B. walls. airway damage with to inflammation Due to severe Causes 1. include

2.

the Primary is defect dynein dyskinesia-inherited ciliary of which necessary movement. ciliary arm, for is called sperm), and sinusitis, Kartagener motility syndrome (position major is infertility right (poor reversed, heart which of side is with situs of inversus on thorax), Associated of e.g., organs

Fig. in 9.9 AT hepatocytes. Al accumulation Fig. diameter, Increased 9,10 emphysema. AP Fig. asthma. crystals, 9.11 Charcot-Leyden (Courtesy James MD, 3. Wikipedia) of Heilman,

4.

5.

in inflammatory Allergic damage; chronic or reaction aspergillosis-Hypersensitivity usually to bronchopulmonary fibrosis asthma to individuals seen with leads cystic Aspergillus

Clinical C. features 1.

sputum dyspnea, foul-smelling Cough, and 2.

secondary cor amyloidosis. pulmonale and hypoxemia with (AA) include Complications

I. BASIC PRINCIPLES

A. and filling , FVC; TLC, of .,I.. restricted Characterized the FEV by .,I.. .,1...,1.. lung;

:FVC is FEV increased. ratio

B. diseases due wall to abnormalities massive (e.g., commonly of obesity) Most the chest lung; also arise with may interstitial

II. IDIOPATHIC PULMONARY FIBROSIS

(Fig. Fibrosis A. oflung interstitium 9.13)

unknown. Etiology B. is related lung from injured induces Likely TGF-~ cyclical fibrosis. to pneumocytes injury;

1. fibrosis such therapy must excluded. bleomycin of be Secondary and interstitial as and (e.g., causes drugs amiodarone) radiation

C. Clinical 1. features

2.

lung results end-stage fibrosis extensive seen 'honeycomb' patches, with lung 3. in initially subpleural fibrosis in on but CT; eventually Bilateral

4.

lung treatment transplantation. is Definitive

III. PNEUMOCONIOSES

exposure; due fibrosis requires to are chronic 9.4) (Table exposure that Interstitial occupational particles 1. fibrogenic A. small to foreign Alveolar engulf macrophages and particles induce fibrosis.

IV. SARCOIDOSIS

A. Systemic African disease noncaseating American classically granulomas in by seen multiple females in organs; characterized

Fig. Bronchiectasis. 9.12 Fig. of Yale Rosen, (Courtesy Interstitial pulmonary MD) fibrosis, idiopathic 9.13 fibrosis.

of Summary Pneumoconioses Table 9.4:

fibrosis ('black Coal diffuse exposure leads to associated Massive Workers' lung');

with syndrome) the rheumatoid miners arthritis silica lung (Caplan Pneumoconiosis

lymph granulomas Berylliosis aerospace industry hilar the lung, workers in organs in miners Beryllium; Noncaseating and the beryllium nodes, in seen and systemic

and workers and fibers; carcinoma commonand seen individuals. carcinoma for shipyard in more oflung exposed increased workers, lung is mesothelioma risk construction Fibrosis (plaques) pleura mesothelioma;Asbestosis plumbers, than Asbestos lung in with

helper unknown • an to response is antigen T-cell due unknown; B. likely CD4 to Etiology

C. lymph most lung the Granulomas (Fig. nodes commonly and hilar involve lung to restrictive leading 9.15A), disease.

1. ('asteroid often are inclusions the of (Fig. within giant bodies') Characteristic seen stellate granulomas cells 9.15B).

nodosum), involved. uvea tissue lacrimal include salivary involved glands be can nodules or Sjogren and any D. commonly and almost skin the (mimics erythema (uveitis), (cutaneous syndrome); Other tissues

features Clinical 1. E.

2.

3.

epithelioid of to Hypercalcemia active hydroxylase 4. histiocytes (I-alpha converts D vitamin form) activity its

spontaneously immunosuppression; often Treatment treatment. without is resolves

(e.g., macrophages); clinically to carbon-laden (collections not in results carbon anthracosis of Mild pollution) exposure significant

by formation phagolysosome impairs for Increased risk macrophages. silica TB;

bodies, associated contain long, may iron goldenbrown (asbestos fibers with Lesions Fig. which confirm exposure to 9.14), asbestos

Fig. Asbestos 9.14 bodies. (Courtesy Nephron, Fig. of 9.15 Sarcoidosis. Noncaseating lung. involving A, granuloma B, body. Asteroid vl.3) GNU-FOL

HYPERSENSITIVITY V. PNEUMONITIS

organic inhaled to A. pigeon antigens lung) reaction (e.g., Granulomatous breeder's

removal of after with dyspnea Presents with the resolves hours exposure; fever, exposure cough, and B.

fibrosis. exposure leads C. Chronic to interstitial

I. PRINCIPLES BASIC

A. mm > pulmonary pressure 10 High circuit 25 the is mm in pressure Hg) arterial normal (mean Hg;

B. disease hypertrophy of (Fig. by intimal atherosclerosis lesions with plexiform pulmonary long-standing muscle trunk, Characterized pulmonary of seen and are arteries, the fibrosis; severe, smooth 9.16).

eventual hypertrophy Leads to C. pulmonale with cor ventricular right

with right-sided or heart dyspnea Presents failure D. exertional

Subclassified based on or as secondary etiology primary E.

II. HYPERTENSION PULMONARY PRIMARY

Classically females A. young seen in adult

muscle. mutations proliferation are related leading forms to of BMPR2, some to ofvascular inactivating B. familial is Etiology unknown; smooth

III. HYPERTENSION SECONDARY PULMONARY

A. interstitial pulmonary Due or hypoxemia with volume to embolism lung may (e.g., pulmonary (e.g., circuit congenital heart disease) and arise the also in COPD recurrent increased disease);

I. DISTRESS RESPIRATORY SYNDROME ACUTE

the A. (diffuse alveolar-capillary interface to damage) alveolar Diffuse damage

B. necrotic lining edema hyaline with combines of to to that membranes leads cells (Fig. alveoli epithelial protein-rich form fluid Leakage 9.17A).

Clinical features C. 1.

to respiratory surface cyanosis with Hypoxemia barrier collapse of tension) distress-due 2. (increased and diffusion air thickened sacs and

'White-out' on x-ray (Fig. chest 9.17B)

reactions, disease including aspiration, shock, a drugs. variety trauma, pancreatitis, of DIC, sepsis, Secondary infection, and processes to hypersensitivity D.

Fig. pulmonary primary 9.16 Fig. Plexiform lesion, 9.17 ARDS. membranes. Hyaline A, of lung x-ray. B, 'White-out' on (B, GNUhypertension. Samir, of Courtesy FDL 1. vl.2) and induces Activation of free radical-mediated neutrophils II type damage pneumocytes. I protease-and of

Treatment 1. E.

2.

pressure end-expiratory positive with (PEEP) Ventilation

by and interstitial may of loss fibrosis; complicated be Recovery scarring damage leads F. II pneumocytes type and fibrosis. to

II. SYNDROME NEONATAL DISTRESS RESPIRATORY

A. due to levels distress Respiratory inadequate 1. surfactant

(lecithin) phosphatidylcholine pneumocytes; II the Surfactant component. major made type is is by

2.

after of Surfactant lung, preventing decreases surface collapse alveolar the expiration. tension air sacs in

3.

collapse hyaline of sacs and to formation air of leads membranes. Lack of surfactant

B. Associated with 1. reached begins Prematurity-Surfactant levels 28 until weeks. production are weeks; at not 34 adequate

maturity. Amniotic screen ratio for is used sphingomyelin lecithin to lung fluid to i.

ii. remains sphingomyelin Phosphatidylcholine produced; is surfactant as levels (lecithin) increase constant.

iii. ratio surfactant indicates adequate 2 A production. >

2.

lack Caesarian steroids delivery-due of stress-induced increase synthesis steroids; of surfactant. section to

3.

diabetes-Insulin production. surfactant Maternal decreases

features C. Clinical 1.

use effort after Increasing grunting with 2. and accessory of respiratory birth, tachypnea muscles,

with cyanosis 3. Hypoxemia

granularity Diffuse ('ground-glass' (Fig. the x-ray of lung appearance) on 9.18)

Complications D. 1.

the ductus persistence of enterocolitis. increases for and necrotizing risk patent arteriosus Hypoxemia

2.

the radical injury. oxygen free Supplemental risk increases for bronchopulmonary blindness; Retinal lung to to leads leads damage injury dysplasia.

I. PRINCIPLES BASIC

A. 60 of age US; mortality in the years. is cause Most common presentation average at cancer

B. factors Key radon, and cigarette asbestos. are risk smoke,

1. 85% over 60 in carcinogens; contains Cigarette smoke smokers. cancer occurs oflung

arsenic particularly and are i. aromatic hydrocarbons mutagenic. Polycyclic

ii. of related amount directly is Cancer smoking and risk the to ('packyears'). duration

2. of radioactive which soil. is by in Radon formed is decay uranium, present

ii. in Accumulates basements i. closed as such spaces carcinoma most in exposure US Responsible frequent ionizing most oflung cause iii. 2nd to for radiation; public of the also Increased seen cancer lung in is uranium miners. of risk

3. coal (arsenic, asbestos, metals Environmental stoves, toxins chromium, and and nickel) fueled include

post-obstructive pneumonia). and C. symptoms weight Presenting nonspecific dyspnea, cough, (e.g., hemoptysis, loss, are

reveals a seen. D. Imaging be usually can solitary large, however, a ('coinlesion') nodule mass; spiculated diagnosis necessary is cancer. for a Biopsy of

1. 'coin-lesion,' in also Benign produce especially a younger lesions may patients. in Midwest) include Histoplasma Granuloma-often i. (especially to or the Examples TB fungus due ii. composed hamartoma-benign cartilage; often imaging calcified tumor on tissue and oflung Bronchial

is divided classically into categories 9.5). (Table Lung carcinoma E. 2

1.

2.

, Cancers , Lung 9.5: Table HISTOLOGY of the

Poorly small (Fig. differentiated cells differentiation, chromogranin positive 9.19)

(Fig. Glands, mucin TTF- or 9.20A),

carcinoma Squamous pearls, cell (Fig. Keratin intercellular bridges p40 9.22A,B), or

(Fig. bridges, chromogranin positive neuroendocrine carcinoma pearls, large (nests); p40) TTF-1, (no keratin glands, or Large differentiated intercellular cell mucin, Poorly cells 9.23A,B)

Most colon lung to carcinoma. sources Metastasis common and breast are

and radiation) i. not surgical (treated Non-small to (85%) with chemotherapy carcinoma (15%)-usually resection carcinoma amenable cell Small cell ii. amenable surgical resection to Usually carcinoma cell neuroendocrine Major cell include squamous carcinoid (30%), carcinoma (5%), adenocarcinoma (50%), (5%). tumor large and subtypes

smoking to related Not significantly

Peripheral (Fig. 9.20B)

Central (Fig. 9.22C)

bronchus forms in Central when central, (Fig. polyp-like or a peripheral; mass the classically 9.23C)

and may (e.g., Lambert-Eaton nervous ACTH) early syndrome) or (e.g., syndromes metastasis; paraneoplastic myasthenic produce or endocrine growth ADH system Rapid

Adenocarcinoma alveoli columnar (Fig. bronchioles that in-situ grow along exhibits preexisting and cells pneumonia-like may consolidation present imaging as 9.21); on

Diagnosis of exclusion

cause carcinoid Low-grade can syndrome rarely, malignancy;

Fig. neonatal lung, 9.18 respiratory of Granularity Fig. cell carcinoma. Small 9.19 syndrome. distress LearningRadiology.com) (Published from with permission

I .. ·.°'

Fig. Adenocarcinoma. 9.20 mucin formation Gland A, production. and location. B, Peripheral (B, Fig. Adenocarcinoma 9.21 in-situ. ofThomas Krausz, MD) Courtesy

Fig . carcinoma. cell 9.22 Squamous pearls. Keratin A, B, bridges. lntercellular location. C, Central Courtesy Krausz, Thomas (B, MD. C, Courtesy of Rosen, Yale MD)

Fig. Carcinoid tumor. 9.23 appea rance. Microscopic A, immunohistochemistry. B, expression by Chromogranin the in growth Polyp-like bronchus. C, (C, le Courtesy Rosen, Ya of MD)

1. F. TNM staging extension and T-Tumor size i. local blue (superior to arms Obstruction vena veins distended of syndrome). SVC cava leads with neck edema head and of discoloration and face and

ii. paralysis) nerve iii. (diaphragmatic or laryngeal of Involvement recurrent (hoarseness) phrenic Horner of and syndrome) anhidrosis; brachia! sympathetic miosis, chain and Involvement the (ptosis, 2. (Pancoast is (shoulder tumor) involving sulcus the apical hand tumors seen plexus superior pain and weakness) with

nodes (hilar and mediastinal) regional to lymph N-spread 3.

of gland. M-a distant the site metastasis is unique adrenal

4.

presents survival; 15% lung carcinoma often 5-year late Overall, i. long patients CT recommended smoking history Screening low-dose with by for 5.

be (erlotinib) ALK or EGFR (crizotinib) translocation in are common EGFR especially non-smokers. adenocarcinoma; mutations Asian i. may present females is who in

6.

for PD-Ll expression carcinoma. Testing PD-Ll cell guides advanced may non-small immunotherapy present (pembrolizumab) any disease; in be in

I. PNEUMOTHORAX

in the air A. Accumulation space pleural of

young is emphysematous of seen adults B. due rupture pneumothorax in Spontaneous bleb; to an 1. a lung of of collapse Results portion the (Fig. in side the 9.24); trachea of to collapse. shifts

with injury. C. Tension penetrating wall pneumothorax arises chest

1.

of enters the the but side pushed to space, trachea is pleural injury. cannot Air opposite exit;

2.

insertion tube of emergency; with chest a Medical treated

II. MESOTHELIOMA

asbestos mesothelial Malignant exposure occupational associated A. to highly cells; of with neoplasm

pain; encases B. with Presents dyspnea, chest lung the recurrent pleural effusions, (Fig. and tumor 9.25).

Fig. Spontaneous pneumothorax. 9.24 Fig. (Courtesy Mesothelioma. 9.25 James (Courtesy ia.) of Wikiped MD, Jamie Heilman, of MD) Steinmetz,

AND LIP CLEFT I. PALATE

(Fig. lip of defect A. or Full-thickness palate 10.1)

B. Due failure of facial to prominences to 1. fuse and and grow together superior, pregnancy, from two form facial two the early prominences (one sides, from inferior) fuse from the face. During to

palate common. or Cleft and C. usually lip together; isolated lip occur less palate cleft is

II. ULCER APHTHOUS

A. ulceration mucosa oral superficial of the Painful, (Fig. 10.2)

stress resolves B. relation to Arises and often spontaneously, recurs in but

base erythema a by by grayish C. Characterized surrounded

III. BEH<;:ET SYNDROME

Recurrent ulcers, and ulcers, A. uveitis genital aphthous

B. to small involving immune Due complex vessels vasculitis

after etiology seen but C. Can be unknown infection, is viral

IV.

red A. shallow, in painful, mucosa oral involving that ulcers rupture, Vesicles resulting

B. due to Usually HSV-1

in trigeminal heal, remains C. infection childhood; nerve. but occurs virus dormant Primary in lesions the of ganglia

the virus, to often vesicles and arise the of reactivation leading lips sunlight Fig. Stress on (cold sore, D. cause that 10.3).

V.

lining the Malignant squamous mucosa A. neoplasm oral cells of

B. and major factors. Tobacco alcohol are risk

location. common most is mouth Floor of the C.

precursor and lesions. D. Oral are leukoplakia erythroplakia

1.

dysplasia away; often cannot be plaque squamous a represents that scraped white is cell Leukoplakia 2.

candidiasis leukoplakia. hairy from is (thrush) oral and Leukoplakia distinct

i. the which easily on tongue, a is white scraped Oral away candidiasis is deposit (Fig. states immunocompromised seen in 10.4); usually ii. lateral tongue. white, rough arises is ('hairy') the that patch Hairy leukoplakia on a 3. hyperplasia; and to (e.g., squamous seen not pre-malignant AIDS) is due is EBY-induced cell in It immunocompromised usually individuals

(red vascularized dysplasia. squamous Erythroplakia leukoplakia is and of plaque) suggestive represents highly cell

4.

Erythroplakia biopsied to rule carcinoma. and are leukoplakia out often

pathoma.com

I. BASIC PRINCIPLES

saliva. exocrine glands are Salivary that glands secrete A.

B. sublingual glands major and (hundreds oral distributed into of minor glands microscopic the glands) submandibular, (parotid, Divided mucosa) throughout and

II. MUMPS

A. mumps virus bilateral Infection resulting with parotid inflamed in glands

also Orchitis, meningitis may and be B. aseptic present. pancreatitis,

1.

or due gland to involvement. salivary amylase Serum is pancreatic increased

2.

of sterility, carries Orchitis especially risk teenagers. in

III. SIALADENITIS

the of Inflammation gland A. salivary

B. Staphylococcus infection; leading unilateral stone (sialolithiasis) to usually commonly aureus due obstructing an Most to

IV.

tumor salivary composed the A. common cartilage) of gland most Benign tissue; tumor stromal of (e.g., and epithelial

B. circumscribed painless, as mass jaw in of arises angle mobile, a the at presents parotid; the Usually

islands of capsule C. of High tumor small leads extension recurrence; through tumor of (Fig. resection rate often incomplete to 10.5).

carcinoma, parotid into D. nerve (facial nerve which runs through gland) may damage facial presents with signs of transform Rarely

V.

cystic stroma); A. salivary Benign lymphocytes 2nd the most germinal and node-like tumor centers (lymph gland abundant with common tumor of

B. arises Almost the parotid always in

VI. CARCINOMA MUCOEPIDERMOID

mucinous gland malignant cells; common of the A. tumor squamous Malignant most composed of salivary and tumor

B. Usually nerve involves in parotid; arises the commonly facial the

10,1 and palate. Cleft lip Fig, Fig. of (Courtesy James Aphthous 10.2 ulcer. 10.3 sore. from Cold (Reproduced Fig, 3.0) Dr. Wikipedia) Heilman, CCBY-SA (Courtesy Herrmann, MD, of CDC) wikipedia.org,

FISTULA I. TRACHEOESOPHAGEAL

the a trachea connection resulting defect Congenital esophagus in A. and between

B. consists of esophageal the with proximal common esophagus distal from trachea arising variant the Most atresia (Fig. 10.6).

1. distension, polyhydramnios, abdominal with Presents aspiration vomiting, and

II. WEB ESOPHAGEAL

A. most Thin the often of mucosa, esophagus esophageal in protrusion upper

poorly for chewed B. dysphagia with food Presents

Increased carcinoma C. cell squamous for risk esophageal

iron is beefy-red tongue due deficiency web, and by characterized esophageal severe D. glossitis. atrophic anemia, Plummer-Vinson to syndrome

III. DIVERTICULUM ZENKER

A. pharyngeal defect through in (false of diverticulum) mucosa Outpouching wall an the acquired muscular

pharynx esophagus junction upper of sphincter the B. the and at Arises above esophageal the

and breath) with (bad obstruction, C. halitosis Presents dysphagia,

IV.

gastroesophageal Longitudinal mucosa the of (GE) at laceration A. junction

B. by alcoholism or Caused to usually vomiting, bulimia due severe

hematemesis Presents C. painful with

in ofBoerhaave emphysema mediastinum leading subcutaneous of the esophagus D. air and to Risk syndrome-rupture

V.

esophagus A. submucosal the Dilated veins lower in

portal secondary B. to Arise hypertension 1.

the Distal the portal vein esophageal vein. into vein gastric left drains via normally

2.

in esophageal vein portal vein, (varices). gastric hypertension, the resulting the dilation up left into In backs

rupture risk 1. C. Asymptomatic, exists but of

with Presents painless hematemesis 2.

of Most common in cause death cirrhosis

Fig. candidiasis. Oral 10.4 Fig. James (Courtesy of adenoma. 10.5 Pleomorphic (Courtesy of Fig. fistula. 10.6 Tracheoesophageal of humpath.com) MD, Bu (Courtesy Celasun, Wikipedia) lent Heilman, MD)

VI. ACHALASIA

inability to motility with esophageal Disordered esophageal relax A. (LES) sphincter the lower

B. myenteric cells ganglion in Due to 1. plexus the damaged

are the Ganglion and longitudinal inner for muscularis between plexus of of located and the important and circular regulating LES. outer myenteric relaxing layers cells the are motility propria bowel

2.

or idiopathic to can Trypanosoma Chagas be (e.g., Damage infection in disease). cells known secondary insult cruzi a ganglion to

features 1. C. Clinical

2.

3.

4.

barium study on sign 'Bird-beak' (Fig. swallow 5. 10.7)

VII. GASTROESOPHAGEAL (GERD) DISEASE REFLUX

reduced the A. Reflux due stomach from of tone to LES acid

B. and tobacco, fat-rich Risk caffeine, include alcohol, factors obesity, hiatal diet, hernia.

Clinical features C. 1.

2.

3.

to enamel ofteeth 4. Damage

are Barrett complications. stricture with Ulceration esophagus and late

VIII. ESOPHAGUS BARRETT

goblet to mucosa columnar stratified from of the lower cells nonciliated epithelium A. with epithelium squamous Metaplasia (Fig. esophageal with GERD of seen 10.8); patients in 10% 1. stress oflower acidic stem esophageal Response cells to

B. dysplasia to and May adenocarcinoma progress

IX. CARCINOMA ESOPHAGEAL

carcinoma cell adenocarcinoma or as A. squamous Subclassified

is a of glands; esophageal in of type B. malignant carcinoma most West proliferation Adenocarcinoma the 1. common lower from Barrett the Arises usually esophagus; preexisting one-third esophagus of involves the

Fig. 'Bird-beak' 10.7 sign, achalasia. of Fig. (Courtesy Barrett esophagus. 10.8

Farrokhi, and MD) M. Vaezi, MD F.

most cancer 1. carcinoma Squamous esophageal is C. of common malignant proliferation cell cells; squamous a worldwide of upper middle risk third in the arises esophagus; factors major or Usually include 1. and tobacco common (most causes) Alcohol ii. Very tea iii. hot iv. Achalasia

Plummer-Vinson (e.g., web Esophageal v. syndrome)

ingestion) injury Esophageal (e.g., lye

prognosis). presents Esophageal carcinoma (poor late D.

1.

Symptoms weight to pain, liquids), progressive and hematemesis. (solids dysphagia include loss,

2.

may cell involvement) nerve Squamous hoarse laryngeal (tracheal (recurrent cough involvement). carcinoma voice with present and additionally

esophagus spread the of the Location on involved. is level oflymph that node depends E.

1.

2.

3.

GASTROSCHISIS I.

anterior of abdominal wall malformation the leading Congenital abdominal contents A. exposure (Fig. of to 10.9)

II. OMPHALOCELE

A. Persistent bowel herniation into umbilical cord of

B. cavity to during of intestines Due failure the 1. to herniated return body to development the (Fig. peritoneum Contents are covered of umbilical by and cord amnion 10.10).

III. STENOSIS PYLORIC

pyloric common males more A. hypertrophy muscle; Congenital of in smooth

B. weeks after two presents birth Classically 1. as

2.

3.

abdomen in the mass Olive-like

Treatment myotomy. is C.

Fig. 10.9 Gastroschisis. of humpath. (Courtesy Fig.10.10 Omphalocele. J.T. of (Courtesy Fig.10.11 metaplasia, chronic Intestinal gastritis. Stocker, MD) com)

IV.

A. the damage mucosa to Acidic stomach

B. to imbalance between mucosa! Due defenses environment and acidic 1. and supply foveolar acid). cells, up mucin epithelium, picks (provides and include layer bicarbonate leaked by normal secretion Defenses surface blood produced nutrients by

C. factors 1. Risk

blood Severe burn supply. decreased to (Curling ulcer)-Hypovolemia leads

2.

3.

4.

5.

acid production. to leads stimulation pressure ulcer)-Increased increased Increased (Cushing intracranial nerve ofvagus

6.

Shock-Multiple ulcers may (stress) be seen patients. in ICU

results in superficial mucosa! Acid ulcer superficial of epithelium), (loss D. of damage or inflammation, erosion (loss layer).

V.

A. of Chronic stomach mucosa inflammation

B. autoimmune types underlying two into gastritis pylori chronic etiology: gastritis based Divided H on chronic and

body to gastric located due is autoimmune in and destruction the are Chronic autoimmune stomach which parietal gastritis cells, C. of fundus.

1.

pathogenesis and/or hypersensitivity) by cells useful with is for but against intrinsic IV mediated parietal Associated antibodies (type factor; cells 2. T diagnosis,

i. Atrophy mucosa metaplasia intestinal (Fig. with of 10.11) ii. increased gastrin hyperplasia levels iii. Achlorhydria antral G-cell and with lack iv. Megaloblastic to due of intrinsic factor anemia (pernicious) Increased risk type) gastric adenocarcinoma for (intestinal

most H to is pylori-induced Chronic gastritis inflammation; common H 1. of pylori gastritis due form chronic and (90%) D. acute

pylori ureases H proteases weaken mucosa! with along and inflammation the common antrum site is defenses; most (Fig. 10.12).

2.

(intestinal risk gastric disease), ulcer and MALT (peptic increased ulceration for Presents 3. pain; abdominal type), epigastric with lymphoma adenocarcinoma

triple therapy. involves Treatment

i. intestinal and metaplasia reverses Resolves gastritis/ulcer ii. of of antigen lack eradication stool confirm test and breath Negative urea

Hpylori.

Fig. pylori. 10.12 H of Fig. MD) Uthman, Ed (Courtesy ulcer. Gastric 10.13 ulcer disease. Peptic A, Carcinoma. B, of Husain, Aliya (Courtesy MD)

VI. DISEASE ULCER PEPTIC

A. Solitary mucosa! (10%) stomach proximal ulcer duodenum or (90%) distal involving

may to Duodenal (> due H 95%); ZE B. ulcer syndrome rarely, due 1. is almost always to pylori be

with pain 2. improves Presents epigastric with that meals

glands. endoscopic ulcer with Brunner hypertrophy biopsy of shows Diagnostic

3.

pancreatitis from acute duodenum; to the arises anterior lead gastroduodenal may present or in duodenum, in posterior when rupture Usually artery bleeding

and causes to usually include is other pylori due Gastric NSAIDs bile ulcer C. (75%); H reflux.

1.

that with with meals epigastric 2. pain Presents worsens

antrum. is curvature lesser Ulcer located of on the the usually

3.

risk Rupture artery. gastric of bleeding left carries from

D. includes diagnosis of ulcers Differential carcinoma.

1.

are (duodenal almost ulcers Duodenal rare). malignant never is carcinoma extremely

2.

be ulcers (intestinal by caused subtype). can gastric Gastric carcinoma

cm), (Fig. surrounded ("punched-out"), 3 mucosa ulcers of sharply (< i. usually demarcated small and radiating peptic are folds Benign by 10.13A).

11. heaped (Fig. Malignant with irregular margins ulcers up large are and 10.13B) iii. required definitive is diagnosis. Biopsy for

VII. CARCINOMA GASTRIC

surface A. Malignant proliferation cells (adenocarcinoma) of epithelial

into Subclassified diffuse types intestinal and B.

to as a commonly C. curvature type (similar ulcer antrum ulcer) large, presents most the irregular of heaped up with common) involves gastric lesser (more 1. the Intestinal margins; and factors to and foods smoked include in nitrosamines pylori due (Japan), A. (e.g., metaplasia blood gastritis), Risk intestinal type autoimmune H

characterized is that type cells ring signet diffusely (Fig. wall by infiltrate gastric D. the Diffuse 10.14B); thickening Fig. stomach (linitis plastica, desmoplasia results of wall in 10.14A).

1. H nitrosamines with metaplasia, or intestinal pylori, Not associated

rarely as early anemia, nigricans with Leser-Trelat acanthosis presents carcinoma E. presents and abdominal late loss, weight pain, satiety; or Gastric sign

(Virchow lymph Spread can node the F. involve left nodes to node). supraclavicular

most involves G. liver; Distant metastasis sites include other 1. commonly nodule); seen intestinal with (Sister region Mary Joseph Periumbilical type

Fig. type. 10.14 diffuse Gastric carcinoma, A, plastica. Linitis Signet-ring B, cells. (A, 2. Courtesy MD) of Ed Uthman, tumor); diffuse with seen type ovaries (Krukenberg Bilateral

DUODENAL ATRESIA I.

with syndrome duodenum of Down Congenital failure A. canalize; to associated

B. 1. features Clinical

2.

blind Distension sign, and ('double of duodenum stomach bubble' of loop Fig. 10.15) 3.

II. DIVERTICULUM MECKEL

layers A. all of Outpouching wall the of Fig. three (true diverticulum, bowel 10.16)

to Arises the failure due B. of involute vitelline duct to

of 2s' 1. C. 'Rule

the congenital Seen anomaly of 2% common (most GI 2. of in the tract) population

bowel long and feet valve 2 within the inches ileocecal in of small the located 3. 2

cases (due during intussusception, years (mimics first appendicitis); the gastric are to Can with however, heterotopic life or of most mucosa), obstruction present 2 volvulus, bleeding asymptomatic.

III. VOLVULUS

mesentery bowel A. along Twisting its of

B. in supply of blood with obstruction disruption (Fig. infarction Results the and 10.17)

sigmoid (elderly) and adults). locations cecum C. Most (young common are colon

IV.

of segment of A. bowel Telescoping 1. into segment proximal distal forward infarction. disruption of pulled and resulting with segment in blood obstruction peristalsis, Telescoped supply by forward is

B. Associated a 1. leading with edge of (focus traction)

in the children, into cecum hyperplasia terminal due cause most is rotavirus); the (e.g., to leading ileum, usually In the arises intussusception to lymphoid common 2.

In tumor. most cause common is adults, the

V.

A. injury. is Small to highly susceptible ischemic bowel

1.

mesenteric artery occurs of Transmural superior or with infarction the thrombosis/embolism the of thrombosis mesenteric vein.

2.

Mucosa! occurs hypotension. marked infarction with

B. abdominal bowel bloody diarrhea, Clinical pain, include and features sounds. decreased

VI. INTOLERANCE LACTOSE

A. 1. lactase brush enzyme of the of in found function border Decreased enterocytes the normally and galactose. into breaks down glucose Lactase lactose

with upon distension milk products; and Presents diarrhea lactose abdominal is B. consumption undigested of active. osmotically

develops is late acquired susceptible infection be recessive congenital or deficiency Deficiency disorder) injury). bowel highly childhood); (]actase seen (often to autosomal is may small in C. temporary after (rare

VII. CELIAC DISEASE

to associated HLA-DQ2 gluten bowel of A. villi with DQS due Immune-mediated small exposure; and damage

present and gliadin. Gluten in its is wheat most grains; component is pathogenic B.

1.

gliadin (tTG). deamidated is by absorbed, tissue transglutaminase Once

2.

Deamidated presenting class antigen by cells presented II. is gliadin MHC via

3.

damage. mediate T cells Helper tissue

C. 1. presentation Clinical

abdominal classically distension, with present Children thrive. to diarrhea, and failure

2.

diarrhea Adults bloating. classically and chronic with present

3.

on herpes-like arise vesicles (dermatitis herpetiformis). may skin Small, at dermal gluten-free with papillae; Due diet to the of deposition resolves tips IgA

Laboratory findings 1. D.

in celiac incidence diagnosis for IgA endomysium, present and or tTG, deficiency is antibodies IgA seen IgG ofigA individuals in (increased useful deficiency disease). are with against gliadin; are also antibodies

2.

increased of reveals villi, crypts, lymphocytes hyperplasia of (Fig. Duodenal intraepithelial flattening biopsy and 10.18). Damage in most less prominent the jejunum ileum involved. and duodenum; is are

diet. Symptoms resolve E. gluten-free with

1. Small despite late carcinoma are refractory dietary present complications bowel good lymphoma that control. and disease as T-cell

Fig. disease. 10.18 Celiac Flattened A, villi. Normal B, villi for comparison.

SPRUE VIII.TROPICAL

A. to unknown organism small in due to villi resulting malabsorption an Damage bowel

B. celiac Similar except 1. disease to

Occurs tropical Caribbean) 2. (e.g., in regions

3. infectious antibiotics and responds after Arises to diarrhea

involved. prominent most jejunum vitamin ileum and deficiency is folate is may B12 duodenum (secondary in ensue); less commonly or Damage

IX.

A. characterized tissue Systemic are Tropheryma destroyed damage by whippelii organisms; with organisms for partially (positive lysosomes PAS). macrophages macrophage loaded present in

B. Classic (Fig. of bowel the involvement propria site small is lamina 10.19).

1.

compress lacteals. Macrophages

2.

from be lymphatics. cannot enterocytes transferred Chylomicrons to

3.

include and ofjoints synovium Other nodes, CNS. ofinvolvement C. cardiac common sites valves, (arthritis), lymph

X.

B-100 of Autosomal recessive B-48 deficiency apolipoprotein A. and

B. 1. Clinical features

2. (requires formation defective chylomicron B-48) to Malabsorption-due

XI. CARCINOID TUMOR

low-grade Malignant malignancy neuroendocrine A. of 1. cells; proliferation granules that for positive contain are Tumor neurosecretory chromogranin. cells

B. common anywhere is bowel the the Can site. gut; most along small arise

1. polyp-like as a nodule submucosal (Fig. Grows 10.20)

1. C. secretes serotonin Often

oxidase monoamine Serotonin liver portal metabolized the (MAO) and into into circulation released 5-HIAA. is by

2.

is 5-HIAA the excreted urine. in

to Metastasis liver tumor metabolism. allows to D. of carcinoid the bypass liver serotonin

1. carcinoid released circulation into disease. systemic heart is via carcinoid the in Serotonin leaks syndrome into and vein hepato-systemic hepatic shunts, and resulting

Fig. disease. Whipple 10.19 lamina Macrophages within villi. of propria small bowel A, Twhippelii B, Fig. 10.20 tumor. Carcinoid organisms by stain. PAS highlighted

2.

of serotonin Carcinoid alcohol and from tumor. which diarrhea, or characterized symptoms emotional flushing stimulate by is the by bronchospasm, be release skin; triggered can syndrome stress,

3.

left-sided by oxidase valvular lesions lung. Carcinoid collagen) to serotonin) heart in characterized and seen (increased monoamine not right-sided tricuspid regurgitation due to valve disease stenosis; of fibrosis the are leading (metabolizes valvular presence is pulmonary

I. APPENDICITIS ACUTE

A. the cause abdomen of common Acute most acute inflammation appendix; of

B. or the Related to appendix a by hyperplasia of fecalith obstruction lymphoid (adults) (children)

1. C. Clinical include features

lower point). to pain nausea; (McBurney localizes pain, Periumbilical right and quadrant fever, eventually

2.

that Rupture and results guarding tenderness. peritonitis in presents with rebound

3.

common is a complication. Periappendiceal abscess

I. BASIC PRINCIPLES

A. relapsing bowel of inflammation Chronic,

B. abnormal flora to Possibly to due response immune enteric

as bouts C. Classically presents 30s) young of pain diarrhea abdominal (teens 1. bloody women to and in recurrent West, the and prevalent Eastern More Jews European in Caucasians particularly in

bowel inflammation (e.g., mimic Diagnosis exclusion; D. of symptoms other of causes infection).

(Table or E. as Crohn 10.1) colitis Subclassified disease ulcerative

HIRSCHSPRUNG I. DISEASE

A. of peristalsis and colon rectum relaxation Defective 1. sigmoid distal and syndrome Associated with Down

B. Due (neural to of crest-derived) to 1. failure ganglion descend congenital myenteric submucosal into cells and plexus

located muscle between is outer motility. (Auerbach) plexus Myenteric layers regulates inner propria the muscularis of the and and longitudinal circular

2.

and in plexus and regulates secretions, absorption. is the flow, Submucosal located submucosa (Meissner) blood

on features C. based Clinical are obstruction.

1.

meconium 2. to Failure pass

3.

to risk obstruction rupture Massive bowel (megacolon) dilatation with for of proximal

ganglion Rectal suction biopsy lack of reveals D. cells.

Treatment ganglion proximal bowel; E. the resection are of in cells to involved diseased segment. bowel the the involves present

Features Main 10.1: Disease and Ulcerative Colitis Table of Crohn

can in cecum and rectum the proximally is continuous, Begins Fig. up to (involvement extend unaffected. of GI tract the 10.21A); remainder is

diarrhea with lower pain bloody quadrant (rectum) Left

with neutrophils (Fig. abscesses Crypt 10.21B)

pipe' imaging, loss ofhaustra ('lead sign Fig. on Pseudopolyps; 10.21C)

and megacolon concern DISEASE CROHN duration (risk Toxic carcinoma on colonic not extent of is disease) of > involvement until generally disease; of and 10 years a based

fissures inflammation with Full-thickness knife-like

is is Anywhere the with rectum skip anus mouth site, most common to lesions; from terminal least ileum common.

Right diarrhea lower pain (ileum) nonbloody with quadrant

with cases) granulomas (40% of Lymphoid aggregates

mucosa (Fig. Cobblestone and Fig. 10.22A), ('string-sign' strictures fat, imaging, on creeping 10.22B)

with nephrolithiasis, carcinoma, colonic if deficiency, Malabsorption present fistula and oxalate formation, nutritional is calcium disease

(peripheral joints, sacroiliitis, spondylitis, migratory polyarthritis), ankylosing nodosum erythema Arthritis (Fig. uveitis, primary gangrenosum, pyoderma 10.22C), and p-ANCA cholangitis, sclerosing

Fig. Ulcerative 10.21 colitis. appearance. Gross A, B, Crypt abscess. sign MD. Courtesy C, pipe' (A, 'Lead Jamie of Steinmetz, Published with from C, LearningRadiology.com) permission

Fig. Crohn 10.22 disease. Cobblestone with stricture. A, mucosa sign. 'String' B, Fig. Courtesy of (A, Erythema nodosum. 10.22C humpath.com. Published LearningRadiology.com) B, permission with from

II. DIVERTICULA COLONIC

mucosa A. submucosa and Outpouchings through the muscularis (Fig. propria of diverticulum) 10.23, false

B. stress wall Related 1. to

age) in 2. commonly constipation, increases (risk with straining, low-fiber seen and adults with older Associated diet;

the most point is vasa the common recta Arise propria sigmoid traverse colonic (weak muscularis where wall); location. the in colon

Usually asymptomatic; complications include C. 1.

2.

quadrant the lower material; presents obstructing with fecal Diverticulitis-due to 3. left symptoms appendicitis-like in

and Fistula-Inflamed diverticulum attaches a to local ruptures structure. fistula urine. (or stool) with presents air Colovesicular in

III. ANGIODYSPLASIA

A. Acquired malformation mucosa! of submucosal and capillary beds

B. right colon wall high tension in Usually due to and the cecum arises

as presents adult. older C. hematochezia in an Rupture classically

IV.

vessels, mouth disorder blood A. resulting and dominant in GI especially thin-walled the in (Fig. Autosomal tract 10.24)

as bleeding. presents Rupture B.

V.

of the mesenteric Ischemic superior the damage at usually A. to artery splenic [SMA]) (watershed colon, flexure area

is of Atherosclerosis most B. the common cause. SMA

bloody loss; pain Presents pain infarction weight and diarrhea. in postprandial and results C. with

VI. IRRITABLE BOWEL SYNDROME

females defecation; classically change and Relapsing flatulence, abdominal seen with pain or with bowel in that (diarrhea bloating, A. habits improves in middleaged constipation)

B. motility; pathologic Related identifiable disturbed intestinal changes no to

C. may improve symptoms. Increased fiber dietary

Fig. diverticula. 10.23 Colonic A, appearance. Gross B, Microscopic appearance. Fig. telangiectasia. hemorrhagic 10.24 Hereditary (Courtesy Ors. of Images van Cases) H. H. Dijk, and Fred ofMemorable

VII. COLONIC POLYPS

A. colonic mucosa Raised of protrusions

B. hyperplastic Most and polyps. adenomatous types are common

1. of due i. polyps glands; are show Hyperplastic classically 'serrated' appearance microscopy on to a hyperplasia in the usually polyp; Most common (rectosigmoid) ii. colon left arise type of no malignant 2. Benign, potential with polyps due are neoplastic of glands (Fig. proliferation Adenomatous to to may 10.25); adenoma-carcinoma 3. most common Benign, progress colonic the premalignant; 2nd adenocarcinoma i. of type polyp sequence but via molecular adenomatous progression sequence to carcinoma. colonic mucosa normal from describes the to Adenoma-carcinoma polyp

APC polyp. coli of i. increase or gene) for mutations (sporadic polyposis (adenomatous risk germline) formation

ii. of mutation polyp. formation K-ras to leads

iii. for expression of allow aspirin to COX carcinoma; adenoma and carcinoma. p53 progression to impedes progression mutation from increased

polyps Screening usually for fecal occult polyps bleed. can colonoscopy by C. are is for blood; and silent, performed but clinically testing

1. carcinoma. polyps is adenomatous to before progression to remove Goal

and identical. polyps look colonoscopy, D. On hyperplastic adenomatous are polyps examined Hence, removed microscopically. all and

1. cm, progression 2 related and carcinoma is for sessile Greatest to growth, size from risk > to adenoma villous histology.

VIII. (FAP) ADENOMATOUS FAMILIAL POLYPOSIS

by A. dominant disorder adenomatous 100s colonic of (Fig. 1000s polyps Autosomal characterized to 10.26)

B. inherited develop increases Due (chromosome throughout rectum mutation to APC colon polyps adenomatous and to propensity 5);

by almost age. all Colon years removed are C. otherwise, 40 prophylactically; patients rectum carcinoma develop of and

syndrome FAP Gardner D. is with and osteomas. fibromatosis

1.

non-neoplastic proliferation arises retroperitoneum a is and in (desmoid) 2. locally fibroblasts; of Fibromatosis destroys tissue

usually skull. arises the Osteoma benign is of that a bone tumor in

tumors glial E. FAP Turcot with tumors). and is CNS (medulloblastoma syndrome

Fig. Adenomatous polyp. 10.25 Fig. polyposis. adenomatous 10.26 Familial (Courtesy of hum path.com)

IX.

A. children(< hamartomatous (benign) polyp 5 in that arises Sporadic, years) 1. presents and a rectal solitary that Usually bleeds polyp as prolapses

B. large the ofjuvenile and polyposis increase colon; numbers polyps carcinoma. progression Juvenile by juvenile is the characterized stomach of to in polyps risk multiple

X.

dominant (benign) and (freckle-like disorder oral mucosa, genital autosomal GI Hamartomatous throughout tract spots) skin; on mucocutaneous lips, polyps hyperpigmentation and A.

B. risk and Increased breast, for colorectal, cancer gynecologic

XI. CARCINOMA COLORECTAL

rectal cause of 3rd A. death mucosa; or of most and site cancer-related common Carcinoma colonic 3rd 1. common most arising cancer from incidence is 60-70 of years Peak age.

B. pathway commonly from is microsatellite second sequence; molecular arises a instability (MSI). Most adenoma-carcinoma important

1.

maintained sequence is integrity during repeating division. noncoding sequences Microsatellites (stability) are DNA; of cell of

2.

repair copy DNA defective mismatch indicates mechanisms DNA (e.g., Instability enzymes).

3.

enzymes. (HNPCC) to repair mismatch DNA is mutations inherited due Hereditary carcinoma nonpolyposis colorectal in

i. risk colorectal, for endometrial ovarian, ii. carcinoma Increased and age; at relatively novo a Colorectal early carcinoma arises usually from de adenomatous (not right-sided polyps)

C. years and for at 1. colorectal of begins colonoscopy Screening occult age occurs fecal via 50 testing; blood carcinoma to detect symptoms before to carcinoma and cancer polyps is remove adenomatous clinical Goal develops (before early arise).

length anywhere entire along colon. Carcinoma D. of develop can

1.

stool 'napkin-ring' Left-sided 2. usually and left pain, a lesion; as blood-streaked decreased with carcinoma lower presents stool caliber, quadrant grows

irondeficiency Right-sided and presents anemia (occult lesion; usually raised as grows carcinoma vague with pain. a bleeding) An until colorectal iron proven has deficiency adult older with anemia carcinoma otherwise.

associated Streptococcus for increased with is an risk endocarditis. Colonic bovis carcinoma E.

1. Staging F.

tumors due the generally in do mucosa. lack of to invasion; limited lymphatics the mucosa of to T-depth spread not

2.

to nodes N-spread regional 3. lymph

commonly most spread; involves liver M-distant the

marker and G. a that serum useful is treatment not CEA useful is response assessing screening detecting for for tumor recurrence;

Exocrine Pancreas,

Gallbladder, and

PANCREAS I. ANNULAR

ring duodenal pancreas the obstruction around in which A. forms malformation a the risk Developmental duodenum; of

II. ACUTE PANCREATITIS

and of the pancreas A. Inflammation hemorrhage

B. by to Due pancreatic autodigestion enzymes of pancreatic 1. parenchyma pancreatic activation of to Premature other enzymes. leads activation of trypsin

fat in necrosis and (Fig. liquefactive Results pancreas the peripancreatic C. of fat hemorrhagic of necrosis the 11.1)

alcohol commonly D. mumps, to duodenal include causes hyperlipidemia, due a Most gallstones; scorpion and trauma, hypercalcemia, stings, rupture ulcer. drugs, other and of posterior

1. Clinical features E.

2. pain abdominal radiates back to Epigastric the that

3.

tissue retroperitoneum) Periumbilical 4. and flank spreads (necrosis soft the into and periumbilical hemorrhage

for amylase; and lipase is damage. lipase more specific Elevated serum pancreatic

5.

is consumed (calcium saponification Hypocalcemia necrosis) during in fat

1. F. Complications

and peripancreatic fluid to hemorrhage sequestration Shock-due 2.

with amylase mass serum persistently ii. an Presents i. as abdominal elevated cavity is associated ofenzymes Rupture abdominal with release into hemorrhage. and the

3.

elevated 4. amylase and due to persistently E presents fever, Pancreatic coli; abdominal high with abscess-often pain,

III. PANCREATITIS CHRONIC

1. pancreatitis parenchyma, secondary acute most A. often Fibrosis to ofpancreatic recurrent Most and commonly alcohol many to idiopathic. due (children); fibrosis are (adults) cystic cases however,

B. features Clinical 1.

back abdominal 2. to the Epigastric that pain radiates

vitamin fatsoluble and Pancreatic deficiencies. steatorrhea insufficiency-results with malabsorption in useful lipase and ofchronic pancreatitis. serologic not Amylase markers are

3.

pattern contrast studies pancreatic 'chain calcification dilatation on ducts. due of oflakes' of Dystrophic parenchyma to reveal pancreatic a imaging;

4. pathoma.com

mellitus-late 5. of complication diabetes to Secondary due destruction islets

IV. CARCINOMA PANCREATIC

ducts Adenocarcinoma from 1. the pancreatic A. arising elderly age years) the commonly is seen in 70 Most (average

B. factors pancreatitis. risk are chronic and Major smoking

(usually late C. features in 1. occur disease) Clinical

2.

(most location) head common that with jaundice pale gallbladder; with tumors the arise associated stools in 3. and Obstructive pancreas the palpable of

associated Secondary tumors diabetes arise that the 4. mellitus; tail with body or in

5.

erythema, extremities (seen thrombophlebitis Migratory in (Trousseau the tenderness of 6. 10% in and syndrome); swelling, presents as patients)

is Serum CA marker 19-9. tumor

pancreas, of removal of and (Whipple the neck bloc head proximal procedure). duodenum, resection Surgical D. en and involves gallbladder

survival Very E. < 10%. I-year is prognosis; poor

ATRESIA BILIARY I.

A. biliary form to early of extrahepatic tree or Failure destruction

B. obstruction first Leads of months within biliary the to 2 life

and jaundice cirrhosis with progresses Presents to C.

II. (GALLSTONES) CHOLELITHIASIS

A. in Solid, gallbladder stones round the

B. stones) to precipitation bilirubin in cholesterol stones) (bilirubin or Due 1. (cholesterol bile of (2) decreased bile stasis (1) or lecithin) bilirubin, acids or Arises of or with (normally cholesterol supersaturation (e.g., increase (3) phospholipids solubility),

the (90%), type most especially West stones common the are C. (Fig. Cholesterol (yellow) in 11.2A).

1.

calcium) associated (10% are due 2. radiolucent to radiopaque Usually

Crohn obesity, American gender, Native cirrhosis. and (female oral (40s), ethnicity, contraceptives), clofibrate, multiple factors Risk include pregnancies and estrogen age disease,

Fig. 11.1 pancreatitis. Acute Fig. of (Courtesy 11.2 Gallstones. stones. A, Cholesterol B, Bilirubin stones. (A, K.V. Courtesy of Santosh, MD. Courtesy humpath.com) B, of hum path.com)

Gallbladder, Pancreas, Liver Pathology Exocrine and

composed stones D. (Fig. Bilirubin ofbilirubin are (pigmented) 11.2B).

1.

2.

bilirubin E bile) infection include factors tract sinensis). and and in biliary (e.g., Risk coli, hemolysis Clonorchis (increased Ascaris extravascular lumbricoides,

the ii. world's areas poor lumbricoides for 25% that Ascaris a is increasing tract, infects transmission); with (fecal-oral the common i. risk infects gallstones especially of in population, biliary roundworm the sanitation endemic the Korea, Clonorchis tract, liver sinensis cholangitis, in and infects is (Chinese biliary Vietnam risk China, the increasing cholangiocarcinoma for gallstones, fluke); and

include chronic asymptomatic; and Gallstones cholangitis, ileus, and complications colic, gallbladder are usually cancer. gallstone acute ascending cholecystitis, biliary E.

III. BILIARY COLIC

A. pain right and upper Waxing quadrant waning

B. stone cystic against contracting a Due lodged gallbladder the the in to duct

Symptoms passes. relieved C. are if stone the

Common D. pancreatitis bile acute in result jaundice. or duct obstructive may obstruction

IV.

A. of inflammation the wall Acute gallbladder

(E overgrowth and stone B. dilatation Impacted ischemia, pressure bacterial coli), in in inflammation. duct cystic results the with

t damage) nausea, C. phosphatase with serum (from scapula, vomiting, and right WBC fever t count, often radiating pain, alkaline with right Presents upper to quadrant duct

Risk rupture D. ifleft of untreated

V.

A. Chronic inflammation the of gallbladder

B. cholelithiasis, without with to acute irritation superimposed chemical bouts or from Due of longstanding cholecystitis

Characterized (Rokitansky-Aschoff mucosa muscular of C. Fig. sinus, gallbladder the into wall herniation by 11.3A)

with D. right upper after eating especially Presents quadrant vague pain,

complication E. (Fig. late a Porcelain gallbladder is 11.3B).

1. gallbladder calcification dystrophic ·'~{~. hard and due Shrunken, chronic fibrosis, inflammation, :~7~/ to

. . :",A~?·'\),:~;,. ..•'-·.,_ t1 :;,,;_

Fig. Chronic cholecystitis. 11.3 A, Rokitansky-Aschoff sinus. Porcelain ll ga bladder. B, (B, Drs. of Courtesy ofMemorable 2. van Fred Dijk, Images Cases) H. H. and Increased risk carcinoma for

if is present. especially gallbladder cholecystectomy, Treatment porcelain F. is

VI. CHOLANGITIS ASCENDING

of ducts the bile infection Bacterial A.

B. infection Usually gram-negative enteric with due bacteria to ascending

jaundice, (high chills), and and C. abdominal pain sepsis as Presents fever

ducts) incidence D. (stone with choledocholithiasis Increased biliary in

VII. ILEUS GALLSTONE

A. bowel Gallstone obstructs enters small the and

B. Due fistula with to between formation small cholecystitis and gallbladder the bowel

VIII.GALLBLADDER CARCINOMA

the (Fig. A. glandular the epithelium wall that from Adenocarcinoma gallbladder lines arising 11.4)

B. a Gallstones major risk are especially porcelain complicated when by factor, gallbladder.

an as presents in C. cholecystitis woman elderly Classically

Poor prognosis D.

I. JAUNDICE

Yellow discoloration (Fig. of A. the skin of sclera). is the (yellow icterus earliest sign discoloration 11.5); scleral

B. usually to mg/dL bilirubin, t Due 2.5 > serum

(Table 11.1) C. metabolism Arises in disturbances with bilirubin

Normal bilirubin D. metabolism 1.

of macrophages are reticuloendothelial system. by consumed the RBCs

2.

(UCB). to unconjugated heme) Protoporphyrin (from is bilirubin converted

3.

Albumin to carries liver. UCB the

4.

hepatocytes bilirubin. (UGT) in conjugates Uridine transferase glucuronyl

5.

to stored bile transferred to canaliculi (CB) bilirubin in is the form gallbladder. bile, which Conjugated is

6.

into in bowel digestion. Bile small to the released is aid

7.

(partially urine making kidney, oxidized to urobilin CB (makes convert stool urobilinogen, brown) yellow). reabsorbed and filtered Intestinal which blood to and is flora stercobilin into by

.4 Fig.11 Gallbladder carcinoma. of (Courtesy K.V. Fig. Jaundice. 11.5 (Courtesy of Fig. Heilman, James hepatitis. 11 .6 Acute Santosh, MD, Wikipedia) MD)

Gallbladder, Pancreas, and Exocrine Liver Pathology

Table Causes Jaundice 11.1: of

jaundice Physiologic the newborn of

the of High liver. ability the UCB conjugating overwhelm of levels

low liver Newborn transiently UGT has activity.

and gallstones, carcinoma, fluke pancreatic parasites, liver Associated cholangiocarcinoma, with

Inflammation disrupts small hepatocytes bile ductules. and

t urobilinogen, alkaline urine t CB, phosphatase and ..J..

Hepatitis Important of Table Viruses 11.2: Features

travelers. acquired is by HAV commonly commonly is seafood. undercooked HEV acquired from water or contaminated

abuse (e.g., unprotected and transmission stick) drug intercourse, needle intravenous childbirth, Parenteral [IVDA],

almost IVDA, risk (e.g., to Parenteral from screening supply. the unprotected intercourse); nonexistent due of blood is transmission transfusion

for bilirubin to thus, Increased urine) urine absent gallstones water due (UCB urine Dark is is from not urobilinogen soluble t pigmented risk and,

(kernicterus) deposit is in basal deficits UCB can soluble death. neurological the leading and fat to ganglia and is water Treatment (makes UCB soluble). phototherapy

during severe otherwise, Jaundice (e.g., stress not significant infection); clinically

significant is not Liver clinically lacks but liver Rotor dark; to is syndrome discoloration. Dubin-Johnson syndrome, otherwise, similar

fat-soluble with acids with Dark bile (due stool due Pruritus of vitamins t and malabsorption to Hypercholesterolemia urine bilirubinuria) plasma xanthomas to Steatorrhea pale

urobilinogen to Dark normal urine t or urine due urine is decreased. bilirubin;

Acute no state. hepatitis; chronic Anti-virus active infection. IgM marks indicates or is for IgG and prior available Antivirus HAV). its immunization presence protective, is infection (immunization is failure women massive liver in (liver pregnant necrosis). with with associated fulminant HEV hepatitis infection

chronic in Results disease 11.3). hepatitis; occurs cases (Table acute of 20% in

acute chronic Results most in disease occurs in cases. hepatitis; infection; disease. HCV-RNA indicates confirms test levels chronic RNA persistence indicate decreased recovery;

at same f}~,. HBV infection; severe HBV with the time) coinfection for on HBV (infection HDV and superinfection existing is upon more Dependent than

,f:

hepatitis. Fig.11 Chronic .7

of B Markers Virus Hepatitis Serologic Table 11.3:

~! HBsAG STAGE AND HBcAB of > + (presence HBsAB to 6 rise) presence HBV +/-; marker :AG

HBV defines DNA IgG HBeAg indicates months or state) chronic Chronic infectivity.

II. VIRAL HEPATITIS

ofliver CMV. causes usually include to A. 11.2); virus parenchyma, other and Inflammation hepatitis EBV due (Table

B. chronic Hepatitis may hepatitis. hepatitis, virus causes progress acute which to

with AST). jaundice malaise, presents to CB as hepatitis (mixed elevated enzymes C. dark and liver Acute fever, (due > CB), nausea, and UCB) urine (ALT

1.

involves lobules hepatocytes Inflammation characterized liver of and by tracts (Fig. and portal of apoptosis the is 11.6).

2.

elevated with cases may be asymptomatic enzymes. Some liver

3.

months. Symptoms last 6 <

symptoms is D. by Chronic > 6 months. hepatitis characterized that last

1.

Inflammation tract portal involves (Fig. predominantly 11.7) 2.

Risk cirrhosis progression to of

III. CIRRHOSIS

hepatic End-stage by normal liver nodules characterized hepatocytes disruption of damage fibrosis by the regenerative and of of A. (Fig. parenchyma bands 11.8)

which TGF-~ that sinusoids. beneath by mediated Fibrosis lie endothelial stellate the from B. is line the cells cells

C. Clinical features 1. leads to hypertension cavity) the Portal Ascites ii. (fluid in peritoneal i. splenomegaly/hypersplenism iii. Congestive medusae) Portosystemic caput shunts and varices, (esophageal hemorrhoids,

Fig. Cirrhosis. 11.8 A, Microscopic appearance. B, Gross appearance. of humpath.com) (8, Courtesy

Liver Gallbladder, Exocrine Pathology iv. and Pancreas, Hepatorenal (rapidly renal syndrome cirrhosis) developing secondary to failure 2. results i. in Decreased detoxification asterixis, Mental changes, hence metabolic, eventual (due reversible ii. status ammonia); coma serum and tot spider and hyperestrinism due to angiomata, iii. palmar erythema Gynecomastia, 3. Jaundice leads protein Decreased edema with to 11. synthesis i. Hypoalbuminemia degree clotting factors; is PT. deficiency Coagulopathy of due to decreased synthesis of by followed

IV.

A. alcohol due Damage hepatic 1. parenchyma of consumption to to Most common disease cause in the West ofliver

liver (Fig. hepatocytes the of in Fatty fat is accumulation B. 11.9A).

1. liver; heavy, greasy Results abstinence (Fig. with resolves in a 11.9B)

hepatitis hepatocytes; C. results chemical drinking to seen 1. Alcoholic injury from binge with generally

of Acetaldehyde mediates damage. (metabolite alcohol)

2.

Mallory (damaged by bodies hepatocytes formation Fig. swelling Characterized of cytokeratin of filaments, with necrosis, acute 3. 11.10), inflammation and

(AST liver hepatomegaly ALT); result painful with and death > Presents in enzymes elevated may

long-term, 10-20% a complication in occurs Cirrhosis D. of damage; alcohol-induced alcoholics is of liver chronic

V.

known (or cirrhosis that to A. and/or insult) exposure without develop hepatitis, alcohol Fatty other change,

B. with obesity Associated

AST of exclusion; C. ALT > Diagnosis

VI. HEMOCHROMATOSIS

A. (hemochromatosis) damage iron Excess tissues body and 1. organ deposition (hemosiderosis) to in leading mediated damage by radicals. Tissue free of is generation

B. (secondary) defect iron absorption Due (primary) autosomal to chronic recessive in or transfusions

Fig.11.9 Fatty liver. Microscopic appearance. A, B, appearance. Gross Taxy, (B, Fig. of Courtesy Jerome Mallory alcoholic 11.10 bodies, hepatitis. 1. MD) is usually due by to amino gene, C282Y 282). Primary at in the acid tyrosine HFE hemochromatosis replaced is mutations (cysteine

in C. Presents 1. adulthood late

cardiac include cirrhosis, arrhythmias bronze diabetes dilated findings (due atrophy). gonadal cardiomyopathy, is other to dysfunction mellitus, skin; and triad Classic testicular secondary and

2.

t -1, % ferritin, and TIBC, saturation. t iron, show serum t Labs

3.

(Fig. brown biopsy Liver reveals pigment in accumulation hepatocytes of 11.llA); lipofuscin blue (Fig. iron Prussian stain (blue) distinguishes from 11.llB).

the is a Lipofuscin turnover brown present is and in lipids; of tear') is a peroxidized it i. that commonly (Fig. hepatocytes by-product from pigment ('wear 11.llC).

D. risk ofhepatocellular carcinoma Increased

is phlebotomy. Treatment E.

VII. DISEASE WILSON

(ATP7B copper gene) hepatocyte recessive defect transport 1. ATP-mediated in Autosomal A. of in of ceruloplasmin into and incorporation lack transport copper bile into copper lack Results

B. serum, tissues. in builds up in and deposits Copper into leaks hepatocytes,

1. Copper-mediated of leads radicals free production tissue hydroxyl to damage.

in with 1. C. Presents childhood

2.

of dementia, manifestations basal ganglia) copper due Parkinsonian deposition (behavioral chorea, symptoms 3. changes, and to Neurologic in

cornea Kayser-Fleisher the rings in

Labs t copper, on liver and t copper show D. biopsy. ceruloplasmin, urinary -1, serum

of Increased carcinoma E. hepatocellular risk

(chelates copper). is F. D-penicillamine Treatment

VIII. BILIARY PRIMARY CIRRHOSIS

Autoimmune 1. A. of bile ducts granulomatous intrahepatic destruction

Classically women in is years) (average age arises 2. 40

other with Associated autoimmune diseases

B. unknown; is antibody present. antimitochondrial Etiology is

of C. with jaundice Presents obstructive features

a is complication. late D. Cirrhosis

IX. CHOLANGITIS PRIMARY SCLEROSING

fibrosis extrahepatic and and bile intrahepatic A. ducts of Inflammation

Fig. 11.11 Hemochromatosis. in A, deposition hepatocytes. Iron blue B, stain. Prussian in Lipofuscin C, hepatocytes for comparison.

Exocrine Liver and Pancreas, Gallbladder, 1. Pathology

Periductal an appearance fibrosis (Fig. with 'onion-skin' 11.12) 2.

"beaded" contrast are regions Uninvolved dilated on resulting imaging. a in appearance

is positive. colitis; is often with Etiology but B. p-ANCA associated unknown, ulcerative

jaundice; cirrhosis obstructive a late complication. C. is Presents with

cholangiocarcinoma Increased D. risk for

REYE SYNDROME X.

illness A. 1. who with encephalopathy viral in and aspirin take liver children failure Fulminant mitochondrial to damage Likely related ofhepatocytes

nausea vomiting; death to Presents enzymes, with coma progress and hypoglycemia, and with liver may elevated B.

XI. ADENOMA HEPATIC

tumor ofhepatocytes A. Benign

B. Associated contraceptive upon of drug use; oral regresses cessation with

and intraperitoneal rupture Risk bleeding, pregnancy during C. of 1. especially and subcapsular estrogen. grow with Tumors exposure are to

XII. HEPATOCELLULAR CARCINOMA

Malignant hepatocytes A. tumor of

B. 1. factors Risk include

HBV (e.g., Chronic 2. and HCV) hepatitis

3. Wilson alcohol, deficiency) AlAT and hemochromatosis, (e.g., Cirrhosis disease, liver disease, nonalcoholic fatty

Budd-Chiari C. Increased for risk 1. syndrome

vein to Liver secondary 2. hepatic infarction obstruction

ascites Presents hepatomegaly painful and with

cirrhosis; late D. prognosis symptoms poor by are detected often Tumors because masked are

marker E. Serum is alpha-fetoprotein. tumor

XIII. TO LIVER METASTASIS

A. colon, liver tumors; than common pancreas, breast common primary most lung, include sources More and carcinomas.

B. liver Results the in in nodules multiple (Fig. 11.13)

with a edge may the liver be Clinically hepatomegaly as nodular C. of free detected

fibrosis, .12 'Onion-skin' sclerosing primary Fig. Fig.11 liver. carcinoma Metastatic involving 11.13 cholangitis. Jerome (Courtesy of MD) Taxy,

I. HORSESHOE KIDNEY

pole connected (Fig. kidneys usually at Conjoined lower the A. renal most common 12.1); anomaly congenital

is on ascent abdomen. B. abdomen; kidney pelvis Kidney located horseshoe in the mesenteric gets from root the the to abnormally artery its caught lower during inferior the

II. RENAL AGENESIS

A. Absent may formation; or kidney be unilateral bilateral

B. the hyperfiltration in risk Unilateral leads to agenesis failure kidney; increases renal life. existing of of hypertrophy later

the with face and (Potter lung Bilateral defects hypoplasia, ears, agenesis extremities Fig. leads set C. low to oligohydramnios developmental of flat with sequence, with incompatible life 12.2);

III. KIDNEY DYSPLASTIC

by cysts Fig. Noninherited, the congenital abnormal cartilage, A. tissue and malformation (e.g., parenchyma of characterized renal 12.3)

B. distinguished be unilateral; disease Usually bilateral, kidney must when inherited from polycystic

IV.

A. bilateral and (Fig. to leading Inherited enlarged kidneys cysts with in medulla the renal defect cortex 12.4)

in presents and hypertension; worsening may B. recessive present with Potter form failure as renal Autosomal sequence. infants newborns

1. and cysts with fibrosis portal to (leads hypertension) Associated hepatic hepatic congenital

and as renin), hypertension presents renal in hematuria, form increased dominant (due worsening young Autosomal C. failure. to adults

1.

develop the gene; time. APKD2 mutation APKDl over to in cysts Due or

2.

cysts, berry with aneurysm, prolapse and mitral Associated hepatic valve

V.

A. medullary dominant) ducts (autosomal collecting to in leading defect Inherited cysts the

in failure. worsening results fibrosis and B. kidneys Parenchymal renal shrunken

I. PRINCIPLES BASIC

A. decrease severe Acute, renal days) (develops in function within

Hallmark is with oliguria. BUN [Cr]), creatinine B. azotemia often (increased and

pathoma.com

etiology Divided azotemia intrarenal C. based prerenal, and into on postrenal,

II. PRERENAL AZOTEMIA

A. (e.g., decreased cardiac ARF blood kidneys to to Due failure); flow common cause of

B. blood and GFR, Decreased azotemia, oliguria. in results flow ,I,

sodium BUN:Cr and excretion 15); (fractional function ensues BUN osmolality C. intact remains and (serum tubular > of 500 [FENa] Reabsorption > < fluid ratio [osm] mOsm/kg). urine of 1%

III. POSTRENAL AZOTEMIA

A. from ureters) downstream tract the of (e.g., urinary obstruction kidney to Due

B. in Decreased oliguria. azotemia, outflow results and ,I, GFR,

increased blood C. tubular 15); 1% function 500 > and obstruction, remains intact of ratio the (serum urine early "forces" stage BUN (FENa into BUN:Cr During osm > tubular mOsm/kg). pressure <

osm and decreased (urine of < to concentrate tubular BUN > (serum (FEN ratio long-standing obstruction, decreased of sodium 15), a resulting urine < reabsorption D. With in mOsm/kg). 2%), 500 reabsorption damage BUN:Cr inability ensues,

IV. TUBULAR ACUTE NECROSIS

A. tubular Injury (Fig. cells necrosis of and epithelial renal cause common failure 12.5); acute (intrarenal azotemia) most of

B. obstruction tubules; cells decreases plug Necrotic GFR.

1. casts urine. Brown, are granular in the seen

decreased 15), to epithelium inability mOsm/kg). (serum and of (FEN results (urine reabsorption ratio urine concentrate osm sodium C. BUN < > tubular decreased 2%), reabsorption BUN:Cr of < a 500 in Dysfunctional

may D. be Etiology ischemic nephrotoxic. or

1. Ischemia-Decreased blood in necrosis tubules. supply of results

i. by Often prerenal ii. preceded azotemia particularly medullary susceptible tubule Proximal are limb segment the ascending ischemic and to of damage. thick

2. tubules. agents necrosis of in result Nephrotoxic-Toxic

is Proximal tubule i. particularly susceptible.

ii. muscle), in metals heavy (e.g., aminoglycosides radiocontrast oxalate (associated include from syndrome). ethylene (e.g., tumor and crush with urine), (e.g., (most common), myoglobinuria injury dye, crystals lead), lysis Causes urate to glycol

iii. chemotherapy risk Hydration allopurinol to of ATN. are decrease prior to of initiation urate-induced and used

f \ ~-.,;i· .• :,j.U,,J ♦ ',· , t~.. ~4' i". /J',.// ,

: .. ', ~·t,)l

ti'•;',,1 . : ~··~t:, >,,:' •..' . .·· !~,-~i / :. ,. l6 :-~ 1 ,:j~I ,f'•~,.~,,,1' • 1,'' ' I ;' .....,-.-·.\· I, , •• ~••• ~~

Fig. Horseshoe 12.1 kidney. of Fig. (Courtesy sequence, 12.2 (Courtesy of Fig. humpath, Potter MD) humpath,com) of com) Dysplastic Husain, Aliya 12.3 (Courtesy kidney,

Clinical 1. E. features

casts brown, with 2. granular Oliguria

3.

to with acidosis excretion) (due metabolic decreased renal Hyperkalemia

supportive requires fatal dialysis but 1. often imbalances be electrolyte Reversible, can since F. 2-3 recovery; can regenerate. cell to (stable cells tubular cells) the take reenter for Oliguria persist before time weeks cycle and

NEPHRITIS INTERSTITIAL ACUTE V.

Drug-induced A. and the hypersensitivity tubules involving interstitium (Fig. renal failure azotemia) in (intra acute results renal 12.6);

B. diuretics. and NSAIDs, include Causes penicillin,

fever, weeks seen rash starting a and urine. days drug; be oliguria, in after as eosinophils to C. may Presents

with Resolves of drug D. cessation

E. necrosis to progress papillary renal May

VI. RENAL NECROSIS PAPILLARY

A. Necrosis of renal papillae

pain and B. Presents gross with flank hematuria

Causes 1. C. include

use) phenacetin analgesic aspirin or abuse Chronic long-term (e.g., 2.

3.

4.

I. BASIC PRINCIPLES

by resulting A. 3.5 proteinuria characterized 1. Glomerular in disorders (> g/day)

2.

risk infection of Hypogammaglobulinemia-increased 3.

Hypercoagulable to III loss antithrombin 4. state-due of

II. MINIMAL (MCD) CHANGE DISEASE

A. children of syndrome Most cause in common nephrotic

B. idiopathic; associated may Usually lymphoma with be Hodgkin

Fig. disease. Polycystlc 12.4 kidney of Fig. (Courtesy 12.5 necrosis. Acute tubular Fig. Acute nephritis. 12.6 interstitial Jamie z, MD) Steinmet

on stain H&E (Fig. glomeruli C. Normal seen may proximal 12.7A); lipid cells. in tubule be

processes microscopy of (EM, electron Fig. on D. foot Effacement 12.7B)

(IF) negative E. immune No deposits; immunofluorescence complex

albumin, of but F. immunoglobulin) Selective not proteinuria (loss

G. by T Excellent cells) is cytokines response (damage to from mediated steroids

III. SEGMENTAL GLOMERULOSCLEROSIS FOCAL (FSGS)

A. syndrome African Hispanics and in of common nephrotic cause Americans Most

B. cell and associated idiopathic; be may HIV, use, with disease heroin Usually sickle

Focal part (some and glomerulus) glomeruli) stain on only segmental H&E of sclerosis (Fig. C. the (involving 12.8)

processes EM on Effacement foot of D.

No E. immune complex IF negative deposits;

to steroids; chronic failure renal response Poor to progresses F.

IV.

A. syndrome Caucasian in cause of adults nephrotic Most common

B. hepatitis or (e.g., may solid Usually B be drugs C, with SLE, tumors, associated and idiopathic; NSAIDs penicillamine) or

C. membrane basement Thick on (Fig. H&E glomerular 12.9A)

IF, to Due (granular complex deposition D. immune Fig. 12.9B); dome' with EM 'spike on appearance deposits and (Fig. subepithelial 12.9C)

steroids; renal E. response progresses to failure Poor to chronic

V.

A. glomerular Thick basement membrane on with appearance 'tram-track' H&E, often

B. deposition immune (granular IF) to Due complex

Divided on C. location two based deposits 1. into of types

Type (Fig. I-subendothelial and with 2. 12.10); HCV HBV associated

deposit convertase, inflammation, complement, II with C3 Type overactivation C3) (dense low disease)-intramembranous; circulating that of stabilizes and of to levels factor nephritic associated C3 leading (autoantibody

D. response chronic Poor renal steroids; to failure progresses to

VI. DIABETES MELLITUS

A. the of vascular glucose basement arteriolosclerosis. nonenzymatic resulting membrane High leads serum hyaline glycosylation in to

Fig. change Minimal disease. 12.7 glomerulus. A, Normal foot on EM. Effacement of processes B, Fig. segmental glomerulosclerosis. 12.8 Focal (Courtesy Chang, MD) ofTony

leading the pressure. efferent arteriole, is affected arteriole afferent more to B. filtration than high Glomerular glomerular

1. microalbuminuria. leads to Hyperfiltration injury

C. Eventually syndrome nephrotic progresses 1. to Characterized of of (Fig. the with nodules by sclerosis formation mesangium KimmelstielWilson 12.11)

ofhyperfiltration-induced slow D. progression damage. ACE inhibitors

VII. SYSTEMIC AMYLOIDOSIS

is involved most in Kidney A. amyloidosis. systemic commonly organ the

nephrotic B. resulting in the deposits Amyloid mesangium, in syndrome.

Characterized by apple-green birefringence C. Congo polarized light with under after staining red

I. PRINCIPLES BASIC

inflammation A. and bleeding Glomerular characterized by 1. disorders glomerular

proteinuria Limited g/day) 3.5 2. (<

3.

periorbital 4. edema retention Salt and with hypertension

hypercellular, B. (Fig. inflamed reveals Biopsy glomeruli 12.12).

Fig. Membranous nephropathy. 12.9 membranes. basement A, Thick glomerular B, Granular IF. dome' Subepithelial and appearance. 'spike deposits with C, ofTony (Courtesy 1. MD) Chang, which mediate complement; activates damage. CSa deposition Immune-complex neutrophils, attracts

or (impetigo) syndrome A. of infection skin after streptococcal 1. 0-hemolytic Nephritic group arises pharynx the that A

Occurs 2. strains with nephritogenic

as well occur nonstreptococcal infection May with organisms after

oliguria, as weeks after infection and hypertension, 1. urine), edema Presents periorbital (cola-colored B. hematuria 2-3 in may but in seen Usually occur adults children,

H&E on glomeruli C. Hypercellular, inflamed

Mediated (granular IF); immune D. by EM deposition (Fig. on complex subepithelial 'humps' 12.13)

is Treatment E. supportive.

1.

progress (1%) to renal failure. rarely Children

2.

(RPGN). adults Some glomerulonephritis rapidly progressive develop (25%)

III. RAPIDLY GLOMERULONEPHRITIS PROGRESSIVE

to syndrome progresses in Nephritic failure months A. that weeks to renal

Rapidly Findings Glomerulonephritis in Progressive 12.1: lmmunotluorescence Table

. IMMUNOFI.UORESCENCE > . . • ...

I l'A'ITERN ISl:ASI·. COMMl:N IS antibody, Fig. presents adult and classically hemoptysis, as 12.15) in males young, hematuria

disease renal diffuse in common) to SLE deposition) glomerulonephritis glomerulonephritis deposition, proliferative complex sub-endothelial; due of Diffuse usually PSGN is common most or Granular (most complex proliferative antigen-antibody (immune diffuse type

is c-ANCA; associated Churg-Strauss Wegener granulomatosis with granulomatosis, are associated with microscopic polyangiitis p-ANCA. and microscopic Wegener

and asthma polyangiitis. inflammation, and Churg-Strauss Granulomatous from syndrome Churg-Strauss distinguish microscopic polyangiitis, eosinophilia,

Fig. 'humps,' Subepithelial 12.13 PSGN. Fig. (Courtesy formation, 12.14 progressive ofTony MD) Crescent glomerulonephritis. Chang, rapidly

B. on Bowman H&E of and (Fig. macrophages fibrin stain; glomeruli) crescents by Characterized crescents space are comprised in (of 12.14).

12.1). help etiology resolve C. Clinical picture (Table and IF

IV.

A. mesangium common complex worldwide of glomeruli; nephropathy immune most deposition IgA in

RBC gross following childhood with casts, during or episodic hematuria as Presents mucosa! usually microscopic B. (e.g., 1. gastroenteritis) infections during is production infection. increased IgA

complex on immune IgA deposition IF C. is (Fig. the in seen mesangium 12.16).

renal failure slowly D. to May progress

V.

A. X-linked collagen; commonly type Inherited defect IV in most

B. thinning basement of the and membrane Results glomerular in splitting

sensory loss, isolated Presents as ocular hearing and hematuria, C. disturbances

I. BASIC PRINCIPLES

A. bladder, kidney urethra, of Infection or

B. ascending incidence to due females arises commonly increased infection; Most in

include Risk sexual urinary catheters. stasis, intercourse, factors and C.

II. CYSTITIS

A. of Infection the bladder

B. signs usually are Presents as pain; absent. dysuria, suprapubic (e.g., fever) and urgency, systemic urinary frequency,

1. C. findings Laboratory

> 10 power Urinalysis-cloudy urine field with WBCs/high 2. (hpf)

convert and Dipstick-Positive to pyuria) leukocyte esterase to 3. nitrites nitrates nitrites) (bacteria (due

colony forming standard) units (gold 100,000 Culture-greater than

Etiology D. 1. E 2. coli (80%) population) in is this Staphylococcus still more sexually women saprophyticus-increased (but E 3. in common young, active incidence coli Klebsiella pneumoniae 4. mirabilis-alkaline Proteus urine scent with ammonia

Fig. syndrome. IF, Goodpasture 12.15 Linear Fig. lgA 12.16 nephropathy. Chang, (Courtesy MD) Chang, ofTony 5. MD) ofTony (Courtesy faecalis Enterococcus

leukocyte esterase) with pyuria is pyuria presence WBCs/hpf negative of urine a 10 Sterile and culture. E. the (>

1. is Neisseria or trachomatis urethritis sign to dysuria) Chlamydia of presenting gonorrhoeae (dominant due Suggests urethritis

III. PYELONEPHRITIS

A. Infection the of kidney 1. ascending to increased with risk due infection; reflux Usually vesicoureteral

in Presents with casts, fever, pain, and symptoms to leukocytosis cystitis addition of B. flank WBC

pathogens are common C. 1. Most coli 2. E (90%)

3.

IV. CHRONIC PYELONEPHRITIS

A. bouts tubules pyelonephritis due Interstitial acute fibrosis of multiple and to of atrophy

B. or reflux (e.g., or obstruction carcinoma) to Due cervical BPH (children) vesicoureteral

characteristic and lower poles scarring C. upper reflux. to is with of at calyces; scarring vesicoureteral Leads cortical blunted

follicles containing the D. resemble Fig. tubules of ('thyroidization' material thyroid kidney, Atrophic proteinaceous eosinophilic 12.17); seen be casts in urine. may waxy

I. BASIC PRINCIPLES

as stone (Table 12.2) urinary a a solute A. Precipitation of

B. and of in urine Risk solute low urinary filtrate concentration include high the volume. factors

pain with unilateral hematuria Presents colicky 1. C. and tenderness as flank be surgical intervention may usually passed Stone if within hours; required. not, is

I. BASIC PRINCIPLES

kidney 1. failure A. End-stage

insults vascular from or glomerular, inflammatory, 2. tubular, May result

causes diabetes are glomerular common mellitus, Most disease. and hypertension,

B. features 1. Clinical

deposition Uremia-Increased and result products with asterixis, encephalopathy of waste (azotemia) nitrogenous in nausea, blood in dysfunction, urea crystals pericarditis, anorexia, skin. in platelet

2.

retention Salt resultant water hypertension with and 3.

Hyperkalemia metabolic 4. with acidosis

by renal interstitial due peritubular decreased Anemia to production cells 5. erythropoietin

proximal to hyperphosphatemia decreased 6. Hypocalcemia ofvitamin due cells !-alpha-hydroxylation and renal tubule by D

osteomalacia, to hyperparathyroidism, osteoporosis osteodystrophy due and Renal secondary

involves Treatment renal dialysis or C. transplant.

1. dialysis, increasing cell for renal risk end-stage often within develop Cysts during carcinoma. shrunken kidneys

ANGIOMYOLIPOMA I.

blood vessels, adipose tissue Hamartoma muscle, of A. smooth comprised and

B. tuberous sclerosis frequency in Increased

II. CARCINOMA RENAL CELL

arising tubules from epithelial tumor kidney A. Malignant

Fig. Fig. chronic 12.17 of 'Thyroidization' kidney, pyelonephritis. Ammonium magnesium 12.18 phosphate stone. of webpathology.com) (Courtesy

palpable pain of with triad classic hematuria, 1. flank Presents B. and mass,

together; common the All symptoms most is symptom. three occur hematuria rarely

2.

present. weight Fever, be syndrome or EPO, paraneoplastic renin, PTHrP, may loss, ACTH) (e.g., also or

3.

Rarely may varicocele present i. with left-sided drainage vein of renal carcinoma left left spermatic blocks leading the Involvement the by of vein varicocele. to

11. hence, drains not seen. is the varicocele directly vein Right right-sided into IVC; spermatic

yellow C. (Fig. exam a Gross mass reveals (clear 12.19A); most exhibits clear the variant Fig. common type, cytoplasm cell microscopically, 12.19B).

IGF-1 growth) which to PDGF). VHL increased VEGF tumor involves suppressor Pathogenesis (3p) transcription leads and (promotes and factor D. (increases loss HIF of increased gene,

Tumors be hereditary may or sporadic. E.

1.

as years) in tumors upper single Sporadic is risk the kidney; classically major adult 60 in tumors cigarette for is of sporadic arise age pole a smoke. factor tumor males (average the

2.

tumors younger in Hereditary and arise bilateral. are often adults

i. of hemangioblastoma inactivation autosomal of cerebellum is carcinoma. associated dominant Hippel-Lindau Von the and disease gene cell risk renal VHL disorder increased to leading with an for the

1. F. Staging

(occurs to of vein and and 2. bone) hematogenous lungs increases the T-based the on involvement of risk size commonly spread and renal

to lymph retroperitoneal nodes N-spread

III. WILMS TUMOR

mesenchyme), tubules, kidney ofblastema tumor (Fig. glomeruli stromal comprised cells primitive Malignant kidney (immature and A. and 12.20) 1. years. malignant average is Most common children; in 3 renal tumor age

unilateral B. mass as (due with renin hypertension to hematuria a Presents large, and flank secretion)

(90%) may Most C. syndromic seen are 1. sporadic; with be tumors cases

(located tumor, syndrome-Wilms suppressor Retardation; mental deletion WTl gene and WAGR llpl3) and 2. tumor abnormalities, with Genital Aniridia, associated motor of at

mutations Denys-Drash of associated with WTl syndrome-Wilms male and progressive disease, renal pseudohermaphroditism; (glomerular) tumor,

Fig. Renal 12.19 carcinoma. cell Gross A, appearance. nce. B, appeara Microscopic lms 12,20 tumor. Wl Fig,

3. hemihypertrophy, IGF-2 cluster gene organomegaly llplS.5), mutations at tongue); (including syndrome-Wilms Beckwith-Wiedemann in hypoglycemia, associated muscular (imprinted neonatal genes and tumor, particularly with WT2

CARCINOMA (TRANSITIONAL I. UROTHELIAL CELL)

ureter, Malignant of renal the A. arising from urothelial tumor lining bladder, pelvis, or 1. the urethra common lower of arises urinary Most cancer; in the bladder type usually tract

B. are naphthylamine, use. long-term smoke; phenacetin cyclophosphamide risk additional cigarette dyes, is and risk factor or factors azo Major

presents older in classically Generally with hematuria painless seen adults; C.

D. pathways via two distinct (Fig. Arises 12.21) 1.

tumor high-grade as then with invades; p53 and flat associated a 2. early Flat-develops mutations

papillary a early that then to not with tumor mutations and papillary highgrade progresses associated a tumor as Papillary-develops invades; low-grade p53

are E. multifocal recur defect"). often Tumors ("field and

II. CARCINOMA SQUAMOUS CELL

squamous usually Malignant bladder of A. cells, the involving proliferation

a squamous (normal by Arises ofsquamous is epithelium) not in metaplasia background surface bladder lined B.

infection long-standing haematobium (Egyptian Risk cystitis chronic male), C. nephrolithiasis. and (older woman), Schistosoma factors include

III. ADENOCARCINOMA

A. bladder proliferation usually glands, Malignant involving of

develops urachal walls) failure bladder Arises form bladder), the at anterior (tumor glandularis, or the to (congenital portion remnant the and caudal abdominal cystitis exstrophy of of B. the from dome a

Fig. 12.21 Urothelial carcinoma. Flat. A, B, llary. Papi

I. PRINCIPLES BASIC

vestibule) the skin hymen mucosa of the female minora, the and A. external Anatomically and mons genitalia (labia pubis, to includes majora, labia

B. Lined by epithelium squamous

II. BARTHOLIN CYST

1. Cystic A. gland dilation Bartholin the of via produces vestibule. of is Bartholin lower on side gland ducts mucus-like One canal drains vaginal each present and fluid the into the that

due of to B. and obstruction Arises gland inflammation 1. Usually reproductive in of women age occurs

lesion a painful cystic as adjacent C. the to canal vestibule lower Presents at the unilateral, vaginal

III. CONDYLOMA

vulvar Warty neoplasm often A. of large skin,

B. acuminatum, or due HPV types 6 to (condyloma Fig. commonly 11 Most is 13.lA); latum) cause. a secondary less (condyloma syphilis common are transmitted. Both sexually

koilocytes ofHPV-infected Fig. HPV-associated (hallmark cells, are C. by Histologically, characterized condylomas 13.lB).

progress low-risk (6 and types). to carcinoma D. 11 rarely HPV are Condylomas

IV.

A. the the epidermis dermis by thinning of of and (sclerosis) fibrosis Characterized

vulvar white B. patch with a parchment-like as skin Presents (leukoplakia)

possible in autoimmune commonly etiology seen Most postmenopausal women; C.

squamous for carcinoma cell associated increased but with risk D. slightly a Benign,

V.

A. Characterized by squamous vulvar of the hyperplasia epithelium

thick, Presents leukoplakia B. with skin vulvar leathery as

chronic Associated and C. with scratching irritation

risk of increased D. cell Benign; squamous carcinoma no

VI. VULVAR CARCINOMA

arising vulva Carcinoma squamous epithelium A. from lining the

B. rare, cancers a accounting only small female percentage of Relatively for genital

required from be C. distinguish other leukoplakia; biopsy to Presents carcinoma may ofleukoplakia. causes as

be non-HPV or may related. D. HPV Etiology related

vulvar HPV-related HPV is and high-risk to 16 due 18. types carcinoma E.

1. pathoma.com

reproductive women age and factors partners age early HPV Risk include multiple and intercourse; generally related in of to 2. first exposure of are occurs

activity lesion mitotic atypia, disordered dysplastic precursor change, and neoplasia by intraepithelial cellular maturation, from koilocytic Arises vulvar (VIN), nuclear increased a characterized

often, sclerosis. vulvar lichen carcinoma arises, most long-standing F. Non-HPV from related

1.

to irritation carcinoma. inflammation eventually lead Chronic and

2.

> Generally women seen elderly in is years) 70 age (average

VII. EXTRAMAMMARY PAGET DISEASE

A. by of vulva in the cells epidermis malignant Characterized (Fig. epithelial the 13.2A)

Presents B. skin pruritic, as vulvar ulcerated erythematous,

situ, in underlying carcinoma 1. C. Represents carcinoma usually no with with associated an the malignant nipple by it but disease also nipple, cells of is in is carcinoma. the almost the underlying of epithelial Paget characterized always epidermis

on from be melanoma, which Must occur distinguished can D. 1. vulva the rarely

S-100-. are PAS+, keratin+, cells and Paget

2.

S-100+. PAS-, is and keratin-, Melanoma

I. PRINCIPLES BASIC

to cervix leading A. Canal the

Mucosa squamous non-keratinizing epithelium by lined is B.

II. ADENOSIS

Focal of columnar persistence (Fig. A. the vagina upper epithelium in 1. 13.2B) of epithelium grows vagina from epithelium upward vagina lining the the the of squamous Miillerian lower development, 2/3 the to ducts). (derived columnar sinus) from upper the During urogenital (derived from the 1/3 replace of the

B. incidence in Increased exposed females to in (DES) were diethylstilbestrol utero who

CLEAR Ill. CELL ADENOCARCINOMA

clear of Malignant with cytoplasm A. glands proliferation

B. vaginal DES-associated adenosis but Rare, complication of feared,

Fig. Condyloma 13.1 acuminata. appearance. Microscopic A, iocytic change. B, Koi Fig. Extramammary disease vulva. 13.2A the Paget of (Courtesy webpathology.com) of

as DES-induced tract this the led to (along Discovery shape such cessation abnormal C. of usage. gynecologic of with DES uterus) complication abnormalities other of of the

IV.

muscle; A. immature Malignant mesenchymal of rare skeletal proliferation

(Fig. bleeding protruding penis age); and sarcoma 5 mass Presents grape-like botryoides or known child of as from (usually< a also B. yrs vagina a the of as 13.3)

and immunohistochemical cross-striations characteristic myogenin. exhibits for desmin positive cytoplasmic staining Rhabdomyoblast, and the cell, C.

V.

the epithelium lining arising from Carcinoma vaginal squamous A. mucosa

B. related to high-risk Usually HPV

neoplasia lesion Precursor (VAIN). vaginal is C. intraepithelial

occurs, the and regional cancer lower lymph inguinal cancer to spread 2/3 from the to D. goes nodes When goes 1/3 ofvagina nodes. from regional nodes, iliac upper to

I. PRINCIPLES BASIC

of the Anatomically, the "neck" comprises A. uterus

B. vaginal (visible exam) exocervix the Divided into endocervix on 1. and

Exocervix nonkeratinizing epithelium. lined is squamous by

2.

single layer lined is cells. columnar of a Endocervix by

3.

transformation exocervix Junction between and the the endocervix (Fig. zone is called 13.4A).

II. HPV

the especially in cervix the DNA Sexually tract, transmitted zone the genital infects that A. lower virus transformation

B. CIN). inflammation; (cervical risk an for persistent acute dysplasia infection by to increased leads is usually eradicated intraepithelial neoplasia, Infection cervical

sequencing. type, CIN DNA Risk on C. HPV determined is depends which by of

1.

and 2. 16, 33 High-risk-HPV types 18, 31,

result p53 HPV E6 and of in E7 produce D. Rb, increased which destruction proteins High-risk and respectively. CIN. tumor of suppressor the increases these for risk Loss proteins

Fig. adenosis. Vaginal 13.2B Fig. Embryonal rhabdomyosarcoma. 13.3 (Courtesy of hum path.corn)

III. INTRAEPITHELIAL NEOPLASIA CERVICAL

A. disordered maturation, change, nuclear atypia, within koilocytic increased mitotic cellular the and by epithelium. Characterized activity cervical

B. extent by cells dysplastic on based into grades 1. Divided immature involvement of epithelial the

CIN I the epithelium. of 1/3 the of involves < thickness

2.

involves < thickness CIN epithelium. of of 2/3 the the II

3.

CIN the of less slightly entire III (Fig. the than epithelium involves thickness 13.4B).

4.

situ entire (CIS) Carcinoma the in epithelium. the thickness of involves

CIN fashion II, III, squamous CIN to C. a become and invasive progresses in I, CIS stepwise through carcinoma. classically CIN cell CIN

1.

often Progression inevitable regresses). is (e.g., not CINI

2.

regress likely the higher dysplasia, less The likely it the to normal. it grade the is is of more and carcinoma progress to to to

IV.

cervical from the A. Invasive arises epithelium carcinoma that

B. years) commonly (average age in 40-50 Most women middle-aged seen is

C. especially bleeding, discharge as vaginal Presents cervical bleeding, postcoital or

cervical Key secondary factor infection; illness). HPV risk is high-risk an AIDS-defining carcinoma factors risk (e.g., and include is smoking immunodeficiency D.

cases) common E. carcinoma and Most cell cases). (80% of carcinoma of subtypes (15% of are squamous adenocarcinoma cervical types to infection. Both HPV are related

Advanced the anterior into uterine through blocking wall invade ureters. often the the bladder, F. tumors with cervical a in failure is advanced of cause death common Hydronephrosis postrenal carcinoma.

V.

A. carcinoma. to goal catch before The it of dysplasia into develops screening is (CIN)

1.

carcinoma, 10-20 takes years. on average, to from Progression CIN

2.

Screening 21 initially at performed and years. every is begins age three

Pap for screening. the gold B. standard is smear

1.

analyzed transformation Cells under using brush are from a and scraped the a zone microscope.

2.

high low (CIN as classified (CIN III). II I) or are grade and Dysplastic cells grade

3.

cytoplasmic with hyperchromatic dysplasia (Fig. nuclear and is to by (dark) cells characterized High-grade ratios high nuclei 13.4C).

most smear developed C. date. the test screening Pap successful is to

Fig. Cervix. 13.4 Cervical normal. A, transformation zone, CIN High-grade Pap C, dysplasia, B, smear. Ill. Uthman, 1. (Courtesy MD) Ed of

types the of most being mortality is and the a the gynecologic went least of reduction carcinoma from in cervical It significant for one the (cervical common common US). in of carcinoma responsible to carcinoma morbidity

2.

invasive screening. not usually cervical develop who carcinoma Women have undergone

magnifying smear confirmatory colposcopy glass) abnormal by An is a biopsy. D. Pap with and cervix of (visualization followed

the transformation the adenocarcinoma. screening negative for E. include and smear Pap of Limitations inadequate efficacy zone limited screening) sampling (false in of

1. the incidence Pap adenocarcinoma decreased Despite significantly. not smear screening, has of

preventing HPV F. in is infections. effective Immunization

1.

HPV and quadrivalent 11, vaccine 18. covers 6, types The 16,

2.

types against generated condylomas. 6 protect 11 and Antibodies against

3.

and Antibodies protect and 18 carcinoma. generated against CIN types 16 against

4.

types number to necessary Pap due covered the ofHPV the by still are smears vaccine. limited

I. PRINCIPLES BASIC

is the A. of lining uterine I Endometrium mucosa cavity. the

the smooth wall (Fig. Myometrium B. underlying is endometrium muscle the 13.5).

is hormonally Endometrium sensitive. C.

1.

driven estrogen Growth of endometrium the (proliferative is phase).

2.

progesterone implantation of is for phase). (secretory driven endometrium Preparation the

3.

loss support with of progesterone phase). (menstrual Shedding occurs

II. SYNDROME ASHERMAN

A. amenorrhea due and scarring of basalis to Secondary the loss

B. of (D&C) and curettage dilation Result overaggressive

III. CYCLE ANOVULATORY

A. ovulation Lack of

B. without progesteronedriven secretory in proliferative phase estrogen-driven phase an Results subsequent 1. a in and shed glands resulting Proliferative bleeding. uterine break down

Fig. Fig. overlying myometrium, 13.5 Endometrium polyp. 13.6 Endometrial normal.

2. especially and Represents menopause common uterine of menarche cause bleeding, a dysfunctional during

IV.

infection endometrium A. of Bacterial the

B. retained products (e.g., miscarriage); products due to Usually delivery of retained act a or conception nidus as infection. for after

bleeding, pelvic C. uterine and as fever, pain Presents abnormal

V.

A. the Chronic endometrium inflammation of

B. by plasma lymphocytes cells and 1. Characterized in for are are given endometrium. cells diagnosis the normally found chronic endometritis the lymphocytes of that Plasma necessary

products TB. retained C. include IUD, conception, chronic disease pelvic Chlamydia), Causes of inflammatory and (e.g.,

D. Presents and pain, uterine infertility abnormal bleeding, as

VI. ENDOMETRIAL POLYP

(Fig. of endometrium A. protrusion Hyperplastic 13.6)

B. uterine as bleeding abnormal Presents

effects a which the on effect pro-estrogenic weak the C. anti-estrogenic has side but as of endometrium arise effects tamoxifen, breast on Can

VII. ENDOMETRIOSIS

Endometrial stroma the lining and outside 1. endometrial glands uterine of A. retrograde implantation to with at ectopic Most site menstruation likely an due

pelvic Presents pain; as infertility (pain dysmenorrhea menstruation) during B. 1. and cause may just endometrium. Endometriosis cycles like normal

is site 'chocolate' the C. common formation a cyst of (Fig. which involvement results ovary, Most in of classically 13.7A).

1.

ectopic and increases bladder (scarring risk classically involvement (pain wall pouch nodules yellow-brown of Other with adhesions), pregnancy); of ligaments appear as include with (pain pain for mucosa tubal (pelvic urination), (Fig. tube implants uterine and (abdominal 'gun-powder' Douglas bowel fallopian defecation), the serosa pain), sites 13.7B).

2.

myometrium the of is uterine called Involvement adenomyosis.

site ovary. is the the carcinoma ofendometriosis, of an at especially D. There risk in increased

Fig. 13.7 Endometriosis. A, of cyst' 'Chocolate ovary. nodules. powder' 'Gun B, Fig. (A, Bulent of Courtesy hyperplasia. 13.8 Endometrial (Courtesy Celasun, of MD. Courtesy B, path.com) Ed hum of Uthman, MD)

VIII. ENDOMETRIAL HYPERPLASIA

relative (Fig. A. ofendometrial to stroma glands Hyperplasia 13.8)

B. and estrogen syndrome, (e.g., obesity, Occurs consequence polycystic as a ovary replacement) of unopposed estrogen

presents Classically uterine C. postmenopausal bleeding as

histologically of absence the Classified 1. on growth (simple pattern and based cellular architectural or complex) or presence atypia D. to cellular rarely without progresses important cancer with (30%); hyperplasia Most for hyperplasia predictor the atypia whereas, complex atypia does progression to presence carcinoma atypia; simple complication) of (major often is (<5%).

IX.

(Fig. of endometrial A. proliferation Malignant glands 1. 13.9A) genital Most invasive the tract common carcinoma of female

as Presents bleeding B. postmenopausal

two pathways: and Arises C. via distinct sporadic hyperplasia

carcinoma from of endometrial hyperplasia cases), arises (75% the In pathway hyperplasia. D.

1.

estrogen infertility nulliparity, and obesity. factors are menarche/late exposure and menopause, include to cycles, Risk anovulatory related with early

2.

ofpresentation 60 years. age Average is

3.

Histology is normal (i.e., Fig. endometrioid endometrium-like, 13.9B).

endometrium (25% atrophic lesion. cases), In precursor E. pathway arises no an evident with in the sporadic of carcinoma

1.

70 years. Average age presentation at is

2.

and is papillary is usually structures characterized serous Histology by (Fig. tumor psammoma body with the formation; common, is behavior. and p53 mutation aggressive 13.9C) exhibits

X.

myometrium; proliferation arising smooth of tumor from in females muscle neoplastic most A. common Benign

B. Related 1. estrogen to exposure

2.

3.

well-defined, exam impinge shows multiple, (Fig. the that pelvic may whorled and uterus masses on C. white, distort Gross structures 13.10).

a include present, and abnormal bleeding, symptoms Usually pelvic mass. D. infertility, uterine asymptomatic; when

Fig. Endometrial carcinoma. 13.9 Gross appearance. A, B, Endometrioid type. type. C, Serous (A, of www.anatomiapatologica.com.br) Courtesy

XI. LEIOMYOSARCOMA

from arising smooth myometrium of the Malignant A. proliferation muscle

from leiomyosarcomas arise novo; leiomyomas. Arises B. de not do

C. seen postmenopausal in Usually women

histological features lesion shows D. Gross with necrosis, hemorrhage; areas necrosis of a activity, cellular include and mitotic and single atypia. exam often

I. PRINCIPLES BASIC

A. The ovary the follicle. the of is functional unit

B. granulosa by and consists (Fig. A cells of oocyte follicle an theca surrounded 1. 13.llA)

theca on production. induce LH to acts cells androgen

2.

the to convert FSH phase endometrial of to estradiol (drives androgen cycle). stimulates cells the proliferative granulosa

3.

secretory of which surge beginning cycle). the leads surge, an the (marking induces LH of endometrial ovulation the phase Estradiol to

(Fig. residual corpus After a becomes C. the luteum follicle ovulation, pregnancy). for progesterone primarily secretes endometrium prepares the which secretory a 13.llB), which possible the (drives phase

1. in during cyst, luteal early can especially luteum a result a into pregnancy. corpus hemorrhagic corpus Hemorrhage

in D. follicular Degeneration results follicles of cysts. numbers common of and Small are follicular no have in women clinical cysts significance.

II. (PCOD) OVARIAN DISEASE POLYCYSTIC

A. to ovarian hormone imbalance cysts due 1. Multiple follicular Affects of reproductive age roughly women of 5%

B. low by (LH:FSH 2) FSH Characterized > increased LH 1. and

Increased a distribution). male theca production excess cells) LH in resulting in androgen (excess hirsutism (from hair induces

2.

estrone is converted in adipose tissue. Androgen to

i. feedback Estrone FSH of in follicles. decreases resulting cystic degeneration

ii. increase for circulating estrone levels risk of High carcinoma. endometrial

type have 10-15 patients presentation is young later. insulin infertility, hirsutism; some resistance develop mellitus woman and 2 an Classic and with oligomenorrhea, may obese diabetes years C.

Fig. Uterine leiomyomas. 13.10 (Courtesy Fig. of 13.11 follicle. Ovarian A, Normal. B, Corpus luteum. Ed Steinmetz, Uthman, MD) of MD) Courtesy (B, Jamie

I. BASIC PRINCIPLES

of is cordstroma. types: composed surface cells, cell three sex Ovary A. epithelium, and germ

arise any B. these types Tumor from or of from cell metastases. can

II. EPITHELIAL TUMORS SURFACE

A. of (70% tumor ovarian common type cases) of Most

B. of endocervix lines from cells). ovary; lining embryologically cells), (serous (mucinous epithelial the tube epithelium fallopian endometrium, and produces epithelium that the Derived coelomic the coelomic

serous usually cystic. of The and two tumors both mucinous; epithelial common subtypes C. surface most are are

1.

full fluid. are tumors ofwatery Serous

2.

mucus-like of are full tumors Mucinous fluid.

be D. tumors malignant. or benign, Mucinous borderline, can serous and

1.

lining composed are single simple, tumors cyst flat (Fig. a (cystadenomas) a Benign of with 2. women -40 (30 13.12); in years commonly arise most old) premenopausal

arise composed (60-70 a postmenopausal cysts Malignant commonly are women lining; tumors old) complex thick, in of 3. most shaggy with (cystadenocarcinomas) years

have in tumors Borderline tumors. and benign malignant between features

i. prognosis metastatic 4. Better tumors, but potential than clearly carry malignant still

for tube. and mutation carcinoma carriers have an of ovary the increased serous fallopian risk BRCAl

1. risk prophylactic have with carriers due salpingo-oophorectomy (along increased elect breast prophylactic the cancer). BRCAl for to often to a mastectomy

Less tumors of Brenner subtypes common include E. and tumor. surface epithelial endometrioid

1. endometrial-like tumors are Endometrioid composed of glands usually are malignant. and

i. endometriosis ii. May from arise associated are an carcinoma of endometrial (endometrioid 15% type). ovary of independent endometrioid with the carcinomas

2. usually epithelium bladder-like are Brenner composed are of and benign. tumors

and fullness) with late signs F. Surface abdominal (pain clinically compression or vague frequency). tumors of (urinary symptoms present

Fig. cystadenoma. Ovarian 13.12

1.

of poor is epithelial surface generally tract for female cancers). prognosis carcinoma Prognosis genital (worst

2.

to Epithelial peritoneum. to tend especially locally, the carcinomas spread

a to CA-125 serum recurrence. marker response useful treatment G. and screen monitor for is

III. CELL TUMORS GERM

A. most (15% ovarian tumor type common 2nd of cases) of

B. reproductive occur in Usually age of women

normally cells. germ tissues produced Tumor by subtypes C. mimic

1.

2.

3.

4.

D. 1. Cystic teratoma two (e.g., and logic layers embryo tumor from tissue or bone, thyroid, skin, fetal Cystic gut, cartilage, three composed derived hair, of Fig. 13.13) i. in germ females; tumor common 10% of 2. Most cell in bilateral cases

but of malignant carcinoma somatic squamous potential. presence malignancy tissue (usually cell or skin) Benign, indicates immature of neural) (usually

3.

primarily composed a teratoma of is thyroid tissue. ovarii Struma

E. Dysgerminoma 1.

and cytoplasm cells (resemble oflarge central composed with oocytes, nuclei Fig. Tumor clear tumor 13.14); common germ malignant cell most 2.

germ a males. cell which Testicular seminoma, counterpart in tumor is relatively is called common

3.

responds prognosis; Good radiotherapy 4. to

may be LDH Serum elevated.

sinus Endodermal F. 1. tumor

germ the yolk mimics in most tumor sac; common cell children tumor Malignant 2. that

elevated. often Serum AFP is

3.

histology seen (glomerulus-like classically on are Schiller-Duval structures) (Fig. bodies 13.15).

G. Choriocarcinoma 1.

2. of mimics but placental villi absent are tumor and syncytiotrophoblasts; Malignant composed tissue, cytotrophoblasts

3. with early hematogenous spread hemorrhagic tumor Small,

characteristic by lead in the thecal cysts (produced syncytiotrophoblasts); High to P-hCG may is ovary

Fig. 13.13 Cystic teratoma. Fig. 13.14 Dysgermin oma. Fig. Schiller-Duval 13.15 body. (Courtesy webpathology.com) 4. response to chemotherapy Poor

1. H. carcinoma Embryonal

2.

early with metastasis Aggressive

IV.

the sex that A. Tumors tissues ovary of resemble cord-stromal

cell Granulosa-theca 1. B. tumor

2. cells theca granulosa of Neoplastic and proliferation

presents of signs estrogen; excess 1. Often with produces estrogen puberty to 11. puberty-precocious Prior age-menorrhagia iii. or Reproductive metrorrhagia bleeding postmenopausal uterine setting Postmenopause (most common hyperplasia 3. cell tumors)endometrial with granulosa-theca for

for minimal risk metastasis Malignant, but

1. Sertoli-Leydig C. cell tumor

and Sertoli form cells crystals Reinke characteristic that cells tubules) Leydig 2. of (between Composed with tubules

androgen; produce and hirsutism associated with virilization May

D. 1. Fibroma

of Benign tumor fibroblasts (Fig. 2. 13.16)

syndrome and removal with ascites tumor. syndrome); effusions with Associated resolves of (Meigs pleural

V.

A. commonly a due tumor (diffuse Krukenberg both that is tumor most involves mucinous to ovaries; gastric carcinoma metastatic 1. type) metastatic is mucinous primary unilateral. of carcinoma distinguish Bilaterality ovary, which from the metastases helps usually

amounts peritonei the massive peritoneum. Pseudomyxoma is of mucus in B.

1. the tumor ovary to a with Due to of mucinous appendix, the usually metastasis

ECTOPIC I. PREGNANCY

site Implantation lumen uterine site of common most A. the the tube fallopian than other the ovum a (Fig. of at is fertilized wall; 13.17).

B. is secondary risk factor disease inflammatory (e.g., Key pelvic scarring or endometriosis). to

Fig. 13.16 Ovarian fibroma. Fig. pregnancy. 13.17 Ectopic tubal humpath.com) of (Courtesy

missed Classic presentation few period. lower a pain is abdominal weeks quadrant after a C.

1. bleeding and into tube (hematosalpinx) major fallopian Surgical are complications emergency; rupture.

II. ABORTION SPONTANEOUS

1. 20 weeks A. trimester) occurring gestation during before fetus first (usually of Miscarriage occurs to Common; pregnancies in of 1/4 recognizable up

tissues and of vaginal bleeding, as Presents fetal cramp-like pain, B. passage

of weeks due chromosomal other embryogenesis). include causes C. to antiphospholipid anomalies (especially 2 syndrome), hypercoagulable (especially and first (e.g., trisomy often states Most during congenital the infection, teratogens 16); to exposure

1. agent, time depends on exposure Effect of of generally the (Table and dose, teratogens 12.1).

i. First ii. two weeks gestation-spontaneous abortion of Weeks iii. organ malformation 3-8-risk of organ of Months hypoplasia 3-9-risk

III. PREVIA PLACENTA

placenta Implantation overlies segment; placenta in uterine lower of cervical the A. the (opening). os

as third-trimester Presents bleeding B.

Often of delivery caesarian section fetus C. requires by

IV.

A. placenta the the of of fetus Separation decidua from to prior (Fig. delivery 13.18)

B. cause Common still birth of

insufficiency third-trimester and fetal with C. Presents bleeding

V.

A. the of myometrium intervening placenta into no or little decidua implantation with Improper

difficult and of bleeding delivery placenta with Presents postpartum the B.

Common 12.1: Effects Associated and Teratogens Table

impairment facial visual Most common abortion, cause mental hearing also to retardation; of Spontaneous and leads lsotretinoin

Often requires hysterectomy C.

VI. PREECLAMPSIA

of approximately Pregnancy-induced in the pregnancies in trimester; seen 1. hypertension, usually 5% third proteinuria, and edema, A. arising abnormalities. severe, Hypertension be may headaches and visual leading to

B. to the the in abnormality placenta; vascular with Due interface maternal-fetal of resolves delivery

preeclampsia with Eclampsia seizures. is C.

Low Elevated Hemolysis, by liver; enzymes, HELLP the preeclampsia thrombotic with is Liver microangiopathy and D. characterized Platelets involving

HELLP E. Both immediate eclampsia usually warrant and delivery.

VII. INFANT DEATH SUDDEN SYNDROME

A. cause a infant without (1 obvious Death healthy month year to 1 of old)

B. Infants during usually expire sleep

smoke, exposure and on factors Risk prematurity. to include sleeping cigarette stomach, C.

VIII. HYDATIDIFORM MOLE

villi and of Abnormal swollen edematous characterized with trophoblasts conception A. proliferation by

Table 12.2: Partial Complete and of Moles Features

hydropic, are Some villi some and

Villous villi edema hydropic Most are (Fig. 13.19B).

are normal.

present villi proliferation proliferation hydropic around Trophoblastic hydropic villi proliferation Focal Diffuse, circumferential around

Fig. abruption. 13.18 Placental (Courtesy of Fig. Complete 13.19 mole. villi. 'grape-like' Swollen, A, B, Hydropic villi. Steven Jerome (A, of MD) MD) O'Connor, Taxy, Courtesy

is and ~-hCG much as of for higher present, pregnancy normal gestation. B. if expands much uterus the date but expected larger is Uterus a than

as Classically canal grape-like of presents the second through trimester C. (Fig. in passage the masses vaginal 13.19A).

1. the diagnosed by routine early are in ultrasound moles prenatal With first care, trimester. and a heart on is ultrasound. classically Fetal absent, are sounds 'snowstorm' appearance seen

partial complete or D. Classified (Table 12.2) as

E. is curettage. suction Treatment

1. removal to important for of ensure screen is the adequate mole monitoring and choriocarcinoma. Subsequent to development p-hCG

1. as or germ (spontaneous spontaneous tumor. Choriocarcinoma a of complication gestation or as arise cell abortion, normal mole) pregnancy, hydatidiform a may

ii. the cell the those from that not. to respond that arise arise pathway gestational well from chemotherapy; germ do Choriocarcinomas pathway

choosing for you Pathoma your Thank for studies. the strive keeping highest materials We in educational quality mind. while affordability to provide tremendous we program. this of into developing amount your materials, A appreciate and of gone time legitimate these so effort has use It a ethical ourselves standards integrity taking physician the oath. we to and Hippocratic set for speaks forth future all as that your the when high and contrary materials standards of physician the violation Unauthorized is a use a is copyright. training to ethical of of Pathoma list updated accessed regular errata, of current your most as as basis are Pathoma version, account a complete can and well be the videos a on at through

Pathoma.com.

Sincerely,

Dr. Sattar, MD

I. HYPOSPADIAS

A. Opening of penis inferior on urethra surface of

B. to close of folds the urethral to Due failure

II. EPISPADIAS

A. of superior on surface urethra penis of Opening

B. abnormal of to genital tubercle the Due positioning

bladder exstrophy Associated with C.

III. CONDYLOMA ACUMINATUM

warty skin A. growth on genital Benign

B. 6 or change by Due characterized koilocytic (Fig. type 11; HPV to 14.1)

IV.

granulomatous lymph of Necrotizing the nodes and inguinal A. lymphatics inflammation

by disease caused transmitted (serotypes B. trachomatis Chlamydia Ll-L3) Sexually

stricture. heals may result Eventually involvement fibrosis; C. perianal with in rectal

V.

skin A. of squamous Malignant cells proliferation penile of

B. Risk 1. factors

cases) HPV 2. risk (2/3 High of

as Lack if for of maintained. circumcision-Foreskin nidus not inflammation acts and irritation properly a

lesions C. 1. Precursor situ in

that disease-in leukoplakia 2. of shaft the situ presents or Bowen scrotum penile as carcinoma

Erythroplasia on that the glans 3. as presents situ of Queyrat-in erythroplakia carcinoma

i. presents reddish carcinoma papulosis-in Bowenoid multiple that as papules situ younger Seen of (40s) Queyrat erythroplasia patients disease Bowen to in ii. relative and to carcinoma progress Does not invasive

CRYPTORCHIDISM I.

A. scrotal of 1. into the testicle to sac Failure descend the and normally develop scrotal grows. "descend" fetus the into Testicles abdomen as the sac then in

B. seen in male Most common congenital reproductive pathoma.com abnormality; of male 1% infants

Most performed cases spontaneously; is otherwise, before 2 orchiopexy years of C. resolve age.

for Complications increased atrophy and D. include testicular infertility with seminoma. risk

II. ORCHITIS

the of Inflammation testicle A.

B. 1. Causes

young trachomatis in Neisseria (serotypes D-K) Chlamydia adults. or gonorrhoeae-Seen spared. libido Leydig Increased cells because sterility, affected is not of risk are but

2.

in urinary into older tract pathogens Pseudomonas-Seen tract. reproductive coli Escherichia infection the spread adults; and

3.

children is virus testicular < for years not (teenage males)-increased seen Mumps usually old. risk inflammation infertility; in 10

4.

Autoimmune orchitis-characterized granulomas by tubules the involving seminiferous

III. TORSION TESTICULAR

the obstructed to leading infarction become cord; veins congestion spermatic Twisting (Fig. of and A. thin-walled hemorrhagic 14.2).

B. inner the to scrotum lining congenital due processus failure the of attach to vaginalis) testes (via to the Usually of

Presents in reflex testicular sudden with and cremasteric pain C. absent adolescents

IV.

A. vein of the spermatic due impaired to drainage Dilation

a worms" scrotal with "bag swelling B. as Presents appearance of

IVC. left vein vein left vein, while Usually testicular the the directly into drains testicular the right C. drains into renal sided; left

1. renal invades the Associated carcinoma; left-sided often renal vein. with RCC cell

percentage D. Seen infertile large a of males in

V.

Fluid vaginalis 1. the within A. collection tunica that of as the serous the covers testicle well the a internal Tunica as vaginalis surface scrotum. membrane is

B. drainage incomplete with or the to peritoneal blockage closure the (adults) processus communication with vaginalis (infants) leading oflymphatic of Associated cavity

. Fig 14.1 change. Koilocytic Fig. testicle. of infarction 14.2 Hemorrhagic Fig. 14.3 Hydrocele. of humpath.com) (Courtesy

as scrotal C. swelling be that (Fig. can transilluminated Presents 14.3)

I. PRINCIPLES BASIC

cells A. or Arise germ sex from cord-stroma

B. as testicular Present be a cannot firm, painless that transilluminated mass

removed the 1. of via Usually seeding biopsied scrotum; orchiectomy due to radical risk C. not germ testicular malignant Most are tumors. tumors cell

II. CELL GERM TUMORS

A. Most type common of tumor(> 95% cases) of testicular

B. 15-40 of occur age between Usually years

include and Klinefelter syndrome. factors C. cryptorchidism Risk

nonseminoma Divided into D. seminoma and 1.

excellent radiotherapy, and late, of cases) an (55% prognosis. highly responsive are metastasize Seminomas have to

2.

early. of Nonseminomas metastasize variable to treatment (45% cases) often show and response

with Seminoma E. malignant a spermatogonia, and tumor oflarge clear Fig. is cells comprised cytoplasm (resemble nuclei central no with hemorrhage 14.4A); necrosis mass a or (Fig. forms homogeneous 14.4B) 1.

2.

~-hCG. cases produce Rare may

3.

to responds radiotherapy Good prognosis;

comprised produce a may glands tumor of that Embryonal (Fig. malignant cells primitive immature, is F. carcinoma hemorrhagic 14.SA); (Fig. with necrosis mass a forms 14.SB) 1.

Aggressive 2. spread early hematogenous with

differentiation germ tumor may in result of (e.g., cell type teratoma). into Chemotherapy another

3.

be present. or ~-hCG Increased AFP may

a elements. resembles Yolk tumor is that sac sac tumor malignant (endodermal G. yolk sinus)

1.

2.

seen are structures) on (glomerulus-like Schiller-Duval bodies (Fig. histology 14.6).

3.

elevated. characteristically AFP is

Fig. 14.4 Seminoma. appearance. Microscopic A, Gross B, appearance. of MD) Ed Uthman, Courtesy (A,

and is are villi of tissue, cytotrophoblasts Choriocarcinoma (placenta-like malignant H. a absent, syncytiotrophoblasts but Fig. tumor 14.7).

1.

2.

is hyperthyroidism and to ofFSH, may elevated; characteristically or is (a-subunit that LH, ~-hCG to TSH) lead similar ofhCG gynecomastia

or mature I. is layers. Teratoma composed derived a tumor tissue two fetal of embryonic three from

1.

to in 2. males opposed (as Malignant females)

AFP ~-hCG or be increased. may

J. 1. cell tumors Mixed germ

mixed. tumors Germ cell are usually

2.

is on based component. Prognosis the worst

Ill. TUMORS CORD-STROMAL SEX

testicle tissues Tumors sex resemble A. the that of (Fig. cord-stromal 14.8); usually benign

in or precocious gynecomastia Leydig causing produces B. in tumor adults. androgen, puberty children usually cell

1. may on Reinke seen Characteristic histology. crystals be

of usually tubules is clinically tumor silent. Sertoli comprised cell C. is and

IV. LYMPHOMA

A. in often cause mass Most 60 > bilateral old; testicular of a males common years

B. diffuse Usually B-cell large of type

Fig. carcinoma. Embryonal 14.5 Microscopic appearance. A, Gross B, appearance. (Courtesy of webpathology.com)

Fig. Schiller-Duval tumor. sac 14.6 body, yolk Fig. Choriocarcinoma. 14.7 (Courtesy Fig. of appearance. web of Normal (Courtesy microscopic pathology.com) testicle, 14.8 webpathology.com)

I. BASIC PRINCIPLES

A. round the organ the base Small, that of lies at bladder encircling urethra the

B. of palpable aspect is (DRE). digital the prostate posterior rectum; anterior by Sits exam rectal to

Consists glands and stroma of (Fig. C. 14.9) 1.

of inner composed and layer Glands semen. an outer to that cells fluid added are is layer ofluminal seminal fluid of an secrete to and make basal sperm alkaline, cells; vesicle milky

2.

maintained stroma are androgens. by and Glands

II. ACUTE PROSTATITIS

A. 1. due inflammation usually bacteria prostate; the of Acute to Chlamydia gonorrhoeae are trachomatis in adults. young Neisseria causes common and

2. causes and coli adults. Escherichia are older in Pseudomonas common

fever and dysuria B. as Presents with chills

boggy Prostate C. is on rectal tender digital exam. and

show culture secretions reveals WBCs; bacteria. D. Prostatic

III. PROSTATITIS CHRONIC

A. prostate Chronic inflammation of

pain pelvic with or back B. low as dysuria Presents

negative. are WBCs, secretions C. but show cultures Prostatic

IV. BENIGN HYPERPLASIA PROSTATIC (BPH)

stroma and glands A. prostatic of Hyperplasia

age risk Age-related no years); of change increased cancer the in B. for by 60 men (present most

dihydrotestosterone 1. Related to (DHT) C.

DHT to stromal cells. Sa-reductase in converted is by Testosterone

2.

in resulting and receptor of hyperplastic acts androgen DHT cells epithelial the nodules. on stromal

zone D. prostate the Occurs the in periurethral of central

features include E. Clinical 1.

2.

infection (Fig. for Impaired emptying and increased with bladder risk hydronephrosis 3. 14.10)

Fig. microscopic Fig. prostate, Normal 14.9 14.10 Hydronephrosis. appearance.

4.

smooth for muscle; increased diverticula bladder risk wall of 5. bladder Hypertrophy

may be present. Microscopic hematuria

6.

elevated number increased ng/ prostatic the is liquefies less 10 than semen. is (PSA) antigen often glands; of glands Prostate-specific PSA by (usually slightly made and due mL) to

1. (e.g., F. i. -antagonist to muscle relax terazosin) smooth Treatment a lowering muscle pressure relaxes vascular Also smooth ii. blood blood to -antagonists A used are in vessels. tamsulosin) on effects individuals avoid normotensive Selective (e.g., a a

2. i. 5a-reductase inhibitor to DHT testosterone ii. conversion of Blocks iii. results to months produce Takes iv. useful baldness for pattern male Also effects and are gynecomastia sexual dysfunction. Side

ADENOCARCINOMA PROSTATE V.

of prostatic Malignant A. glands proliferation

B. common 2nd cause Most cancer of in men; most death cancer-related common

> Asians), age, C. and factors (African saturated Americans > in Risk . include race diet high fats Caucasians

is often silent. most carcinoma D. clinically Prostatic

1.

(Fig. peripheral, symptoms not posterior produce hence, Usually on in region early does the prostate and, the urinary arises of 14.llA) 2.

and at the Screening DRE years age begins with PSA. of 50

i. 40-49 Normal 7.5 BPH (2.5 ng/mL ages increases years 70-79 PSA serum with due to years) vs. for age for ng/mL ages ii. at worrisome 10 > any highly ng/mL PSA age. is

iii. is of cancer PSA). bound (cancer free-PSA makes suggestive Decreased%

the E. carcinoma. is required biopsy of Prostatic confirm to presence

1.

Shows with (Fig. glands prominent small, nucleoli invasive 14.llB) 2.

alone on architecture atypia). grading (and is not nuclear based Gleason system

i. varies the architecture because of tumor area assessed regions to area. are from Multiple

ii. is for score assigned a two produce final distinct added areas then (1-5) (2-10). A to score and

iii. Higher prognosis. suggests score worse

Fig. 14.11 Prostatic adenocarcinoma. A, appearance. Gross appearance. Microscopic B, C, metastasis lumbar involving Osteoblastic spine.

(Fig. lumbar Spread or to F. common is pelvis spine 14.llC); serum low PSA, in increased prostatic results and present alkaline phosphatase phosphatase, osteoblastic as (PAP) metastases pain back and that acid

Prostatectomy localized is G. with to disease; for DHT. suppression performed is hormone and disease treated testosterone advanced reduce

1.

(e.g., gonadotrophs pituitary and reduced). analogs are down (LH the Continuous leuprolide) anterior shut FSH GnRH

2.

inhibitor the androgen a at Flutamide competitive as acts receptor.

SYSTEM I. ENDOCRINE

A. homeostasis maintain body Group that glands of

B. release distant organs that blood hormones via by Functions travel of to

hormone release. "Feedback" mechanisms C. control

PITUITARY ADENOMA I.

anterior cells tumor of pituitary A. Benign

B. May nonfunctional or (silent) be (hormone-producing) functional 1. with tumors present often effect. mass Nonfunctional

compression due chiasm. hemianopsia occurs Bitemporal of to i. the optic

ii. normal due pituitary occurs tissue. of to compression Hypopituitarism

iii. Headache 2. features tumors the Functional based produced. present of type on with hormone

(females) as common adenoma (males); presents decreased 1. libido galactorrhea as of amenorrhea most type pituitary or and headache C. Prolactinoma and larger dopamine (shrinks for production suppress lesions. prolactin (e.g., tumor) surgery cabergoline) or agonists bromocriptine Treatment is or to

D. Growth adenoma 1. hormone cell

2. Gigantism growth are not in linear children-increased fused) bone (epiphyses

1. jaw and Enlarged bones feet, ii. of hands, failure) leading organs of cardiac Growth iii. visceral (e.g., dysfunction to Enlarged 3. tongue

diabetes present (GH liver induces Secondary gluconeogenesis). mellitus is often

4.

growth by factor-1 by of insulin levels 5. oral Diagnosed (IGF-1) along GH lack suppression and glucose elevated GH with

surgery. or is GH analog suppresses (somatostatin Treatment that release), GH receptor octreotide antagonists,

Cushing syndrome leading secrete Cortex" ACTH (see below). adenomas to E. cell ACTH "Adrenal

are rare. adenomas TSH FSH-producing F. but and occur, cell, LH-producing,

II. HYPOPITUITARISM

A. lost. > pituitary hormones parenchyma when Insufficient production the pituitary gland; symptoms arise 75% of anterior the is by of

B. include 1. Causes

mass adenoma) an or adenomas (bleeding pituitary (children)-due or into Pituitary apoplexy effect 2. (adults) craniopharyngioma to

of the during blood not pituitary during gland does Sheehan precipitates blood significantly; i. syndrome-pregnancy-related pregnancy, infarction supply size parturition infarction. increase Gland in doubles but loss

ii. pathoma.com poor pubic 3. hair, as Presents loss fatigue of lactation, and defect the CSF destroys compresses and the i. and sella gland. Empty of pituitary Herniation into the sella the arachnoid sella of syndrome-congenital

ii. is imaging. "absent" on gland sella) Pituitary (empty

I. PRINCIPLES BASIC

to posterior release. are pituitary oxytocin in the A. hormone then Antidiuretic the (ADH) transported hypothalamus made and via for axons and

1.

tubules ducts promote the distal to water acts collecting the kidney on of free retention. ADH and

2.

uterine release contraction in labor lactating during (let-down) mothers. Oxytocin and of breast mediates milk

II. INSIPIDUS CENTRAL DIABETES

ADH A. deficiency

B. (e.g., to or posterior inflammation) pathology tumor, or Due trauma, pituitary infection, hypothalamic

Clinical on features based are of water. free loss C.

1.

with and polydipsia dehydration 2. risk Polyuria oflife-threatening

3.

increase test D. (useful osmolality deprivation diagnosis). Water to fails urine for

(ADH is E. Treatment desmopressin analog).

III. NEPHROGENIC INSIPIDUS DIABETES

A. renal Impaired ADH response to

B. inherited drugs Due (e.g., lithium mutations or demeclocycline) and to

no Clinical desmopressin. similar there diabetes C. but response is central insipidus, are features to to

IV. OF SYNDROME (SIADH) INAPPROPRIATE ADH SECRETION

A. ADH Excessive secretion

B. include (e.g., causes trauma, other drugs of Most lung); and CNS (e.g., the small ectopic carcinoma due pulmonary to infection, often production cell cyclophosphamide).

of on Clinical free are C. retention features based water.

1.

2.

edema. and swelling seizures-Hyponatremia and to neuronal leads changes Mental cerebral status

free restriction D. is Treatment or demeclocycline. water

THYROGLOSSAL DUCT I. CYST

remnant thyroglossal dilation duct 1. Cystic of A.

duct base thyroglossal of the anterior tongue travels Thyroid neck. and at the then develops to along the

2.

however, normally a cystic involutes; may persistent duct duct, Thyroglossal undergo dilation.

neck B. an as Presents anterior mass

II. LINGUAL THYROID

tissue of Persistence of at base A. tongue thyroid the

as base a mass Presents of B. tongue

I. PRINCIPLES BASIC

A. circulating level hormone Increased thyroid of 1.

metabolic increased of ATPase) synthesis -K+ basal rate (due to 2. Increases Na+

sympathetic nervous increased system activity to of Increases expression -adrenergic (due ~ receptors)

B. Clinical features include 1.

2.

3.

increased cardiac with Tachycardia 4. output

(e.g., atrial fibrillation), the elderly in Arrhythmia 5. especially

anxiety, and Tremor, 6. insomnia, emotions heightened

lag with Staring gaze lid 7.

8. with malabsorption Diarrhea

9.

(risk osteoporosis) with hypercalcemia resorption Bone 10. for

weakness mass Decreased 11. muscle with

12.

Hyperglycemia (due to and gluconeogenesis glycogenolysis)

II. GRAVES DISEASE

(IgG) hypersensitivity) stimulates II Autoantibody receptor that A. TSH (type

B. of release thyroid synthesis increased Leads to hormone and 1.

cause common Most 2. hyperthyroidism of

Classically age occurs (20-40 years) of childbearing women in

C. features include Clinical 1.

2.

stimulation hyperplasia to (Fig. TSH and leads thyroid Diffuse goiter-Constant hypertrophy 15.lA).

3.

1. the shin Fibroblasts TSH receptor. behind overlying the express and the orbit

ii. to (chondroitin buildup, sulfate inflammation, pretibial glycosaminoglycan TSH activation and leading myxedema. in hyaluronic acid) results fibrosis, exophthalmos and and edema

Fig. 15.1 Graves disease. Diffuse A, goiter. B, appearance. Microscopic (A, Ed Courtesy Uthman, of MD)

chronic follicles and seen (Fig. Irregular with histology colloid on D. scalloped inflammation are 15.lB).

..l, 1. 2. the (free TRH ; to receptors TSH release) anterior decrease t T include TSH T pituitary and total in Laboratory downregulates findings free E.

3.

Treatment thioamide, involves ablation. P-blockers, and F. radioiodine

Thyroid fatal complication. is G. potentially a storm

1.

childbirth) 2. in elevated stress excess, or to surgery (e.g., to usually Due response catecholamines massive and hormone

hyperthermia, arrhythmia, vomiting hypovolemic as 3. with shock Presents and

Treatment steroids. P-blockers, propylthiouracil is and (PTU),

to i. thyroid hormone peripheral organification, and oxidation, of peroxidase-mediated steps T3. as synthesis, of conversion PTU coupling as inhibits well T4

III. MULTINODULAR GOITER

gland thyroid with A. multiple Enlarged nodules (Fig. 15.2)

B. iodine deficiency relative to Due

Usually C. nontoxic (euthyroid)

TSH-independent D. goiter'). regions to leading T and Rarely, become hyperthyroidism ('toxic release

I. CRETINISM

in A. Hypothyroidism neonates infants and

B. features, hernia skeletal 1. abnormalities, facial enlarged short and mental with retardation, stature by coarse Characterized tongue, umbilical for required and is skeletal brain hormone development. Thyroid normal

hypothyroidism pregnancy, C. thyroid early and include iodine dyshormonogenetic Causes maternal goiter, during agenesis, deficiency.

1. production; to a in most thyroid hormone Dyshormonogenetic involves defect goiter due commonly peroxidase thyroid is congenital

II. MYXEDEMA

Hypothyroidism A. children in or adults older

B. system on are based Clinical and activity. decreased basal nervous metabolic decreased rate features sympathetic

1.

Myxedema-accumulation and soft tongue large ofvoice in in glycosaminoglycans the deepening a of 2. results skin and tissue;

3.

4. mental activity Slowing of

5.

sweating decreased 6. intolerance with Cold

decreased 7. cardiac output, Bradycardia fatigue of leading to shortness with breath and

8.

9.

of lithium) causes are drugs surgical and Most radioablation include or common (e.g., causes thyroid. iodine the removal deficiency and thyroiditis; other Hashimoto C.

THYROIDITIS I. HASHIMOTO

HLA-DR5 gland; thyroid Autoimmune A. 1. destruction the with associated of cause hypothyroidism Most levels iodine of regions are adequate where common in

B. 1. features Clinical

Initially (due follicle damage) hyperthyroidism to present as 2. may

and t T4 TSH 3. hypothyroidism; Progresses to ,l.,

peroxidase damage). are Antithyroglobulin (sign antibodies often of thyroid present and antithyroid

Hurthle on metaplasia histology (Fig. cells and line Chronic germinal follicles) centers that is seen cells of C. with inflammation (eosinophilic 15.3).

as for D. presents disease course gland late an (marginal risk Increased lymphoma; B-cell zone) thyroid enlarging in

II. (DE THYROIDITIS GRANULOMATOUS QUERVAIN) SUBACUTE

infection follows Granulomatous a viral A. thyroiditis that

Presents transient thyroid with a tender hyperthyroidism as B.

C. Self-limited; may rarely of progress to (15% cases) hypothyroidism

III. RIEDEL THYROIDITIS FIBROSING

A. fibrosis inflammation extensive gland Chronic thyroid of with the

with as non B. thyroid Presents hypothyroidism tender as 'hard wood,' gland a

(e.g., local structures C. involve airway). to may extend Fibrosis

1. (40s), are younger carcinoma, mimics but absent cells Clinically and patients anaplastic are malignant

I. PRINCIPLES BASIC

A. 1. Usually distinct, presents nodule solitary as a to nodules are than Thyroid more malignant. likely be benign

B.

are 13 to further radioactive 1I nodules. useful studies uptake characterize

1.

disease is nodular Increased uptake seen or Graves nodule) ('hot' in goiter.

2.

('cold' Decreased biopsy and nodule) uptake warrants adenoma carcinoma; often seen in is

fine needle is by Biopsy (FNA). performed C. aspiration

II. FOLLICULAR ADENOMA

proliferation surrounded fibrous (Fig. by Benign capsule of A. follicles a 15.4)

Fig. goiter. Multinodular 15.2 Jamie of Fig. (Courtesy thyroiditis. Hashimoto 15.3 Fig. Follicular adenoma. 15.4 MD) Steinmetz,

B. commonly, thyroid may secrete less hormone Usually nonfunctional;

III. PAPILLARY CARCINOMA

A. Most carcinoma cases) common of (80% type thyroid of

B. major ionizing radiation factor. is in risk a childhood to Exposure

of with (Fig. by papillae Comprised lined cells nuclei 'Orphan Annie C. and nuclear clear, grooves eye' bodies are 15.5A); psammoma (Fig. with often papillae associated 15.5B).

Often excellent (10-year 95%) cervical D. to (neck) > survival spreads lymph is nodes, prognosis but

IV.

(Fig. invasion surrounded of Malignant A. through the with capsule by fibrous follicles proliferation capsule a 1. 15.6)

helps the adenoma. distinguish carcinoma follicular through Invasion follicular from capsule

2.

must microscopically. examined be capsule Entire

3.

a not FNA between made be distinction by and only adenoma examines cells carcinoma and cannot FNA. the hence, capsule; follicular follicular

generally Metastasis B. hematogenously. occurs

V.

of cells; C 5% parafollicular Malignant carcinomas 1. proliferation comprises thyroid of A.

cells secrete C calcitonin. neuroendocrine that cells are

2.

Calcitonin inactive at physiologic increasing normal serum levels. by excretion lowers calcium is but calcium renal

3.

calcitonin hypocalcemia. produced by High levels may lead to of tumor

4.

Calcitonin tumor amyloid. the within often as deposits

Biopsy sheets stroma (Fig. amyloid of cells an malignant reveals B. in 15.7).

with are 2B, C. often and to in the cases endocrine multiple due 2A (MEN) Familial are neoplasia RET which oncogene. associated mutations

1.

MEN parathyroid (2B). pheochromocytoma, adenomas ganglioneuromas in 2 (2A) carcinoma, oral of mucosa or the results medullary and

2.

mutation RET thyroidectomy. Detection warrants of prophylactic the

VI. ANAPLASTIC CARCINOMA

thyroid (Fig. malignant of Undifferentiated tumor A. the 15.8); elderly seen in usually

B. compromise or Often invades leading to dysphagia respiratory structures, local

Poor C. prognosis

Fig. 15.5 carcinoma. Papillary features. A, Nuclear B, Psammoma bodies. Fig. carcinoma. 15.6 Follicular lent of Bu MD) (Courtesy Celasun,

I. BASIC PRINCIPLES

A. free parathyroid (PTH) via calcium regulate which cells hormone Chief (ionized) 1. secretion, serum

2. activity, Increases phosphate bone and osteoclast releasing calcium

3. Increases vitamin by small phosphate absorption bowel activating D) calcium (indirectly and of

B. calcium levels Increased to provide negative decrease serum ionized feedback secretion. PTH

II. PRIMARY HYPERPARATHYROIDISM

A. of parathyroid itself the a disorder to Excess PTH due gland

B. adenoma and causes. (>80% hyperplasia carcinoma parathyroid common Most common parathyroid sporadic less are cause is parathyroid of cases);

neoplasm, a C. involving is benign usually one gland. Parathyroid adenoma

1. i. Most with increased stones) often hypercalcemia consequences hypercalcemia; however, Nephrolithiasis of in ii. and results PTH may as oxalate (calcium present asymptomatic such of (Fig. Nephrocalcinosis-metastatic tubules calcification renal polyuria renal potentially 15.9), insufficiency and 111. to leading and CNS depression disturbances (e.g., seizures) 1v. acute ulcer fibrosa and disease, fibrosis Osteitis cystica-resorption Constipation, (Fig. to v. peptic cystic of and leading pancreatitis spaces bone 2. 15.10)

t serum J,. include t Laboratory PTH, calcium, findings serum t serum and phosphate, phosphatase. t cAMP, urinary serum alkaline

3.

the involves removal affected Treatment gland. of surgical

III. SECONDARY HYPERPARATHYROIDISM

A. a Excess PTH due process to of parathyroid the disease gland production to extrinsic

B. is cause chronic common Most failure. renal

1.

excretion. phosphate decreased to leads Renal insufficiency

2.

free calcium. phosphate t serum binds

3.

J,. all stimulates free four parathyroid glands. calcium

4.

to leads renal PTH to bone resorption (contributing osteodystrophy). t

5.

findings include J,. PTH, Lab t serum serum calcium, alkaline phosphate, and phosphatase. t t

Fig. carcinoma. Medullary 15.7 Fig. 15.8 carcinoma. plastic Ana Fig. 15.9 Nephrocalcinosis.

IV. HYPOPARATHYROIDISM

A. LowPTH

B. Causes and include autoimmune surgical syndrome damage to parathyroids, DiGeorge excision, the

symptoms to with 1. low related C. Presents calcium serum

2.

the blood or facial Muscle (Chvostek (tetany)-may filling tapping elicited sign) with (Trousseau cuff of sign) spasms on nerve pressure be a

.,J, Labs calcium. and D. levels PTH reveal serum .,J,

resistance E. to due Pseudohypoparathyroidism is to end-organ PTH.

1.

reveal PTH with Labs levels. hypocalcemia t

2.

short 4th digits. with associated stature 5th form and short is and dominant Autosomal

I. PRINCIPLES BASIC

A. cells islets Langerhans Composed termed of of (Fig. of clusters 15.11)

B. hormone. of multiple types, one cell single type each of islet consists producing A

in of beta islets. lie the center C. by which is secreted Insulin cells, the

1.

2.

protein by increased glucose glycogen lipogenesis. Increased synthesis, uptake leads synthesis, to and tissues

order secreted fasting) of to and opposes glucose D. blood lipolysis. Glucagon via levels glycogenolysis increase by states alpha cells; is in in it insulin (e.g.,

to characterized A. metabolic by a deficiency disorder hyperglycemia Insulin leading

B. T 1. destruction Due autoimmune to lymphocytes of by beta cells

inflammation islets by Characterized of 2.

3. with Associated HLA-DR3 and HLA-DR4

of disease are damage) (sign seen be clinical insulin years and develops. against Autoantibodies present may before often

insulin clinical features childhood with 1. Manifests of in deficiency C. High and skeletal decreased glucose-Lack to of by uptake leads glucose fat serum insulin muscle.

Fig. Osteitis 15.10 cystica. fibrosa Fig. 15.11 Langerhans. Islets of Fig. Amyloid islets, II DM. 15.12 type in

2.

and glycogenolysis polyphagia-Unopposed Weight muscle further which glucagon hyperglycemia. to loss, leads gluconeogenesis, low and exacerbates mass, lipolysis,

3.

filtered exceeds polydipsia, osmotic renal diuresis. resorb to excess to Polyuria, glucose; glucose and leads ability glycosuria-Hyperglycemia

4.

lifelong insulin. involves Treatment

for diabetic Risk ketoacidosis D. 1.

2.

lipolysis increasing (e.g., with with gluconeogenesis (along infection); glycogenolysis). epinephrine and Often secretion arises glucagon stress stimulates

i. Increased free increased lipolysis (FFAs). leads to fatty acids

ii. acid Liver (~-hydroxybutyric FFAs to ketone acid). and bodies converts acetoacetic

3.

300 hyperkalemia Results metabolic acidosis, in gap and (> 4. hyperglycemia mg/dL), anion

with (due dehydration, fruity to breath smelling and status mental acetone) vomiting, changes, respirations, nausea, 5. Kussmaul Presents

(e.g., (corrects Treatment electrolytes and from replacement potassium). is polyuria), dehydration insulin, of fluids

Ill. TYPE DIABETES 2 MELLITUS

A. to by hyperglycemia characterized disorder 1. End-organ resistance a metabolic insulin leading

diabetes common US of of type (90% population Most of the 5-10% affects 2. cases);

rising. Incidence is

obese middle-aged, in 1. B. Arises adults

of leads Obesity receptors. insulin decreased to numbers

2.

exists. Strong predisposition genetic

C. early later, insulin due develops deficiency Insulin beta exhaustion; cell to the in reveals levels amyloid in disease, islets deposition (Fig. histology increased are but 15.12).

D. polyuria, clinically is silent. disease Clinical features but include hyperglycemia, often polydipsia, and

made Diagnosis 70-120 E. (normal glucose is by mg/dL). is levels measuring

1.

2.

3.

tolerance test loading 200 Glucose > with a level two hours mg/dL glucose serum glucose after

loss involves Treatment initially; therapy resistance exhaustion and or after drug of may weight exercise) insulin sulfonylureas or F. insulin exogenous metformin) require beta cells (diet counter to (e.g.,

non-ketotic for 1. Risk hyperosmolar G. coma

mg/dL) diuresis to hypotension glucose and coma. (> High 500 life-threatening with leads

2.

circulating insulin. amounts are due to Ketones of small absent

IV. CONSEQUENCES DIABETES OF LONG-TERM

basement A. Nonenzymatic (NEG) 1. glycosylation ofvascular membranes leads resultant to and medium-sized atherosclerosis its vessels oflarge-and complications. NEG

death among cause diabetics. disease of is the Cardiovascular i. leading

ii. Peripheral vascular of disease non in the amputations. cause diabetics traumatic is leading

2. of to hyaline NEG vessels (arterioles) small (Fig. arteriolosclerosis leads 15.13A).

i. scarred to surface leads renal granular kidneys of (Fig. in Involvement resulting a small, arterioles with glomerulosclerosis, 15.13B).

ii. characterized injury in nephrotic 3. nodules by Kimmelstiel-Wilson involvement glomerular of syndrome; progresses microalbuminuria leads efferent with eventually arterioles that hyperfiltration Preferential to glomeruli to a control. of produces hemoglobin glycemic of hemoglobin glycated marker NEG (HbA1c),

B. damage 1. Osmotic

freely into cells peripheral nerves), vessels, (which and Schwann Glucose pericytes myelinate retinal blood lens. enters of the

2.

converts damage. glucose reductase osmotic sorbitol, to in Aldose resulting

3.

impotence, diabetes leading and the blindness to blindness, neuropathy, in cataracts; cause Leads of is world. peripheral the developed

V. NEOPLASMS ENDOCRINE PANCREATIC

A. islet Tumors 5% of pancreatic of < neoplasms. cells; account for

1. a along with Often parathyroid component MEN and adenomas 1 hyperplasia pituitary of

mental hypoglycemia as present relieved Insulinomas that administration status of glucose. with changes B. episodic by are

1. levels by insulin, 50 -l.-serum t Diagnosed mg/dL), (usually < t glucose and C-peptide

multiple ulcers jejunum. ulcers and may extend the Gastrinomas C. syndrome); (Zollinger-Ellison peptic be treatment-resistant into as present can

cholelithiasis of Somatostatinomas inhibition achlorhydria as cholecystokinin). (due to D. and inhibition with gastrin) present of to (due steatorrhea

watery peptide excessive and secrete VIPomas to intestinal hypokalemia, vasoactive E. leading diarrhea, achlorhydria.

I. BASIC PRINCIPLES

A. Composed of hormones. predominantly three layers; of secretes class each one

1.

mineralocorticoids (e.g., aldosterone). Glomerulosa produces

2.

produces (e.g., glucocorticoids cortisol). Fasciculata

3.

DHEA). Reticularis androgens weak produces (e.g.,

derived hormones cholesterol. B. from Cortical are

Fig. diabetes. Complications of 15.13 Hyaline A, arteriolosclerosis. B, Glomerul osclerosis.

1.

and (Fig. glucocorticoids, modification Sequential mineralocorticoids, enzymatic produces androgens 15.14).

2.

based in hormones secretes present Each layer. distinct that enzymes layer on

II. HYPERALDOSTERONISM

A. aldosterone Excess

and 1. metabolic hypokalemia, HTN, alkalosis Classically presents B. as

in distal duct. Aldosterone increases and hydrogen and and tubule of secretion ions potassium collecting the of sodium absorption

2.

leading Increased plasma sodium volume to expands HTN.

is commonly Fig. C. most to bilateral adrenal (60%, hyperaldosteronism Primary due hyperplasia syndrome, or Conn adenoma Fig. (40%, adrenal 15.15) adrenal 15.16); rare. carcinoma is

1.

determine useful to CT is 2. pathology

mineralocorticoid (e.g., or surgically spironolactone adrenal antagonist Treatment resected. for are adenoma receptor eplerenone); carcinoma and hyperplasia is bilateral

renovascular hypertension or (e.g., activation of with D. arises system Secondary renin-angiotensin the hyperaldosteronism CHF).

Fig. Steroidogenesis, adrenal cortex. 15.14

Fig. hyperplasia. Adrenal 15.15 Fig. 15.16 l Adrena adenoma.

edema and Primary are plasma hyperaldosteronism by secondary and 1. distinguished E. renin

by no is renin (aldosterone Primary and escape). edema low characterized

2.

edema renin; characterized present. Secondary often high is is by

Glucocorticoid-remediable to hyperaldosteron leads ism (GRA) aldosteronism F. familial 1.

expression autosomal dominant the due Aberrant fasciculata of to mutation; aldosterone genetic 2. in synthase

low. and hypokalemia; and as HTN is child is with presents renin Classically high aldosterone

3.

to genetic with dexamethasone; confirmed testing Responds

G. mimics syndrome hyperaldosteronism. Liddle

1.

of 2. Decreased mutation; dominant tubules autosomal to in collecting genetic channels sodium degradation due

child hypokalemia, renin metabolic with and with 3. but low and HTN, Presents aldosterone alkalosis, as low

4.

not channels; amiloride spironolactone block sodium is Treatment triamterene), or diuretics potassium-sparing tubular which (e.g., effective. is

mimics also Syndrome excess H. (SAME) mineralocorticoid of apparent hyperaldosteronism.

1.

cortisol to 2. aldosterone 11~-hydroxysteroid receptors; dehydrogenase (ll~-HSD2) recessive activate renal allows autosomal deficiency 2

but renin with as HTN, child alkalosis, low and Presents low metabolic with and aldosterone hypokalemia, 3.

4.

with acid), ll~-HSD2 licorice which May blocks arise also (glycyrrhetinic

III. (CUSHING SYNDROME) HYPERCORTISOLISM

A. cortisol Excess

B. include 1. features Clinical

extremities-Cortisol acids with down produce amino for Muscle breaks to weakness gluconeogenesis. thin muscle

2.

of facies, obesity-High (due centrally. fat buffalo increases hump, insulin glucose) high and Moon to storage truncal

3.

collagen skin thinning striae-Impaired results synthesis 4. Abdominal of in

often and metabolic 1. with HTN alkalosis hypokalemia of High to cortisol catecholamines. increases sensitivity vessels peripheral

ii. very cortisol cross-reacts At levels, mineralocorticoid with high not receptors is increased). (aldosterone

5.

6.

dexamethasone cortisol late cortisol test. (increased), suppression 24-hour low-dose urine level and on Diagnosis (increased), based salivary is night level C.

1. normal dexamethasone cortisol Cushing in in to suppress all cortisol causes syndrome. individuals of Low-dose fails but suppresses

15.1). ACTH-independent of distinguishes Cushing syndrome D. from Plasma ACTH (table causes ACTH-dependent causes

1.

to next an lesion. for look is CT adrenal step IfACTH-independent,

2.

is step high-dose test. dexamethasone next IfACTH-dependent,

production E. ectopic by (serum cortisol but high). production cortisol is lowered) pituitary ACTH not a ACTH remains adenoma (serum suppresses dexamethasone does High-dose suppress

_____________11111,

Cushing Syndrome Table 15.1

NIA possible NIA Low steroids, of Tapering if

may resulting of ACTH-secreting adenoma; adenoma, cases refractory to Transsphenoidal adenoma pituitary present. in lead resection can pituitary bilateral adrenalectomy in be pituitary (70%, of enlargement

syndrome) bitemporal disease) hemianopsia headaches, and (Nelson hyperpigmentation, Cushing

No Ectopic ACTH Resection of and small may source ectopic suppression (e.g., ACTH excess be present.

carcinoma adrenal Primary Adenomal with

(10%), adenomalcarcinoma of Resection adenoma or contralateral

hyperplasia of hyperplasia, with NIA or atrophy resection Low or bilateral

involves 1. Treatment resection surgical generally F. is if surgery not Ketoconazole or useful option an metyrapone

IV. CONGENITAL ADRENAL HYPERPLASIA

A. 1. autosomal to production; in Due enzymatic recessive cortisol defects

feedback) bilateral (decreased ACTH leads adrenal High negative hyperplasia. to

2.

increased be enzyme on decreased Mineralocorticoids defect. depending and the may androgens or

B. cases). common (90% of is deficiency the most cause 21-hydroxylase

1.

shunted androgens. towards are and decreased; Aldosterone steroidogenesis is cortisol

2.

neonates with lifethreatening type); (salt-wasting females in as and enlargement hypotension form clitoral Classic have ambiguity). presents (genital hyponatremia hyperkalemia

3.

menstrual or (males) precocious hirsutism with in life irregularities form with later to presents excess Nonclassic leading (females). androgen puberty

weak also increased. excess, to deficiency are mineralocorticoids C. 11-hydroxylase (DOC) but androgen leads

1.

leads and with low. are mild to Deoxycorticosterone retention) HTN hypokalemia; (sodium aldosterone renin (DOC)

2.

in is enlargement Clitoral females seen

decreased and deficiency 17-hydroxylase leads to cortisol D. androgens.

1.

hypokalemia; to HTN low. with are aldosterone leading are Weak (DOC) mild renin and mineralocorticoids increased

2.

androgens of Decreased lack hair primary genitalia amenorrhea testes lead (males). ambiguous to with (females) pubic or and undescended

is screening for via Newborn serum CAH E. 1. 17-hydroxyprogesterone routine

2.

for necessary. mineralocorticoids Treatment deficiency) or CAH steroids sex deficiency) as F. is (17-hydroxylase glucocorticoids; given (21-hydroxylase

INSUFFICIENCY ADRENAL V.

A. of hormones Deficiency adrenal

B. insufficiency shock. weakness presents Acute as and include Causes 1.

2. withdrawal of Abrupt glucocorticoids

Treatment of 3. syndrome Cushing

glands adrenal necrosis of syndrome-hemorrhagic (Fig. the Waterhouse-Friderichsen young DIC and infection children to with in classically Neisseria meningitidis due sepsis 15.17),

vomiting, weakness, Chronic and progressive such weight disease) as fatigue, loss. vague, with (Addison insufficiency symptoms C. nausea, hypotension, presents

most disease adrenal D. damage. often Addison with arises progressive

1.

(e.g., autoimmune (most cause world), metastatic common in from developing (most common West), causes the Common lung). and destruction cause carcinoma TB in include the

2.

of autoimmune polyendocrine adrenalitis be Autoimmune syndromes a can component

with pituitary hypothalamic or (secondary) disease. E. (tertiary) Addison also may disease arise

1.

secondary/tertiary suggest and hyperkalemia primary (normal (high Hyperpigmentation (low insufficiency aldosterone) ACTH) hyperpigmentation has no insufficiency; potassium ACTH) and aldosterone). normal (low adrenal

2.

test a stimulation supports secondary of ACTH metyrapone or tertiary response Lack cause. with

3.

response suggests with test hypothalamic CRH disease. ACTH (tertiary) stimulation

mineralocorticoids. F. glucocorticoids is Treatment and

I. PRINCIPLES BASIC

A. Composed crest-derived cells of neural chromaffin

B. (epinephrine source and Main of physiologic catecholamines norepinephrine)

II. PHEOCHROMOCYTOMA

chromaffin (Fig. A. Tumor cells of 15.18)

Fig. 15.17 Waterhouse-Friderichsen syndrome. Fig. 15.18 Pheochromocytoma. hum (Courtesy of path.com) humpath.com) of (Courtesy

B. are features catecholamines. due to of Clinical release episodic

1. headaches, palpitations, tachycardia, HTN, and sweating Episodic

and metanephrines catecholamines and Diagnosed by serum in increased C. urine

adrenalectomy. is D. Treatment

1.

the manipulation upon the tumor. into Catecholamines may bloodstream of leak

2.

crisis. is Phenoxybenzamine hypertensive to (irreversible a a-blocker) prevent administered followed ~-blocker preoperatively by

bladder familial, Often inferior Zuckerkandl adrenal at 10% located artery 10% follows 'rule bilateral, 10% or 10s:' medulla 1. wall) E. root the (e.g., 10% and the the of of malignant, outside mesenteric of organ long-term is metastatic spread; by require patients follow-up Malignancy defined

and 2B type von Hippel-Lindau F. disease, (RET), neurofibromatosis Associated 2A MEN 1 with and

I. BREAST

A. embryologically sweat the 1. derived skin gland Modified from develop anywhere (e.g., which runs line, the from can tissue Breast vulva along axilla supernumerary to the nipples). the milk

B. breast of lobular functional unit duct The the the terminal (Fig. is unit 16.1); to lobules the make ducts milk drains that nipple. via

Lobules ducts epithelium. two of lined C. and are layers by

1.

lobules lobules; the cell the production lining cell and in milk 2. layer-inner Luminal layer for responsible ducts

layer the propels ducts layer-outer and cell towards function lobules; lining milk Myoepithelial nipple. contractile cell

tissue hormone D. Breast is sensitive.

1.

the and male breast nipple. oflarge under puberty, consists ducts tissue female primarily Before

2.

primarily Development by form are density present in and quadrant. estrogen lobules ducts after the and in is highest small and driven outer progesterone; upper menarche

3.

tenderness cycle is the a common to during especially prior Breast complaint, menstrual menstruation.

4.

undergo hyperplasia. pregnancy, lobules During breast

by (early corpus estrogen 5. progesterone is (later by and pregnancy) in the driven and produced placenta i. first Hyperplasia trimester), fetus, luteum

menopause, breast undergoes atrophy. After tissue

to E. outside Galactorrhea milk oflactation. production refers

1.

of not It a cancer. breast symptom is

2.

prolactinoma drugs. cause), the (common anterior physiologic cause), (common Causes nipple of pituitary stimulation and include pathologic

I. MASTITIS ACUTE

infection of the Bacterial usually due A. aureus to breast, Staphylococcus

B. entry of breast-feeding; the fissures develop Associated in for a route with nipple providing microbes.

breast Presents abscess formation may C. as discharge; purulent progress with erythematous nipple to an

feeding) Treatment dicloxacillin). D. and drainage continued (e.g., involves (e.g., antibiotics

II. PERIDUCTAL MASTITIS

the Inflammation ducts of A. subareolar

B. Usually 1. in pathoma.com smokers seen Relative in A deficiency oflactiferous inflammation. results ducts, vitamin metaplasia squamous and duct blockage producing

a subareolar presents as retraction mass with nipple C. Clinically

III. DUCT ECTASIA MAMMARY

1. (ectasia) with of A. subareolar ducts the dilation Inflammation women arises multiparous in Rare; classically postmenopausal

debris) nipple green-brown (inflammatory B. mass with as discharge a periareolar 1. Presents with is cells Chronic inflammation biopsy. seen on plasma

IV. NECROSIS FAT

breast Necrosis fat of A.

B. may however, of always related not to trauma; history be Usually trauma evident. a

on Presents (due calcification as physical on to C. saponification) abnormal mammography mass or exam a

with necrotic cells. associated shows giant calcifications D. fat Biopsy and

CHANGE I. FIBROCYSTIC

A. the of 1. breast cysts fibrosis Development and in to breast; premenopausal thought common change the in mediated hormone Most be

of as breast'), usually Presents upper outer quadrant in irregularity tissue breast the vague the ('lumpy B.

blue-dome have gross on C. Cysts appearance exam. a

changes with but D. an both risk associated some to invasive applies 1. risk fibrocystic-related increased (increased for are Benign, breasts) carcinoma

apocrine and cysts, metaplasia Fibrosis, (Fig. 2. 16.2)-no risk increased

3.

II. PAPILLOMA INTRADUCTAL

Papillary duct usually A. a into growth, large

B. by and projections cells fibrovascular epithelial Characterized by lined (luminal) myoepithelial

as woman Classically nipple C. a presents discharge bloody premenopausal in

papillary bloody discharge which Must nipple as D. distinguished o•o. from carcinoma, be presents also 0~

O)~",..

·~"-0 0 ... o·. ; • ·••~:?.t,00 ::>i;

Fig. unit. lobular Terminal 16.1 duct Fig. change Fig. apocrine Fibrocystic 16.2 with Fibroadenoma. 16.3 metaplasia.

1.

is cells. Papillary underlying lined projections fibrovascular myoepithelial cells by without characterized epithelial carcinoma by

2.

increases postmenopausal carcinoma in commonly thus, is age; with it women. of more papillary seen Risk

III. FIBROADENOMA

fibrous of tissue and (Fig. glands A. Tumor 16.3)

B. benign neoplasm common breast; of seen premenopausal usually the women Most in

Presents C. as marble-like mobile well-circumscribed, mass a

menstrual may Estrogen cycle painful the pregnancy sensitive-grows during D. and be during

of with risk no carcinoma Benign, E. increased

IV. TUMOR PHYLLODES

(Fig. with Fibroadenoma-like overgrowth seen characteristic tumor of A. biopsy fibrous projections component; on the 'leaf-like' are 16.4).

B. seen in Most postmenopausal commonly women

C. cases some be malignant Can in

I. PRINCIPLES BASIC

A. Most skin incidence common in by cancer) carcinoma women (excluding

B. of common 2nd most cancer cause mortality in women

factors exposure. C. to estrogen related are mostly Risk

1.

2.

cancer. postmenopausal breast hereditary usually in Age-Cancer the women, notable exception of arises with

3.

4.

5.

6.

or relative (mother, with cancer breast First-degree daughter) sister,

II. CARCINOMA SITU (DCIS) DUCTAL IN

cells basement membrane of in proliferation with the no invasion of A. ducts Malignant

B. DCIS usually calcification produce as mammography; does on mass. detected not Often a

1. as associated benign also (especially conditions fibrocystic changes be necrosis. can and with such fat Mammographic calcifications adenosis) sclerosing

Fig. Phyllodes tumor. 16.4 Fig. 16.5 comedo carcinoma in situ, Ductal type.

2. often between benign necessary and distinguish calcifications malignant of is Biopsy to conditions.

of are the center based necrosis calcification characterized cells by with and ducts architecture; subtypes C. Histologic high-grade is dystrophic type comedo in (Fig. on 16.5).

DCIS D. is skin disease the involve that the extends the up Paget the (Fig. to ducts of of breast nipple 16.6).

1.

2. ulceration and Presents erythema as nipple

of Paget with an underlying almost the is disease carcinoma. breast always associated

III. INVASIVE DUCTAL CARCINOMA

structures A. Invasive forms carcinoma that classically duct-like

B. > of 80% carcinoma cases in type the breast, Most common accounting invasive for of

mass by Presents detected by C. physical mammography as 1. or exam a

are cm or 2 detected Clinically masses usually greater.

2.

usually or masses greater. detected are Mammographically 1 cm

3.

or may Advanced skin of result of dimpling the tumors the retraction in nipple.

special D. stroma; desmoplastic Biopsy carcinoma 1. invasive subtypes structures a duct-like include ductal of shows in usually

cells tubules well-differentiated that lack (Fig. carcinoma-characterized Tubular myoepithelial by relatively good 2. 16.7A); prognosis

abundant Fig. extracellular with floating by Mucinous mucus a in cells carcinoma ('tumor carcinoma-characterized pool', mucin 16.7B)

Fig. disease nipple. 16.6 Paget of the Clinical appearance. A, B, Microscopic appearance. of . Taxy, ,';,: Courtesy MD) Jerome (A, ,, -~: ~ . i, :1/

r:. rt·.·

.~!t_ ·~ p.•'l

Fig. carcinoma. 16.7 Invasive ductal A, Tubular carcinoma. ca rcinoma. B, Mucinous

i. women in occur older years) is (average 70 11. Tends to age good Relatively prognosis 3. high-grade i. large, with growing carcinoma-characterized in cells plasma by lymphocytes and associated cells sheets Medullary on Grows a that fibroadenoma well-circumscribed mammography mimic can as ii. mass 111. good Relatively prognosis incidence Increased in carriers BRCAl 4. carcinoma-characterized lymphatics (Fig. in carcinoma Inflammatory dermal by no block ii. of 16.8) swollen mass; discrete acute cells for lymphatics) be inflamed, breast an Presents (tumor as i. drainage with classically mastitis can mistaken Poor prognosis

IV.

the proliferation with lobules in cells membrane of no of A. Malignant invasion basement

not discovered on is B. incidentally a mass LCIS biopsy. or does and produce calcifications usually

dyscohesive adhesion Characterized E-cadherin protein by C. lacking cells

and multifocal D. bilateral Often

E. carcinoma) close carcinoma invasive is to risk Treatment tamoxifen of the of progression (to subsequent risk and low follow-up; reduce

V.

a pattern single-file (Fig. characteristically grows Invasive in carcinoma that A. morphology. may cells 16.9); signet-ring exhibit

1. to No ofE-cadherin. due duct formation lack

VI. PROGNOSTIC PREDICTIVE FACTORS AND

TNM cancer A. breast Prognosis based is staging. in on

1.

most metastasis is important present Metastasis before but factor, most the patients occurs.

2.

Spread assess node used common sentinel metastasis nodes. is biopsy factor presentation); is axillary useful to not prognostic lymph is that at nodes lymph axillary most (given the lymph to

treatment. factors Predictive B. to response predict

1. progesterone (overexpression) factors and HER2/neu are status. estrogen (PR), amplification important Most receptor gene receptor (ER),

Fig. 16.8 Inflammatory carcinoma. appearance. Microscopic A, Clinical B, appearance. (8, Fig. of Courtesy Invasive carcinoma. 16.9 lobular MD) Jerome Taxy, 2.

in both associated Presence antiestrogenic (Fig. PR response nucleus with agents located the are (e.g., tamoxifen); ER receptors of and to is 16.10).

3.

on is antibody amplification present surface to receptor; growth trastuzumab factor HER2 a the with is (Fig. designer directed a receptor response the (Herceptin), against associated HER2/neu cell HER2/neu 16.11).

4.

to carcinoma. and develop women and an propensity African a prognosis; are increased PR, 'Triple-negative' poor HER2/neu have ER, American tumors triple-negative for negative have

VII. BREAST HEREDITARY CANCER

A. cases breast Represents cancer of 10%

B. at patient. features Clinical multiple cancer with multiple tumors first-degree in single early and include relatives age hereditary breast that a breast an cancer, suggest (premenopausal), tumor

hereditary single mutations C. important associated are breast cancer. and most with gene the BRCAl BRCA2 mutations

1.

ovarian mutation associated and with BRCAl breast is carcinoma.

2.

mutation carcinoma associated in breast males. with BRCA2 is

undergo developing to genetic carcinoma. develop of breast to the breasts removal risk to (bilateral cancer a decrease may of both mastectomy) with Women propensity choose D.

1. small into for the or cancer chest subcutaneous breast of wall. axilla extends A because the remains sometimes risk tissue tissue

VIII. MALE CANCER BREAST

A. of all cancer 1 rare is cancers). % males in Breast breast (represents

B. males 1. as a in presents mass subareolar Usually older

in breast underneath density nipple. Highest the males tissue is of

2.

carcinoma. ductal subtype is common invasive C. histological Most

1. develops rare carcinoma lobules). Lobular breast male few is very (the

syndrome Klinefelter D. BRCA2 with Associated and mutations

Fig. 16.10 Estrogen receptor, Fig. HER2/neu stain. amplification, 16.11 immunohistochemical immunohistochemical stain.

DEFECTS TUBE I. NEURAL

A. of closure 1. Arise the incomplete tube neural from

the which gestation form of plate embryo. runs the to along cranial-caudal invaginates the neural early tube, axis in Neural

2.

of wall nervous spinal the crest The the hollow forms neural and forms central the lumen tube and system. nervous tissue, the canal, peripheral the ventricles cord system neural forms

B. folate levels prior to conception Associated with low

C. maternal by blood levels Detected (AFP) during in prenatal the care and alpha-fetoprotein amniotic fluid elevated

Anencephaly of absence neural cranial end the D. of skull (disruption the is the tube). brain of and

1.

'frog-like' to Leads the (Fig. of appearance fetus a 17.1) 2.

is since in polyhydramnios maternal of Results fluid fetal impaired swallowing amniotic

failure caudal vertebral arch the bifida end of Spina is a the (disruption in to defect the E. resulting vertebral neural of tube). of close, posterior

1.

overlying occulta as bifida defect. hair a presents vertebral or the dimple of patch Spina

2.

defect. underlying vertebral protrusion the cystic of with Spina the through tissue bifida presents

ii. Meningocele-protrusion of i. meninges cord spinal meninges and Meningomyelocele-protrusion of

II. CEREBRAL AQUEDUCT STENOSIS

(CSF) stenosis fluid A. from the of ventricle Congenital cerebrospinal that ventricle channel 4th into the drains the 3rd

B. of Leads CSF in of in the cause 1. accumulation space; ventricular common to hydrocephalus most newborns

lining the CSF produced plexus by the is choroid ventricles.

2.

foramen the into of the 3. ventricle lateral Flows via the ventricles interventricular Monro 3rd from

cerebral ventricle 3rd via into from the 4th ventricle Flows the 4. the aqueduct

space subarachnoid the the of from ventricle 4th Magendie and the Luschka foramina via into Flows

C. fused) due lines (cranial suture of head ventricles dilation Presents to circumference enlarging the not with are

Ill. MALFORMATION DANDY-WALKER

A. Congenital develop failure cerebellar to vermis of the

absent dilated ventricle cerebellum 4th with massively Presents (Fig. a B. fossa) (posterior an as often 17.2); hydrocephalus by pathoma.com accompanied

IV. (TYPE ARNOLD-CHIARI II) MALFORMATION

foramen vermis displacement and tonsils magnum of the A. Congenital through cerebellar downward

B. in commonly of Obstruction flow results CSF hydrocephalus.

C. Often with meningomyelocele associated

SYRINGOMYELIA I.

spinal A. cord degeneration Cystic of the

malformation B. a with trauma or association 1 type in with Arnold-Chiari Arises

CS-Tl at C. Usually 1. occurs and distribution)-due to sparing fine position of commissure spinothalamic of like" the of 17.1) the involvement with {Table touch loss upper pain with white in the as dorsal sparing temperature sensory and anterior extremities the of sense Presents ("cape column tract of

of other results to in tracts leading spinal 1. expansion involvement Syrinx D.

weakness 2. to atrophy decreased to anterior of Muscle horn impaired and motor damage neurons tone reflexes-due lower and with the muscle

{Table 17.1) ptosis of anhidrosis the disruption sweating)-due tract {droopy hypothalamospinal Horner pupil), (decreased syndrome eyelid), and horn lateral with of to the (constricted miosis

II. POLIOMYELITIS

A. anterior poliovirus to due motor to horn infection Damage the

neuron (downgoing Babinski with motor tone, fasciculations, atrophy, reflexes, Presents with toes) and decreased muscle signs-flaccid impaired weakness paralysis with negative lower B. sign muscle

III. WERDNIG-HOFFMAN DISEASE

A. autosomal of the anterior recessive motor horn; Inherited degeneration

as a after death within "floppy birth. Presents baby;" B. a occurs years few

IV. LATERAL AMYOTROPHIC (ALS) SCLEROSIS

Degenerative upper lower of of A. (Table 1. motor corticospinal the disorder 17.1) tract and neurons with Babinski with reflexes, and fasciculations, horn lower weakness neuron motor atrophy, leads sign. negative Anterior signs-flaccid impaired decreased degeneration tone, motor paralysis muscle muscle to

Fig. Anencephaly. 17.1 (Courtesy humpath. of Fig. malformation, Dandy-Walker MRI. 17.2 Fig. meningitis, 17.3 gross Bacterial appearance. Robert (Courtesy com) of MD) 2. Heng, and upper Lateral to tone, corticospinal Babinski paralysis degeneration with muscle tract increased positive motor hyperreflexia, signsspastic leads sign. neuron

of Atrophy sign. is early an B. and weakness hands

1. impairment Lack syringomyelia. from ALS of distinguishes sensory

age are adults. arising C. middle Most sporadic, cases in

1. mutation present to in is familial dismutase radical Zinc-copper (SODJ) neurons injury some superoxide leads free in cases;

ATAXIA V. FRIEDREICH

A. and cord Degenerative spinal cerebellum the disorder of 1.

Degeneration of cerebellum leads ataxia. to the

2.

cord of reflexes. Degeneration proprioception, tracts of vibratory and loss to extremities, leads the in of sense spinal multiple weakness muscle lower deep tendon and loss

in of unstable expansion recessive; trinucleotide the (GAA) an B. 1. gene frataxin Autosomal repeat due to damage. for essential loss is mitochondrial regulation; with radical results iron iron free buildup Frataxin in

wheelchair few Presents childhood; in a bound within patients C. early are years.

D. with cardiomyopathy Associated hypertrophic

I. BASIC PRINCIPLES

leptomeninges Inflammation of A. (Fig. the 1. 17.3)

lie Meninges between consist pia) that brain and layers and the (dura, arachnoid, three of the skull.

2.

leptomeninges. arachnoid Pia termed are and together

Tracts 17.1: Table Spinal Cord

crosses and to horn, root commissure, body via to dorsal temperature ascends cortex immediately cell is nerves posterior sensation) ganglion. horn; in posterior Arises Peripheral from Thalamus

to thalamus spinothalamic tract the

medulla, and is via lemniscus via ascends dorsal over, body Arises touch, medial cell root to dorsal in Thalamus thalamus medulla crosses from cortex the (pressure, and column; proprioception) to to ganglion. vibration, lemniscus

cortex cross Pyramidal descend, neurons over in

from anterior the motor Arises

medullary synapses (upper movement) pyramids, horn the the in cord muscle on synapse (None)(voluntary motor horn corticospinal neuron) anterior neuron). and (lower motor on of motor and Lateral

the the the of at on and hypothalamus pupil, the and face superior synapses skin from eyelids, synapses (sympathetic lateral and Tl of on Arises Arises horn input lateral Hypothalamospinal from

B. 1. infectious commonly Most agent an to due

2. Group E (neonates) Listeria coli, and B streptococci, monocytogenes

H (nonvaccinated Streptococcus elderly), pneumoniae infants) influenza and and (adults teenagers), (children N meningitidis and 3.

4.

Presents also with vomiting, be nuchal may C. headache, present. and classic fever; of status rigidity, triad altered mental photophobia, and

D. lumbar of puncture CSF). is (sampling by Diagnosis made

1.

L4 crest). LS by placing Performed between of a needle iliac the (level and S2. space and equina ends cauda continue to subarachnoid but at L2, Spinal cord

2.

Layers skin, ligaments, crossed epidural include dura, arachnoid. space, and

E. 1. CSF findings

causative organism. culture often stain identify glucose; the gram with meningitis-neutrophils Bacterial and 1-CSF

2.

normal 3. Viral meningitis-lymphocytes with glucose CSF

meningitis-lymphocytes glucose with Fungal 1-CSF

bacterial F. are usually with Complications seen meningitis.

1.

cerebral secondary 2. Death-herniation to edema

and fibrosis hearing seizures-sequelae related Hydrocephalus, to loss,

I. PRINCIPLES BASIC

due Neurologic cause morbidity deficit mortality and cerebrovascular A. major to compromise; of

B. of cases) hemorrhage (85% cases) ischemia (15% to 1. Due or of necrosis on are particularly essential an serum 3-5 dependent glucose ischemia susceptible minutes). and within as (undergo source to Neurons energy are

II. GLOBAL CEREBRAL ISCHEMIA

A. Global brain the ischemia to

B. Major 1. etiologies

(e.g., Low 2. atherosclerosis) perfusion

decrease flow (e.g., blood 3. in Acute shock) cardiogenic

anemia) (e.g., Chronic 4. hypoxia

hypoglycemia (e.g., of insulinoma) episodes Repeated

of features duration magnitude based C. on are Clinical and the insult.

1. recovery. confusion transient prompt results with in ischemia Mild global

. Fig 17.4 cortex. infarct, Pale of Robert Fig. (Courtesy 17.5 infarcts. Lacunar MD) Wollmann, Wollmann, 2. MD) Robert of (Courtesy

leads ischemia necrosis; Severe global results survival diffuse 'vegetative in state.' a to 3.

and as global such 5, areas 6)-leads regions cortex to area in fed middle the cerebral (layers the and ii. i. ischemia (e.g., by artery) leads between cerebral necrosis to vulnerable neurons 3, Pyramidal and watershed damage laminar lying anterior regions highly of to infarcts Moderate memory in Pyramidal (temporal of iii. the hippocampus longterm lobe)-important neurons control sensory the perception cerebellum-integrates layer motor of Purkinje with

III. STROKE ISCHEMIC

A. results Regional deficits that > 1. in hours the lasting neurologic to focal 24 ischemia brain (TIA). hours, ischemic symptoms attack event 24 the last < If is termed a transient

lacunar include B. embolic, Subtypes and thrombotic, strokes.

1. stroke rupture due Thrombotic of an is to atherosclerotic plaque.

(e.g., carotid bifurcation branch cerebral in the Atherosclerosis develops at and of Willis). of circle points artery middle internal i. usually

ii. infarct pale of Results the periphery a cortex at in the (Fig. 17.4) 2. to thromboemboli. stroke Embolic is due

1. emboli of of heart (e.g., left fibrillation). Most the source the common is atrial side

ii. the middle Usually cerebral artery involves u1. the infarct hemorrhagic cortex the in of Results a at 3. periphery of hypertension. to complication occurs a Lacunar hyaline secondary stroke arteriolosclerosis,

i. lenticulostriate in Most infarction (Fig. cystic resulting involves small commonly vessels, of areas 17.5) 11. internal leads the capsule a motor stroke. Involvement pure to of u1. to of a pure leads stroke. the sensory Involvement thalamus

Ischemic liquefactive C. necrosis. results in stroke

1.

in Eosinophilic neurons cytoplasm change (red Fig. the of neurons, 17.6A) infarction). hours early finding (12 microscopic an after is

2.

(days 4-7), ensue. and infiltration Necrosis microglial (24 gliosis by hours), and then 2-3) 1-3) neutrophils (days (weeks cells

3.

of space a by fluid-filled Results surrounded cystic (Fig. formation gliosis in , ' i ' . 17.6B) w •> f

Fig. 17.6 infarct. Brain neurons. A, Red Cyst B, formation. Robert (Courtesy MD) of Wollmann,

IV.

A. brain parenchyma Bleeding into

the rupture due lenticulostriate Charcot-Bouchard Classically microaneurysms to B. of of 1. vessels

treatment of hypertension; reduces by of incidence half. Complication hypertension

2.

(Fig. is the common Basal most site ganglia 17.7).

eventual Presents and C. severe nausea, as vomiting, headache, coma

V.

A. into the subarachnoid space (Fig. Bleeding 17.8)

sudden Presents of life") B. headache with ("worst as headache rigidity a nuchal my

due to xanthochromia hue (yellow shows bilirubin). Lumbar C. puncture

Most include causes a AV anticoagulated (85%) frequently D. other aneurysm; state. an due berry malformations to of rupture and

1.

aneurysms Berry outpouchings saccular thin-walled a (Fig. lack that layer media are risk for 17.9), rupture. the increasing

2.

3. artery located communicating anterior frequently in at of circle the branch of Willis anterior points the Most

disease Marfan with Associated syndrome and kidney autosomal dominant polycystic

HEMATOMA EPIDURAL I.

A. between Collection and dura blood skull the the of

bone from to rupture fracture meningeal the Classically due the middle skull. with artery; bleeding the separates temporal B. dura of of the

1.

2.

signs. neurologic Lucid precede may interval

lethal C. Herniation is complication. a

II. HEMATOMA SUBDURAL

A. the dura; surface of of blood blood the (Fig. the brain Collection covers underneath 17.10).

B. tearing between with arises trauma that veins and to 1. arachnoid; Due of lie bridging the dura usually

2.

progressive neurologic Presents with signs

Fig. 17.7 basal lntracerebral Fig. hemorrhage, hemorrhage. 17.8 Subarachnoid of ganglia. (Courtesy Jerome MD) MD) 3. Robert Wollmann, of Taxy, (Courtesy to the veins in stretches cerebral occurrence which age-related elderly due of atrophy, rate Increased the

a lethal Herniation is C. complication.

III. HERNIATION

intracranial brain due of pressure increased Displacement or tissue mass to A. effect

Tonsillar magnum. involves tonsils foramen the displacement of cerebellar herniation B. the into

1. of brain cardiopulmonary to the Compression stem arrest. leads

C. cerebri. the involves of under falx gyrus the herniation cingulate Subfalcine displacement

1. infarction. artery cerebral of the leads Compression to anterior

under Uncal cerebelli. the involves uncus D. displacement herniation temporal of lobe tentorium the

1.

eye nerve a moving (oculomotor) out" "down dilated of and to III Compression pupil. leads and the cranial

2.

to hemianopsia). Compression lobe infarction leads occipital of homonymous of artery cerebral posterior (contralateral

3.

of Rupture (brainstem) the leads to Duret hemorrhage. artery paramedian

I. PRINCIPLES BASIC

efficiency axons, speed improving and the conduction. Myelin of insulates A.

1.

Oligodendrocytes the nervous central system. myelinate

2.

nervous system. Schwann the cells myelinate peripheral

by myelin B. destruction of disorders axons Demyelinating are oligodendrocytes; or are characterized generally preserved.

II. LEUKODYSTROPHIES

A. myelin necessary maintenance for enzymes or in production of Inherited mutations

arylsulfatase recessive); 1. leukodystrophy is most common a deficiency (autosomal leukodystrophy to Metachromatic B. of due disease). Sulfatides the degraded accumulate in oligodendrocytes lysosomes storage (lysosomal be cannot of and

Krabbe deficiency recessive). of disease is due C. a to galactocerebrosidase (autosomal

1. macrophages. accumulates Galactocerebroside in

(X-linked acids coenzyme is addition fatty long-chain to to due impaired A D. of Adrenoleukodystrophy defect).

Fig. Berry 17.9 aneurysm. Jerome (Courtesy of Fig. hematoma. Subdural 17.10 of (Courtesy Fig. Gray multiple 17.11 plaque, sclerosis. Robert (Courtesy Taxy, of 1. Peter MD) MD) MD) Wollmann, Pytel, acids damages Accumulation brain. matter fatty the of glands adrenal and white of

III. MULTIPLE SCLEROSIS

and oligodendrocytes CNS of Autoimmune 1. destruction myelin A.

2. adults of of commonly (20-30 young age); disease more CNS years chronic common women Most in seen

with 3. HLA-DR2 Associated

in from seen the equator regions commonly away More

deficits space). of with remission in periods neurologic B. with and (multiple relapsing time lesions Presents features include 1. Clinical

2.

3.

4.

matter, white unilateral 5. or (cerebral sensation Hemiparesis of periventricular) usually loss

sensation cord) (spinal weakness loss of Lower extremity 6. or

system) (autonomic Bowel, sexual and dysfunction nervous bladder,

puncture. and by MRI is Diagnosis lumbar made C.

1.

of plaques matter MRI reveals (areas demyelination). white

2.

myelin IgG increased bands lymphocytes, resolution oligoclonal electrophoresis, Lumbar on increased and basic puncture with protein. high immunoglobulins shows

examination in Gross gray-appearing white plaques matter D. shows the (Fig. 17.11).

steroids. includes E. high-dose of acute attacks Treatment

1. Long-term treatment with slows of disease. progression beta interferon

IV.

A. death to encephalitis debilitating leading Progressive,

B. by Due of to slowly brain measles the infection persistent virus. progressing,

1. in infancy; (during arise neurologic occurs later childhood). Infection years signs

within neurons (white by matter) C. matter) viral and oligodendrocytes (gray inclusions Characterized

V.

A. JC virus (white infection oligodendrocytes 1. of matter) to of reactivation latent virus. the Immunosuppression leads leukemia) or AIDS (e.g.,

dementia) to with loss, Presents leading death weakness, B. rapidly progressive neurologic (visual signs

VI. CENTRAL MYELINOLYSIS PONTINE

of the brain (anterior demyelination A. Focal pons stem)

B. Due of rapid to intravenous hyponatremia correction 1. (e.g., alcoholics liver severely patients patients disease) Occurs and with malnourished in

C. bilateral as ("locked presents paralysis syndrome) in" acute Classically

I. BASIC PRINCIPLES

A. by Characterized neurons accumulation of neurons protein which the matter; to of loss damages gray often within due

the dementia. leads B. of Degeneration cortex to

of ganglia to Degeneration disorders. basal and the leads movement C. brainstem

II. ALZHEIMER DISEASE (AD)

disease most cortex; A. dementia Degenerative cause of of common

B. Clinical 1. features

with progresses short-term progressive Slow-onset (begins disorientation memory loss long-term and memory 2. loss) and to loss memory

3.

4.

mute common a Patients infection cause of is and death. bedridden; become

5.

early seen neurologic are deficits in disease. Focal not

and (95%) seen elderly. are the cases in Most C. sporadic

1.

with the age Risk after increases age of60). (doubles years 5 every

2.

risk. risk, with is associated E E4 ofapolipoprotein increased allele (APOE) with decreased E2 allele

D. seen Early-onset in is 1. AD

presenilin 2 cases-associated 1 presenilin 2. and Familial mutations with

years Down 40 occurs syndrome-commonly by of age

1. include E. features Morphologic

widening of with the ventricles (Fig. gyri, Cerebral the of the sulci, and dilation atrophy of narrowing 17.12A) 2.

plaques-extracellular entangled comprised (Fig. with core of neuritic A~ amyloid Neuritic processes i. chromosome is derived 21. 17.12B) which (APP), A~ is on amyloid protein coded from amyloid precursor cleavage; cleavage in alpha APP A~ beta undergoes normally amyloid. results

ii. may around hemorrhage. of increasing the also vessels, Amyloid risk deposit

3.

tangles-intracellular hyperphosphorylated (Fig. tau of composed protein aggregates of Neurofibrillary fibers is microtubule-associated 17.12C) Tau protein. a i.

4.

nucleus of of the Loss neurons in basalis cholinergic Meynert

F. is and Diagnosis by correlation. pathological made clinical

1.

Presumptive made excluding clinically other causes. after is diagnosis

2.

III. DEMENTIA VASCULAR

infarction or and hypertension, vasculitis due A. injury atherosclerosis, to Multifocal

B. common of cause most dementia 2nd

Fig. 17.12 Alzheimer disease. Cerebral atrophy. A, plaque. Neuritic B, tangle. Neurofibrillary C, of Jerome Taxy, MD. Courtesy (A, Band MD) Courtesy Pytel, Peter of C,

IV.

and of occipital the temporal lobes frontal A. spares cortex; the and disease Degenerative parietal

B. tau Characterized round bodies) in neurons cortex aggregates (Pick of of by protein the

Behavioral to C. dementia early; and eventually progresses arise language symptoms

V.

in neurons of Degenerative the substantia of (Fig. basal nigra loss A. ganglia dopaminergic the 1. 17.13A,B) basal to initiate pathway ganglia dopamine of Nigrostriatal movement. uses

B. of 2% aging; older to in adults disorder related Common seen

were C. (a illicit cases to etiology; MPTP related Unknown exposure rare historically, in contaminant drugs).

Clinical 1. ('TRAP') D. features

with movement Tremor-pill disappears at 2. rolling rest; tremor

the 3. Rigidity-cogwheel rigidity extremities in

voluntary face 4. movement; expressionless of Akinesia/bradykinesia-slowing

substantia eosinophilic of neurons nigra loss and in Histology (Lewy Fig. the of bodies, pigmented reveals a-synuclein round, E. inclusions 17.13C) in affected neurons.

Dementia feature F. common disease. is a oflate

1. Lewy which features; is Early-onset dementia, body dementia cortical suggestive dementia, bodies. of and by hallucinations histology reveals is Lewy characterized parkinsonian

VI. HUNTINGTON DISEASE

of the A. nucleus Degeneration in the GABAergic (Fig. basal ganglia caudate of neurons 1. 17.14)

2. trinucleotide in (chromosome huntingtin 4) disorder expanded (CAG) Autosomal the dominant gene repeats characterized by

of leads spermatogenesis Further repeats during expansion to anticipation.

with to that is presentation 40 progress and average Presents B. dementia chorea age years. depression; at can

cause C. Suicide is a common death. of

VII. HYDROCEPHALUS PRESSURE NORMAL

A. in CSF dilated resulting Increased ventricles

B. adults; in Can dementia usually cause idiopathic

Fig. 17.13 disease. Parkinson Loss pigmented nigra. in A, substantia of neurons for B, Normal nigra substantia comparison. C, Lewy body. Courtesy MD) (A Robert and of Wollmann, B,

urinary instability, wobbly, and dementia wacky") C. Presents of and as incontinence, gait triad ("wet,

is treatment D. ventriculoperitoneal shunting. Lumbar symptoms; puncture improves

VIII. ENCEPHALOPATHY SPONGIFORM

prion to A. due 1. Degenerative protein disease in neurons (PrPc). Prion configuration is an normally CNS expressed a-helical in protein

B. (PrP'c). conformation to arises Disease a ~-pleated with conversion

1. of disease), Conversion be inherited sporadic, transmitted. or (familial forms can

pathologic vicious not Pathologic form, degradable a and is protein in normal converts cycle. into C. resulting protein the

1. vacuoles glial cells to degeneration, neurons intracellular by (spongy Fig. and is characterized Damage 17.15).

encephalopathy. Creutzfeldt-Jakob (CJD) D. most spongiform disease is common the

1.

rarely (e.g., human exposure to tissue or transplant) corneal human 2. due can growth sporadic; Usually arise prion-infected to hormone

(cerebellar myoclonus dementia startle rapidly and involvement) with associated as progressive Presents ataxia i. waves seen are Periodic EEG. sharp on

ii. 3. usually Results year 1 death, < in in

bovine Variant exposure is related that encephalopathy CJD to special to is disease cow'). of ('mad spongiform a form

E. an response. form characterized disease fatal startle is of severe insomnia and prion Familial by insomnia exaggerated inherited an

I. PRINCIPLES BASIC

A. primary (50%) be or Can metastatic (50%)

gray-white well-circumscribed present Metastatic multiple, characteristically at as tumors junction. the B. lesions

1. sources. are Lung, and breast, kidney common

cell cells, ependymal tumors meningothelial type to origin C. (e.g., astrocytes, classified cells, neuroectoderm). of or are according oligodendrocytes, Primary

adults, are D. In usually supratentorial. tumors primary

1. Most glioblastoma tumors adults meningioma, multiforme, and schwannoma. are in common

primary usually children, are In tumors infratentorial. E.

Fig. 17.14 disease. Huntington nucleus. caudate A, of Degeneration nucleus Normal caudate B, for Fig. Spongiform y. encephalopath 17.15 (Courtesy comparison. Pytel, (Courtesy of Peter Peter 1. of MD) Pytel, MD) ependymoma, medulloblastoma. in common and tumors are pilocytic children astrocytoma, Most

malignant F. are but rarely Primary tumors CNS metastasize. locally destructive,

II. MULTIFORME GLIOBLASTOMA (GBM)

high-grade of tumor Malignant, A. astrocytes

B. primary tumor CNS adults Most in malignant common

hemisphere; callosum arises Usually ('butterfly' cerebral in corpus the C. crosses Fig. characteristically the lesion, 17.16A)

surrounded Characterized of Fig. necrosis (pseudopalisading, D. by tumor by cells regions cell are and proliferation; cells positive. endothelial 17.16B) tumor GFAP

Poor E. prognosis

III. MENINGIOMA

arachnoid Benign cells of tumor A.

B. tumor Most adults in CNS common 1. benign seen children in in women; More rare commonly

invade, present cortex. as seizures; May tumor does C. but not the compresses,

mass reveals Imaging attached the dura. D. to a round

a pattern shows whorled (Fig. E. Histology 17.17); present. bodies psammoma may be

IV.

cells tumor Schwann Benign A. of

B. the cranium, hearing of the loss nerve cranial cerebellopontine frequently cranial angle or as involves within at (presents tinnitus) most VIII nerves; Involves and spinal

C. are cells Tumor S-100+.

are 2. tumors type D. neurofibromatosis Bilateral in seen

V.

Malignant of A. tumor oligodendrocytes

B. present usually with the frontal the a may Imaging tumor reveals calcified matter, white seizures in lobe; involving

appearance cells C. (Fig. on 'Fried-egg' biopsy of 17.18)

VI. ASTROCYTOMA PILOCYTIC

astrocytes Benign of tumor A.

B. tumor CNS in children; in usually the cerebellum arises Most common

(Fig. reveals mural Imaging a cystic C. with a nodule lesion 17.19A).

Fig. Glioblastoma multiforme. 17.16 'Butterfly' A, lesion. B, Pseudopalisading. (Courtesy of MD) Pytel, Peter

D. astrocytes, Rosenthal (thick eosinophilic processes shows Fig. Biopsy of fibers are cells granular and eosinophilic positive. 17.19B) bodies; GFAP tumor

VII. MEDULLOBLASTOMA

granular from A. cerebellum tumor cells the derived Malignant (neuroectoderm) the of

B. in children Usually arises

present. may Homer-Wright be rosettes small, reveals cells; round blue C. Histology

D. Poor rapidly grows prognosis; tumor spreads and CSF. via

1. metastasis.' is to cauda equina Metastasis the termed 'drop

VIII. EPENDYMOMA

Malignant ependymal A. tumor children usually in of seen cells;

B. in ventricle; the Most arises hydrocephalus with 4th may commonly present

are on C. characteristic finding (Fig. Perivascular biopsy a pseudorosettes 17.20).

IX. CRANIOPHARYNGIOMA

remnants arises A. epithelial from ofRathke's Tumor pouch that

to leading chiasm or Presents bitemporal a B. mass compress in as the young hemianopsia may adult; child a supratentorial optic

C. imaging (derived on seen Calcifications commonly are from "tooth-like" tissue).

Benign, resection after recur tends D. to but

Fig. 17.17 Meningioma. Fig. 17.18 Oligodendroglioma. Peter MD) (Courtesy Pytel, of . : ~i'~'.

f, , . ,. l

Fig. Pi locytic astrocytoma. 17.19 with Cystic mural A, nodule. lesion l B, Rosentha fibers. (A, Courtesy Fig. 17.20 Ependymoma. MD) Peter of Pytel,

I. ACHONDROPLASIA

A. cause of plate; dwarfism in cartilage growth common Impaired the proliferation

B. activating (FGFR3); dominant 1. 3 Due in autosomal fibroblast an factor receptor mutation growth to

growth. Overexpression FGFR3 of inhibits

2.

Most age. sporadic are related mutations and increased to paternal

C. Clinical features 1. to with formation not normal-sized endochondral bone formation; affected. head chest-due intramembranous is Short and poor bone extremities

by is which a bones by Endochondral the characterized formation grow. cartilage long which it of by matrix, is formation replaced i. bone; mechanism then is bone

ii. flat mechanism formation develop. (e.g., skull formation cage) bone a and rib matrix; cartilage by without Intramembranous is it by the preexisting is bone of which bones characterized

function, not life fertility span, and are Mental D. affected.

II. IMPERFECTA OSTEOGENESIS

bone structurally formation A. resulting Congenital of defect bone weak in

B. in autosomal synthesis collagen defect due type Most an commonly dominant I to

1. features Clinical C.

bruising of fractures mimic Multiple child but bone 2. is abuse, (can absent)

ofscleral collagen choroidal veins. sclera-Thinning reveals Blue underlying

3.

ear loss-Bones the middle of Hearing easily fracture.

III. OSTEOPETROSIS

A. abnormally of that Inherited bone easily resorption bone thick, heavy resulting fractures defect in

B. poor function osteoclast to Due

genetic mutation anhydrase C. bone required resorption. leads variants the loss of carbonic to for Multiple II exist; acidic microenvironment

features 1. Clinical D. include

2.

with replacement hematopoiesis-due (myelophthisic bony process, marrow Anemia, of leukopenia Fig. and the to thrombocytopenia, extramedullary 3. 18.1)

Vision cranial on hearing impairment-due impingement and nerves to 4.

the Hydrocephalus-due narrowing 5. of men fora magnum to

acidosis-seen tubular with Renal mutation II anhydrase i. carbonic to results ofcarbonic Lack decreased in acidosis. HCO reabsorption of -, anhydrase metabolic leading tubular

osteoclasts monocytes. E. transplant; are derived marrow Treatment is from bone

pathoma.com

IV.

A. of Defective osteoid mineralization 1. then phosphate produce form osteoid, bone. calcium and to normally mineralized is Osteoblasts with which

B. phosphate serum 1. D, Due levels low calcium which low results ofvitamin and in to

Dis skin derived normally diet to Vitamin sunlight (15%). and the (85%) from upon exposure from the

2.

cells -hydroxylation followed proximal kidney. Activation of 1-alphahydroxylation tubule 25 by liver by the requires by the the

3.

calcium i. absorption phosphate of and Intestine-increases ii. iii. and phosphate calcium reabsorption Kidney-increases of phosphate resorption calcium of 4. Bone-increases and

sun diet, with seen (e.g., deficiency poor liver renal failure. northern failure, Vitamin is and D exposure latitudes), malabsorption, decreased

resulting in bone C. is in abnormal Rickets due vitamin to D low mineralization. children,

1. deformity-inward i. the Most children anterior presents protrusion arises Pigeon-breast the commonly 1 age; bending of with of of in year ii. sternum with < ribs -due skull forehead) the (enlarged osteoid on iii. Frontal to deposition bossing Rachi at tic junction to the deposition iv. costochondral rosary-due osteoid ambulating the be children. legs Bowing of seen in may

is adults. to Osteomalacia D. D in due vitamin low

1.

results fracture. in bone mineralization risk with an for Inadequate weak increased

2.

Laboratory include findings --1.-serum t PTH, phosphate, phosphatase. calcium, and t --1.-serum alkaline

V.

A. trabecular mass Reduction in bone

B. for bone with Results porous an increased risk fracture in

and (attained is C. peak mass of of follows in that early on osteoporosis based adulthood) bone Risk thereafter. loss bone rate

1.

diet, (1) (3) and variants), of is genetics years by vitamin on is age D bone Peak based (2) and achieved (e.g., exercise. mass 30 receptor

2.

of each year; lost mass poor decreased more exercise of slightly weight-bearing (e.g., Thereafter, is mass with diet, travel), quickly menopause). less lack bone (e.g., space is than estrogen or lost bone 1%

D. common senile Most of forms postmenopausal. and are osteoporosis

Fig. 18.1 Osteopetrosis. Fig. with (Published bone. of 18.2 disease Paget from permission LearningRadiology.com)

E. Clinical 1. features

and to radius and and height pain (leads fractures in hip, such the of distal kyphosis), 2. loss vertebrae as areas weight-bearing Bone

measured scan. a is Bone density DEXA using

3.

(which calcium, exclude and clinical help labs similar alkaline a has osteomalacia to presentation). Serum are PTH, phosphatase phosphate, normal;

includes Treatment F. 1.

loss Exercise, bone D, calcium-limit and vitamin 2.

of 3. apoptosis Bisphosphonates-induce osteoclasts

not replacement is Estrogen therapy (currently debated recommended).

4.

osteoporosis). Glucocorticoids (worsen are contraindicated

VI. BONE DISEASE PAGET OF

osteoclast osteoblast 1. between function A. Imbalance and seen (average years) age > in adulthood late Usually 60

B. Etiology possibly is viral unknown;

C. more entire the or skeleton bones; does process involving involve one not Localized

stages osteoblastic-osteoclastic, (3) are D. Three osteoblastic. mixed osteoclastic, and (1) (2) distinct

1.

result is that easily. bone thick, sclerotic fractures End

2.

reveals (Fig. a bone of pattern mosaic lamellar Biopsy 18.2).

E. features 1. Clinical

Bone to pain-due 2. microfractures

commonly size-Skull affected. hat Increasing is

3.

4.

bones facies-involvement 5. craniofacial of Lion-like

Isolated patients 40 elevated alkaline in years cause elevated > of old isolated alkaline common phosphatase-most phosphatase

1. includes F. Treatment

2.

apoptosis osteoclasts of Bisphosphonates-induces

Complications include G. 1.

failure-due of bone in High-output shunts cardiac formation 2. to AV

VII. OSTEOMYELITIS

A. and marrow 1. Infection bone of in children Usually occurs

B. 1. spread bacterial; commonly Most arises hematogenous via

Transient bacteremia seeds metaphysis. (children)

2.

epiphysis. seeds bacteremia Open-wound (adults)

1. Causes include C. cases) Staphylococcus of (90% cause common 2. aureus-most

3.

4.

5.

with dog or 6. cat Pasteurella-associated bite/scratches

Clinical D. features 1.

infection with pain Bone leukocytosis) fever and signs of (e.g., systemic 2.

Lytic sclerosis is (abscess) called on focus by of surrounded called sequestrum, sclerosis and lytic x-ray; involucrum. bone focus is

made Diagnosis E. blood culture. is by

_ OF _____________F_U_N_D_AMENTALS PATHOLOGY________.

VIII. NECROSIS (ASEPTIC) AVASCULAR

A. bone bone Ischemic marrow and of necrosis

B. fracture Causes sickle or common), and disease. steroids, trauma (most cell anemia, caisson include

fracture Osteoarthritis complications. and are major C.

I. OSTEOMA

bone A. tumor Benign of

B. facial the surface bones of arises Most on commonly

Associated Gardner C. with syndrome

II. OSTEOID OSTEOMA

tumor produce (that osteoblasts reactive osteoid) Benign bone rim of A. a by surrounded of

B. young in < in Occurs years males) (more ofage 25 common adults

in long of C. cortex bones Arises femur) (e.g.,

pain aspirin that D. resolves with as bone Presents

with 2 bony reveals a E. Imaging a radiolucent mass(< (osteoid). core cm)

2 that F. vertebrae, larger(> aspirin. to presents does as to similar is arises in bone and respond osteoid Osteoblastoma is cm), osteoma not but pain

III. OSTEOCHONDROMA

cartilage an Tumor A. bone overlying with (Fig. of cap common 18.3); most ofbone tumor benign

is (metaphysis); projection a with bone B. lateral plate the the marrow continuous Arises space. from of growth

chondrosarcoma. can to C. transform Overlying (rarely) cartilage

IV. OSTEOSARCOMA

of Malignant A. osteoblasts proliferation

B. the teenagers; 1. seen Peak commonly is incidence elderly seen in in less

factors Risk Paget include exposure. radiation disease, retinoblastoma, and familial

2.

proximal of femur long in (region tibia of the the distal Arises or metaphysis bones, usually the knee)

pain bone or Presents as a with fracture pathologic swelling C.

a Fig. reveals Imaging 'sunburst' triangle, periosteum lifting appearance destructive mass and (Codman D. of with a the 18.4A).

Fig. Osteochondroma. 18.3 of (Courtesy Fig. 18.4 Osteosarcoma. X-ray. A, Microscopic appearance. B, Courtesy of lent Bu (A, Celasun, MD) humpath.com)

E. Biopsy (Fig. osteoid that reveals produce pleomorphic cells 18.4B).

V. CELL TUMOR GIANT

A. multinucleated cells Tumor of and comprised cells stromal giant

B. in young Occurs adults

epiphysis distal proximal knee) of the C. or Arises in bones, of (region usually the the long tibia femur

'Soap-bubble' D. appearance x-ray on

E. aggressive tumor; Locally may recur

VI. SARCOMA EWING

Malignant poorly-differentiated from of neuroectoderm cells A. proliferation derived

ofage) the 15 Arises in male years diaphysis children(< bones; oflong usually B. in

on C. appearance 'Onion-skin' x-ray

(Fig. D. lymphocytes blue round resemble Biopsy reveals cells small, that 18.5).

1.

chronic be with 2. or lymphoma osteomyelitis Can confused

(11;22) is translocation characteristic.

Often E. with chemotherapy metastasis; responsive presents to

Vil. CHONDROMA

Benign tumor cartilage of A.

B. feet small and in the of Usually medulla of hands arises bones (Fig. the 18.6)

VIII. CHONDROSARCOMA

A. cartilage-forming Malignant tumor

pelvis or central medulla B. of in Arises skeleton the

IX. METASTATIC TUMORS

A. than More tumors primary common

B. result osteolytic in Usually (punched-out) lesions 1. carcinoma osteoblastic produces Prostatic classically lesions.

I. BASIC PRINCIPLES

A. between Connection bones two

B. tightly are connected provide to strength (e.g., joints cranial Solid sutures). structural

a motion. joint to Synovial have C. for joints allow space

1. that capsule. (type of made surface bones is Articular is adjoining joint by cartilage ofhyaline a collagen) II surrounded

Fig. Ewing sarcoma. 18.S Fig. Chondroma. 18.6 (Published with ssion from 2. permi LearningRadiology.com) capsule the hyaluronic joint and lining fluid lubricate in smooth acid to joint Synovium rich the secretes motion. facilitate

II. DISEASE (OSTEOARTHRITIS) DEGENERATIVE JOINT

A. degeneration cartilage; of articular Progressive most type of arthritis common

B. Most due 'wear often tear' and to

factor 60 years); include after obesity C. additional and risk trauma. age risk Major factors is (common

spine, fingers a the knees, distal of joints (PIP) and common D. joints joints (oligoarticular); hips, limited (DIP) number interphalangeal lumbar sites. Affects interphalangeal are and lower proximal of

presentation during the that the in E. is morning worsens Classic stiffness joint day.

Pathologic 1. F. include features

of surface Disruption cartilage the that (Fig. articular the lines in mice.' space joint of fragments floating 'joint cartilage the 18.7); are called 2.

Eburnation subchondral the of bone 3.

bony nodes) DIP formation outgrowths); nodes) arises PIP in Osteophyte and (reactive joints fingers (Bouchard the the classically of (Heberden

III. ARTHRITIS RHEUMATOID

A. 1. autoimmune systemic Chronic, disease

in childbearing Classically late arises age of 2. women

Associated with HLA-DR4

B. involvement by 1. Characterized ofjoints

a Hallmark tissue). synovitis (inflamed is leading formation pannus to granulation of

2.

joint and of of destruction ankylosis cartilage to Leads (fusion) the

1. C. features Clinical stiffness morning Arthritis that with improves with activity.

characteristic of of PIP Symmetric involvement deformity), (swan-neck i. elbows, (radial deviation), wrists joints (Fig. the is ankles, and fingers knees 18.8); DIP osteoarthritis). (unlike spared usually is

ii. and osteopenia x-ray. cartilage, narrowing, on are of loss Joint-space seen

2.

and myalgias malaise, 3. loss, Fever, weight

surrounded zone arise organs necrosis and in Rheumatoid 4. epithelioid by visceral histiocytes; of nodules-central skin

be Vasculitis-Multiple organs may involved.

5.

knee cyst-swelling of the bursa Baker behind 6.

fibrosis interstitial Pleural lung lymphadenopathy, effusions, and

Fig. Degenerative 18.7 joint disease. Fig. 18.8 Rheumatoid arthritis. MD, Wikipedia) James (Courtesy of Heilman,

1. findings D. Laboratory

portion against IgM damage tissue of autoantibody factor); Fe 2. disease marker activity ofigG and (rheumatoid

anemia E. of disease and include Complications amyloidosis. secondary chronic

IV.

A. Group 1. characterized disorders ofjoint by

factor Lack 2. of rheumatoid

Axial involvement 3. skeleton HLA-B27 association

sacroiliac joints and spondyloarthritis B. the spine. Ankylosing involves

1.

in often young adults, male Arises most 2.

fusion vertebrae spine'). leading of arises, with back ofvertebral ('bamboo bodies eventually low the pain; Presents involvement to

3.

include and Extra-articular aortic uveitis regurgitation). to (leading manifestations aortitis

and urethritis, triad the C. is Reactive of conjunctivitis. arthritis, characterized arthritis by

1. Chlamydia infection (usually in after males) young a weeks adults Arises trachomatis GI or

in D. of arthritis seen is 10% psoriasis. Psoriatic cases of

1. to affected, and DIP feet fingers axial peripheral joints Involves commonly are most of toes. joints; or "sausage" and the hands leading

V.

usually A. agent, to Arthritis infectious an due bacterial

B. Causes include 1. 2. gonorrhoeae-young adults; most cause common N cause children most aureus-older 2nd and S adults; common

Classically single C. knee involves a joint, usually the

ESR present. white warm motion; count, fever, of D. Presents a with limited range increased joint are elevated as often and

VI. GOUT

especially tissues, monosodium urate A. of Deposition crystals in (MSU) the joints

B. or to related overproduction uric 1. acid Due hyperuricemia; to of excretion decreased kidney. purine excreted acid metabolism Uric is the derived is by and from

etiology most Primary unknown. gout common ofhyperuricemia the is form; C. is

is 1. gout seen D. with Secondary

hyperuricemia. disorders-Increased leads and myeloproliferative Leukemia cell turnover to

2.

phosphoribosyltransferase with retardation mental and Lesch-Nyhan 3. presents syndrome-X-linked deficiency selfmutilation (HGPRT); ofhypoxanthine-guanine

of Renal renal uric insufficiency-decreased acid excretion

exquisitely of as great gout presents (podagra) arthritis E. 1. toe painful the Acute

inflammatory MSU deposit an crystals triggering in reaction. joint, the acute

2.

precipitate consumption arthritis. Alcohol may meat or of

to Chronic leads 1. gout F.

uric tissue giant soft the fibrosis aggregates of crystals and tophi-white, Development reaction and in chalky with cell joints of (Fig. acid 18.9A) 2.

Renal failure-Urate crystals nephropathy). (urate kidney may in tubules deposit

fluid synovial G. negative hyperuricemia; crystals under polarized needle-shaped include light with findings Laboratory birefringence (Fig. shows 18.9B).

(CPPD); clinically, crystals dihydrate Pseudogout birefringence rhomboid-shaped gout polarized synovial is light. due calcium positive weakly with shows resembles to under but H. fluid of pyrophosphate deposition

I. DERMATOMYOSITIS

A. skin skeletal the and of muscle disorder Inflammatory

B. gastric some etiology; cases are (e.g., carcinoma carcinoma). with Unknown associated

features C. 1. Clinical

proximal Bilateral disease. can distal weakness; develop involvement in muscle late

2.

upper seen. may eyelids Rash rash of the also malar rash); (heliotrope be

3.

elbows, papules) (Gottron knuckles, papules on and knees Red the

1. findings D. Laboratory

2.

3.

T on atrophy (CD4+ with biopsy cells) inflammation (Fig. perifascicular Perimysial 18.10)

Treatment corticosteroids. is E.

II. POLYMYOSITIS

A